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The carotid body (CB) is a small-paired organ sensitive to changes in 
blood PaO2, PaCO2 and pH. Type I (glomus) cells of the CB, the sensor units, 
detect the stimulus and release neurotransmitters. These neurotransmitters bind 
either to pos-synaptic receptors in the terminals of the carotid sinus nerve (CSN) 
to trigger the hyperventilatory reflex, or to pre-synaptic receptors located in cells to 
modulate their activity. These receptors can be ionotropic or metabotropic; the 
later are coupled to transmembrane adenylyl cyclases (tmAC). The exact 
mechanism by which changes in O2/CO2 are detected in the CB is not fully 
understood, but changes in cAMP levels have been associated with the O2/CO2 
transduction mechanism of this organ. cAMP levels are regulated by their 
synthesis via two types of adenylyl cyclase: neurotransmitter-sensitive 
transmembrane (tmAC) and bicarbonate sensitive-soluble adenylate cyclase 
(sAC), and by their hydrolysis mediated by phosphodiesterases (PDE). The work 
present in this dissertation was aimed to investigate the role of cAMP in the rat CB 
chemotransduction mechanisms, how specific is cAMP signaling pathways in the 
CB mainly in different CO2 conditions, and to determine whether the enzymes that 
participate in cAMP signal transduction in the CB are regulated by O2/CO2. To 
achieve this aim we characterized pharmacologically PDE4 in the CB and non-
chemoreceptor tissues and studied the effects of acute hypoxia on the cAMP 
accumulation induced by PDE inhibitors.  Concentration-response curves for the 
effects of a non-specific (IBMX) and specific PDE2 and PDE4 inhibitors (EHNA, 
Rolipram and Ro 20-1724, respectively) on cAMP levels were performed in 
normoxic (20%O2/5%CO2) and hypoxic conditions (5%O2/5%CO2).  We further 
explored the characterization of PDEs in the superior cervical ganglia (SCG) using 
FRET-based sensors in primary dissociated neurons in the presence of non-
specific (IBMX) and specific PDE3 and PDE4 inhibitors (milrinone and rolipram, 
respectively). Additionally, we assayed for changes in PDE3A-B and PDE4A-D 
xvi  
expression using qRT-PCR in whole SCG, under different O2 tensions. We also 
characterized the cAMP synthesis pathway in the CB under different 
concentrations of HCO3/CO2. Our work was focused on the characterization of 
sAC, an enzyme activated by changes in HCO3/CO2, in the CB and peripheral non 
chemoreceptor tissues (SCG and petrosal and nodose ganglia). We also 
compared the relative contribution of tmAC and sAC to the CO2-sensing 
mechanism in the CB.  The experiments assayed for changes in sAC and tmAC 
mRNA expression (qRT-PCR), cAMP levels (ELISA), activation of protein kinase 
A (PKA, FRET-based sensors in type I cells) and carotid sinus nerve activity 
(recording) in the presence and absence of activators or inhibitors of sAC, tmAC 
and PKA. Lastly, we investigated sAC and tmAC expression and activity in central 
chemoreceptors (locus coeruleus, raphe nuclei and the ventrolateral medulla) and 
compared the role of these enzymes in these tissues and CB.  
The main findings of this work were: 1) PDE4 isoforms are functional in 
rat CBs, SCG and carotid arteries (CA), while PDE2 is only functional in the SCG; 
2) The effects of PDE inhibitors on cAMP accumulation were increased by acute 
hypoxia in both CB and CA, but reduced in the SCG; 3) a differential pattern of 
PDE regulation in the SCG was observed that potentially represents 
subpopulations of ganglion cells with different physiological functions; 4) sAC is 
ubiquitously expressed and functional in CB and central chemoreceptors, but 
apparently does not mediate a role in hypercapnia sensing; instead sAC activity 
seems to be maximal under normocapnic conditions; 5) tmAC and sAC apparently 
contribute more to cAMP accumulation when situations of low HCO3/CO2 occur; 6) 
Inhibition of tmAC activity decrease the CSN discharge in the same extent 
between normocapnic and hypercapnic conditions; 7) The sensibility of the CB to 
CO2 seems to be mediated by pH.  
Taken together, our results suggest that cAMP has a role in the 
homeostasis of the CB, and it is not a specific mediator of hypoxia/hypercapnia 
transduction of this organ. The O2/CO2 regulation of the enzymes studied in this 






increases in cAMP described by others in hypercapnic conditions are not 








O corpo carotídeo (CB) é um pequeno órgão sensível a variações na 
PaO2, PaCO2 e pH. As células tipo I (células glómicas) do corpo carotídeo, as 
unidades sensoriais deste órgão, libertam neurotransmissores em resposta às 
variações dos gases arteriais. Estes neurotransmissores atuam em recetores 
pós-sinápticos localizados nas terminações do nervo do seio carotídeo (CSN) 
desencadeando hiperventilação, ou em recetores pré-sinápticos localizados nas 
células do CB, modulando assim a atividade deste órgão. Estes recetores podem 
ser classificados em ionotrópicos ou metabotrópicos, estando estes últimos 
acoplados a adenilatos ciclases transmembranares (tmAC). O mecanismo exato 
pelo qual as variações dos gases arteriais são detetadas pelo CB ainda não está 
completamente elucidado, mas tem sido sugerido que as alterações nos níveis de 
cAMP estejam associadas ao mecanismo de deteção de variações de O2 e CO2. 
Os níveis de cAMP podem ser regulados pela sua via de síntese, mediada por 
dois tipos de adenilatos ciclases: tmAC sensível aos neurotransmissores e 
adenilato ciclase solúvel (sAC) sensível a variações de HCO3/CO2; e pela sua via 
de degradação mediada por fosfodiesterases.  
Os principais objetivos do presente trabalho foram, em primeiro lugar, 
esclarecer o papel da via de sinalização do cAMP no mecanismo de 
quimiotransdução do CB de rato; foi igualmente nosso propósito investigar qual a 
especificidade da via de sinalização do cAMP no CB em resposta a diferentes 
concentrações de CO2 e, por fim, determinar se os enzimas que participam na via 
de transdução de sinal do cAMP são reguladas por O2/CO2. 
Com este intuito, caracterizamos farmacologicamente a PDE4 no CB e em 
tecidos não quimiorecetores e, observámos o efeito de hipóxia aguda na 
acumulação dos níveis de cAMP, induzidos pelos inibidores de PDEs. Foram 
elaboradas curvas de dose-resposta para os efeitos de inibidores, não 
específicos (IBMX) e específicos para a PDE2 e PDE4 (EHNA, Rolipram e Ro 20-
1724), nos níveis de cAMP acumulados, em situações de normóxia 
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(20%O2/5%CO2) e hipóxia (5%O2/5%CO2). Foi aprofundada a caracterização das 
PDE no gânglio cervical superior (SCG) utilizando-se a técnica de FRET em 
culturas primárias de neurónios na presença de inibidores não específicos (IBMX) 
e específicos para a PDE3 e 
PDE4 (milrinone e rolipram, respetivamente). Foram ainda estudadas as 
alterações na expressão de PDE3A-B e PDE4A-D em resposta a diferentes 
percentagens de oxigénio no SCG através de RT-qPCR. Caracterizámos a via de 
síntese do cAMP no CB em resposta a variações na concentração de HCO3/CO2. 
Esta componente do trabalho baseou-se na caracterização da sAC, um enzima 
regulado por HCO3/CO2, no CB e em tecidos não quimioreceptores periféricos 
(SCG, gânglio petroso e gânglio nodoso). Foi ainda comparada a contribuição 
relativa da tmAC e sAC no mecanismo de sensibilidade ao CO2 no CB. Para o 
efeito, foram estudadas as alterações nos níveis de expressão de sAC e tmAC 
(RT-qPCR), nos níveis de cAMP (ELISA), na ativação da proteína cinase A (PKA, 
FRET baseado em sensores) e na atividade do CSN (registos) na presença e 
ausência de ativadores e inibidores das AC, tmAC e PKA. Por último, a 
expressão e actividade da sAC e da tmAC foram estudadas em tecidos 
quimioreceptores centrais (locus ceruleus, rafe e medula ventro-lateral) e não 
quimioreceptores (córtex), comparando a sua actividade com a observada no CB.  
O nosso trabalho teve os seguintes resultados principais: 1) PDE4 está funcional 
no corpo carotídeo, SCG e artérias carótidas (CA) de rato, embora a PDE2 só se 
encontre funcional no SCG; 2) Os efeitos dos inibidores de PDE nos níveis de 
acumulação de cAMP foram exacerbados em situações de hipóxia aguda no CB 
e CA, mas foram atenuados no SCG; 3) No SCG, diferentes tipos de células 
apresentaram uma caracterização específica de PDEs, sugerindo uma 
subpopulação de células no gânglio com funções fisiológicas distintas; 4) sAC 
encontra-se expressa e funcional no CB e nos quimiorecetores centrais (locus 
coeruleus, rafe e medula ventrolateral), mas não desempenha qualquer papel na 
deteção de situações de hipercapnia; no entanto a sua actividade parece ser 






contribuição para o aumento dos níveis de cAMP em condições de baixos níveis 
de bicarbonato e CO2; 6) A inibição da atividade da tmAC diminui a frequência de 
descarga do CSN de forma identica quer em condições de nomocapnia quer de 
hipercapnia; 7) A sensibilidade do CB às variações de CO2 é provavelmente 
mediada por variações de pH.  
 Em conclusão, os resultados obtidos neste trabalho sugerem que o 
cAMP tem um papel importante na homeostase do CB, mas que não é um 
mediador específico da transdução à hipóxia e hipercapnia neste orgão. A 
regulação por alterações nos níveis de O2/CO2 dos enzimas estudados neste 
trabalho, e que envolvem a via de sinalização do cAMP, não é específica do 
corpo carotídeo. O presente trabalho demonstrou ainda que os aumentos de 
cAMP, induzidos por condições de hipercápnia, descritos na literatura, não se 




































































































 Organisms closely maintain the partial pressures of oxygen (PaO2) and 
carbon dioxide (PaCO2) in arterial blood within a narrow range in order to maintain 
homeostasis. Small changes in PaO2 and PaCO2 are rapidly detected by 
specialized chemoreceptors that mediate reflex responses to adjust the levels of 
these gases in the blood within the physiological range. Thus, understanding the 
O2 and CO2 transduction and regulation mechanisms of these chemoreceptors is 
of clinical relevance. Although many advances have been made in the recent 
decades, the specific molecules and processes modulating chemotransduction 
are not yet fully understood. 
 
 Oxygen (O2) is fundamental to the survival of mammalian cells. O2 enters 
in the lungs and passes into the alveoli, and diffuses into the bloodstream in 
exchange for CO2. O2 is transported in the blood by hemoglobin or dissolved in 
plasma at a PaO2 of 100 mmHg in most mammalian species, and diffuses into 
systemic tissues in exchange for the CO2 produced in the cell. Once in the cell, O2 
is required directly as the final electron acceptor in the mitochondrial electron 
transport chain, a series of electron carriers embedded in the eukaryotic 
mitochondrial membrane. Through a series of redox reactions, high-energy 
electrons are passed from cofactors nicotinamide adenine dinucleotide (NADH; 
reduced form) and flavin adenine dinucleotide (FADH2; reduced form) to O2. In this 
process, an electrochemical proton (H+) gradient is generated and used to 
synthesize adenosine triphosphate (ATP), the energy currency of the cell, and 
energy-rich organic substrates are broken down into CO2 and water (H2O). CO2 
diffuses readily from cells into the bloodstream, where it can combine with H2O to 
form carbonic acid (H2CO3), which dissociates to liberate a H+ and a bicarbonate 
ion (HCO3-) through the following reaction catalyzed by carbonic anhydrases 
(CAH, EC 4.2.1.1): 
CO2+ H2O <-----> H2CO3<-----> HCO3-+ H+ (1) 
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Cells actively transport H+ and HCO3- across their cell membranes to 
maintain constant intracellular pH (pHi), and to buffer intracellular and extracellular 
fluids. The physiological level of HCO3- in the blood in healthy individuals is 24-27 
mmol/L; higher levels reflect metabolic alkalosis, while lower concentrations are 
indicators of metabolic acidosis. Under normal conditions, CO2 is dissolved in the 
blood at a PaCO2 of approximately 35-45mmHg (4.6-5.9% CO2), the range at 
which CO2 diffuses from the blood into the alveoli in exchange for O2.  
 Hence, the exchange of the blood gases between the alveoli and the 
blood continuously supplies O2 to the cells and reduces CO2 to maintain 
homeostasis. This mechanism is regulated by peripheral and central 
chemoreceptors that send input to the respiratory center in the brainstem to adjust 
ventilation and to maintain the arterial blood gases within a physiological range.  
 
Control of breathing: A role of peripheral and central chemoreceptors 
 In mammals, classic O2-sensitive chemoreceptors are found in the 
peripheral nervous system: the carotid (CB) and aortic bodies. Both organs trigger 
hyperventilation in response to hypoxia (decrease in PaO2), although the major 
contributor to hypoxia-induced hyperventilation is the CB (for a review  (Gonzalez 
et al., 1994). More recently, evidence for O2 sensitivity has been reported in the 
central nervous system (CNS) in the C1 sympathoexcitatory region of the rostral 
ventrolateral medulla, hypothalamus, pre-Botzinger complex (preBotC) and 
nucleus tractus solitarius (nTS) (for a review (Neubauer and Sunderram, 2004).  
 CO2-sensitive chemoreceptors are present primarily in the CNS 
(brainstem). However, specialized cells within the CB also depolarize in response 
to changes in CO2/H+, a mechanism that appears to be faster and important in 
initiating the central CO2 sensitivity mechanism (Smith et al., 2006).  
 The contents of this thesis are devoted to the cellular features of the CB, 

































Peripheral chemoreceptors- Carotid body 
 
 The CB is a small (≈ 40 μg wet weigh and 600 μm length in the rat,  
(McDonald, 1980) and heterogeneous organ composed of type I (glomus or 
chemosensitive units) and type II (sustentacular) cells, afferent and efferent nerve 
endings, blood vessels and connective tissue (Figure 1A). Type I cells are the 
primary sensory element within the CB. Type II cells have a glial-like function and 
it has been shown that these cells may be dormant stem cells, which proliferate in 
response to hypoxia and differentiate into new type I cells (Pardal et al., 2007). 
Recently it has been proposed that type II cells may function as ATP amplifiers 
during chemotransduction via activation of pannexin-1 (a gap junction like protein) 
and P2Y2 receptors (Zhang et al., 2012). 
 The CB is strategically located bilaterally in the bifurcation of the common 
carotid artery (Figure 1B), the artery that provides the main oxygenated blood 
supply to the brain. The arterial blood flows into the CB through a short artery, a 
branch of the internal or external carotid artery, which ends in a dense capillary 
network that supplies a large flow of blood into the organ. Thus, the CB quickly 
detects changes in PaO2 and responds to hypoxic (low PaO2) conditions. 
When type I cells detect decreases in PaO2 they activate a transduction 
mechanism (in more detail in Chemotransduction mechanisms for O2 and CO2 in 
the carotid body) that involves calcium (Ca2+) entry and release of multiple 
neurotransmitters. There are a large variety of neurotransmitters released from 
these cells (Table 1). Once in the synaptic cleft, the neurotransmitters activate 
receptors located on type I cells (pre-synaptic receptors), on afferents of the 
carotid sinus nerve (CSN) (post-synaptic receptors), or both. There are different 
types of metabotropic and ionotropic pre- and post-synaptic receptors 
characterized in the CB that have excitatory or inhibitory effects (Table 2).  The 
activation of excitatory post-synaptic receptors is translated into an increase of 
CSN action potential frequency with subsequent depolarization of petrosal 
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ganglion (PG) neurons and resultant depolarization of a group of specific neurons 
in the NTS in the brainstem. 
 
Figure 1 - Carotid body (CB) peripheral chemoreceptors. A) Representation of the histological structure of 
the CB representing the four principal components of this organ: type I cells (1) grouped in clusters and 
surrounded by type II cells (2), sensory nerve endings (3) originated from the carotid sinus nerve and capillaries 
(4). Synaptic vesicles (5) are a characteristic of type I cells. The CB also contains a large fraction of connective 
tissue. B) Representation of the carotid artery bifurcation. The CB is at the bifurcation, innervated by sensory 
fibers originated in the petrosal ganglion via the carotid sinus nerve. The superior cervical ganglion also 
innervates the CB via ganglioglomerular nerves. (Figure adapted and modified by Gonzalez et al., 1992, 
Ichikawa, 2002).  
The activation of excitatory pre-synaptic receptors (also called autoreceptors) 
induces an increase in intracellular Ca2+, [Ca2+]i, and subsequent release of other 
neurotransmitters/ neuromodulators from the CB that can thus bind to excitatory 
or inhibitory receptors  (e.g. the effect of Ach reviewed in  (Shirahata et al., 2007)).  
Although some of the neurotransmitters are shown to be important mediators of 
hypoxic sensitivity, they may also be responsible for the transduction of other 
stimuli in the CB (for a review, (Gonzalez et al., 1994)). The CB not only senses 
changes in PaO2, but in PaCO2, pH and glucose, cytokines, circulating hormones, 
extracellular ions (K+), osmolarity and temperature, thereby acting as a polymodal 
receptor  (Gonzalez et al., 1994, Kumar, 2009).  The excitatory/ inhibitory effect on 
the CSN activity of the neurotransmitters released can vary between species (e.g. 
dopamine exerts inhibitory effects on the CB in most species, except rabbit,  
















































SP + + + +  Cat, guinea pig, rat, monkey, feline, 
rabbit, canine 
1 
NA + +    Cat 2 
ENK + +    Cat, rat, rabbit, piglet, dog, human 3 
NY + +    Rat, 4 
ANP +     Cat, human 5 
GA + + +   Guinea pig, monkey, rat, chicken 6 
CCK +     Dog, human 7 
VIP + +  ,  Cat, rat, dog, pig, monkey, human 8 
CGRP  + +   Mammals, birds and amphibious 9 
AM +     Rat, human 10 
NTSin +     Human and experimental animals 11 
ST  +    Chicken, guinea pig, amphibious 12 
BO    +  Human 13 
AT II +   +  Rat 14 














DA +  + +  All mammalian species 16 
NE + + +   Mouse, rat 17 
ADO    +  Rat 18 
5-HT      Human, rat, mouse, chicken 19 
GABA +     Mouse, cat, rat 20 
Ach +   +  Cat, rat, rabbit, cat 21 
ATP +     Cat 22 
NO     + Rat, cat 23 
CO +     Rat, cat 24 
NP, neuropeptide; NT, neurotransmitter; NM, neuromodulator; TIC, type I cells; CA, carotid artery; PG, petrosal ganglia; CB, 
whole carotid body; G, glossopharingeal nerve; SP, Substance P; NA, Neurokinin A; ENK, Leu- and Met- enkephalins; NY, 
Neuropeptide Y; ANP, Atrial natriuretic peptide; GA, Galanin; CCK, Cholescystokinin; VIP, Vasointerstinal peptide; CGRP, 
Calcitonin Gene-related peptide; AM, Adrenomedullin; NTSin, neurotensin; ST, Somatostatin; BO, Bombesin; ATII, Angiotesin II; 
KISS, Kisspeptin1; DA, Dopamine; NE, Norepiniphrine; ADO, Adenosine; 5-HT, Serotonine; GABA, gamma-aminotutyric acid; 
Ach, Acetylcholine; ATP, adenosine triphosphate; NO, nitric oxide; CO, carbon monoxide. 
References: 
1-for a review see Heym and Kummer, 1989; 2-Prabhakar et al, 1989; 3- for a review see Porzionato et al, 2008; 4- Oomori et al, 
1991, 2002; 5-Wang et al, 1991,Benvenuti et al, 1996; 6- for a review see Porzionato et al, 2008, Heym and Kummer, 1989; 7- 
for a review see Porzionato et al, 2008, Heym and Kummer, 1989; 8- for a review see Heym and Kummer, 1989, Smith et al, 
1990; 9-for a review see Porzionato et al, 2008; 10- Martinez et al, 2003; Porzionato et al, 2006; 11- for a review see Porzionato 
et al, 2008; 12- for a review see Porzionato et al, 2008; 13- Smith et al, 1990; 14- Lam and Leung, 2002; 15-Porzionato et al, 
2011; 16- For a review see Gonzalez et al, 1994; 17- Oomori et al. 1994; Christie and Hansen, 1983; 18- Conde et al, 2004; 19- 
Perrin et al, 1986; Oomori et al, 1994; Kameda et al, 1990; 20-Oomori et al. 1994; Igarashi et al, 2009;  Fearon et al, 2003; 21-
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The expression and activity of specific neurotransmitters and their receptors 
changes with postnatal development (Bairam and Carroll, 2005), and can 
influence CB function during development. 
CO2 central chemoreceptors 
 
 The central chemoreceptors mainly sense changes in CO2/pH in the 
brain. The levels of CO2/pH in the brain are determined by changes in PaCO2 that 
occur when alveolar ventilation decreases with a constant rate of CO2 production 
in the tissues, or vice-versa. The arterial blood reaches the brain through the 
carotid and vertebral arteries. Since the CB is located at the bifurcation of the 
carotid artery, this organ detects changes in PaCO2 quicker than the brain and 
modulates the central chemoreceptors sensitivity. The carotid and vertebral 
arteries supply blood to the surface of the ventral medulla and send penetrating 
dorsal branches deep into the tissue, where some central CO2 chemoreceptors 
have been identified: surface of the ventrolateral medulla (VLM), the raphe nuclei 
(RN), the retrotrapezoid nuclei (RTN), the preBötC, the locus coeruleus (LC), and 
the NTS (reviewed in(Nattie, 1999)) (Figure 2). Since CO2 is highly diffusible, 
when PaCO2 rises, it easily crosses the blood brain barrier (which is relatively 
impermeable to H+ and HCO3- ions) and diffuses (from the cerebral blood vessels) 
into the cerebrospinal fluid (CSF), changing the pH. In this sense, the central 
chemoreceptor neurons predominantly sense alterations in pH in response to 
CO2, (i.e., CO2/H+ sensing,  (Lahiri and Forster, 2003, Putnam et al., 2004)). 
However, evidence supports the existence of direct CO2 sensors, which have 
been demonstrated in the LC and the VLM (Filosa and Putnam, 2003). The levels 
of CO2 in the brain are also influenced by the rate of CO2 production in the 


















































































































































































































































































































































   
   


















































































   




















































































































































































































































































































































































































































   
   






























































































































































































a) Mainly inhibitory, occasionally excitatory (rabbit; Iturriaga et al, 2004); b) Although in rat there is less characterization of these 
receptors, in other species, cat and rabbit, the nAchR α3,4,5,7, and ß2,4 are present in type I cell, α7 in the CNS afferents and 
α3,4,7, and ß2,4 in PG; the mAchR M1 and M2 are in type I cells, M1 in CSN afferents and M1 and M2 in PG neurons (for a 
revision, Shirahata e tal, 2007);  
?, suggested, but no direct evidences; Gs, G protein stimulatory; Gi/Go, G protein inhibitory; AC, adenylyl cyclase; PLA2, 
phosholipase A2, PLC, phospholipase C, PLD, phospholipase D, PIP2, Phosphatidylinositol4-5-biphosphate; IP3, Inositol 
triphosphate; DAG, Diacylglycerol, D, (+) excitatory, (-) inhibitory; DA, dopamine; NE, norepiniphrine, Ach, acetylcholine, ATP, 
adenosine triphosphate, ADO, adenosine, 5-HT, serotonine, PG, Petrosal ganglia; SCG, Superior cervical ganglia; CB, carotd 
body.  
Ref: 1 Bairam et al, 1998; Bairam et al, 1997; Czyzyk-KrZeska et al, 1992, Kahlin et al, 2010, Fagerlunde et al, 2010; 2- Bairam 
et al, 1997; Czyzyk-KrZeska et al, 1992, Kahlin et al, 2010, Fagerlunde et al, 2010; 3- Gauda 2002; Almaraz et al.1997; Kou et 
al., 1991.; 4- Mir e tal, 1983; 5- Bairam et al, 2006; 6- Bairam et al, 2006; 7-Meza RC, 2010, 2012; Niane et al, 2009; Zhong and 
Nurse, 1997; He et al, 2005; Gauda, 2002; Conde and Monteiro, 2006; 8- Bairam et al, 2007; 9- Kahin et al, 2010; 10- Ferlunger 
et al, 2010; 11- Prasal et al 2000, Fagerlun et al, 2010; Bairam et al, 2007; Rong et al, 2003; 12- Xu et al, 2005; 13- Xu et al, 
2003; 14- Gauda et al, 2002; 15- Rocher et al, 1999; 16- Kobayashi et al, 2000, Fagerlung et al, 2010; 17- Kobayashi et al, 2000; 
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There is some controversial with the role of histamine: while some considered that it is an excitatory NT in type cells, others 
(Burlon et al, 2009) do not, considering that the excitatory effect may be mediated by terminal afferents; c) EPOR contains a 
number of of phosphotyrosines that are phosphorylated by JaK2 and serve as docking sites for a variety of intracellular pathway 
activators and Stats; d) TrKB has the highest affinity to the binding of brain-derived neurotropjic factor (BDNF) and NT4. TrKB 
receptor is a tyrosine knase family receptor; ??, suggested, but no direct evidences; GABA, gamma-aminobutyric acid, ENK, 
enkephalins, SP, substancia P, ET, endothelin 
Ref: 21- Lazarov et al, 2009; Del Rio et al, 2008; 22- Del Rio et al, 2008; 23- Lazarov et al, 2009; Del Rio et al, 2008; 24- Gauda 
et al, 2002; 25- Chen et al, 2002; 26- Lam et al, 2009; 27- Porzionato et al, 2008; 28- Porzionato et al, 2011; 29- Lam et al, 2008; 
Wang et al, 2002, 2007; 30- Fernandez et al, 2011; 31- Fernandez et al, 2011; 32- Porzionato et al, 2011; 33- Fung et al, 2001; 



































 Some areas of the cerebellum, hypothalamus and midbrain have also 
been identified as areas with chemoreceptor properties (Nattie, 1999) (Figure 2). 
It has also been demonstrated that glia cells in the brain also detect changes in 
CO2 /H+(Erlichman and Leiter, 2010).   
 These central chemoreceptor sites have specific characteristics that are 
presented in Table 3. The putative contribution of these putative regions to the 
overall ventilation may depend on the stimulus intensity, neurotransmitter content, 
arousal state, maturation and gender (Table 3; Nattie, 1999).  
 
 
Figure 2 - CO2 central chemoreceptor localization. LHA, lateral hypothalamus;  DR, dorsal raphe; FN, fastigial 
nucleus; 4v, fourth ventricle; LC, locus coeruleus; 7N, facial nerve; cNTS, caudal nucleus tractus solitarious; 
AMB, ambiguous; VII, facial nucleus; SO, superior olive; PBC, pre-Botzinge complex; rVRG, rostral ventral 
respiratory group; cVLM, caudal ventrolateral medulla; RTN/pFRG, retrotrapezoid nucleus/parafacial respiratory 
group; and Pn, pons. Adapted from Nattie and Li, 2012. 
 
Changes in CO2 are closely linked to changes in O2. Although the main 
O2 sensors are located in the peripheral chemoreceptors in the CB, as previously 
mentioned, some central regions also have been identified as O2-sensitive sites 
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Table 3- Characteristics of the central CO2 chemoreceptors 
CO2 site Location 
Neuron 
type 
CO2 maturation Stimuli 
RTN 
Located 130-230 µm from 
the ventral surface of the 
medulla and in the marginal 
glial layer 
Glutaminergic 
Fully developed at birth and 
does not change during the 





Medullary raphe located in 
close proximity to the VLM 
surface, while the dorsal 
raphe is found at the 
surface of the midbrain 
Serotonergic 
Increase in neurons 
responsive to hypercapnia 
during the 1st two weeks. 
(Wang et al, 1999) 
pH 




Located at the ponto-
medullary border, 
underneath the 4th ventricle 




No activation in newborn 
(Wtckstrom et al, 2002); 
mature electrophysiological 
responses on Postnatal day 
(P)1 (Struden et al 2001) 
and reduction of sensitivity 
and magnitude of the 
chemosensory responses 




Located superficially in the 
dorsal medulla and 
surrounds the 4th ventricle 
Glutaminergic 
Fully developed at birth 




Site of the inspiratory 
rhythm generation 
Glutaminergic N/A pH 







Lateral region of the 
hypothalamus 
Orexinergic N/A pHe 
(Adapted from Hempleman and Pilarski, 2011; Huckstepp and Dale, 2011.) 
Integration of peripheral, central chemoreceptors and respiratory 
neurons 
Breathing is tightly regulated by peripheral and central chemoreceptors, 
which modulate the activity of the respiratory neurons (Figure 3).  As stated by 
Smith and co-workers (Smith et al., 2010), “… central and peripheral 
chemoreceptors are not functionally separate but rather that they are dependent 
upon one another such that the sensitivity of the medullary chemoreceptors is 
critically determined by input from the carotid body chemoreceptors and vice 
































 The excitatory neurotransmitters released by CB type I cells evoke action 
potential discharge in CSN fibers, which projects to the central pattern generator 
in the brainstem. The chemo afferents terminals contain glutamate, which binds to 
NMDA and non-NMDA receptors on second order neurons in the commissural 
subnucleus of the NTS, a CO2 central chemoreceptor area, which contains dorsal 
respiratory group neurons (DRG)  (Vardhan et al., 1993) (see Figure 3C).   The 
DRG neurons consist mainly in inspiratory neurons that project to cervical and 
thoracic spinal motor neurons of the phrenic and intercostal nerves to induce the 
contraction of the diaphragm and external intercostals and subsequently 
inhalation. It also contains interneurons that project to other CO2 sensitive areas 
and/or other respiratory neurons located in the ventral respiratory group (VRG), 
which contains inspiratory and expiratory (project to the abdominal and internal 
intercostals) neurons (Smith et al., 2009). The rostral VRG contains neurons that 
project to low motor neurons that innervate the larynx, pharyngeal and upper 
airways (Figure 3C and D). The ventral respiratory region contains important 
respiratory nuclei including the Bötzinger complex and the preBötC (also CO2 
chemosensitive) involved in rhythmogenesis and setting breathing frequency and 
are regulated by the pontine respiratory group neurons (PRG). The PRG also 
connects and interacts with the NTS and the hypothalamus (for a review, (Nattie, 
1999)).  
Inputs from chemoreceptors, via glutamatergic projections from the NTS, 
converge in the RTN (Takakura et al., 2006).  RTN has been recently considered 
a site of integration between peripheral, central and respiratory neuronal groups 
since RTN neurons also receive innervations from the medullary raphe  (Dias et 
al., 2008), orexinergic neurons of the lateral hypothalamus  (Fortuna et al., 2009) 
and the caudal VLM, and the RTN neurons project to the central pattern generator 
in the VRG  (Smith et al., 1989; Guyenet et al., 2008), activating the inspiratory 
and expiratory neurons and thus inducing ventilation until PaO2 and PaCO2 reach 
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their normal levels. The RTN neurons are subject to negative feedback from the 
respiratory neurons  (Guyenet et al., 2005).   
 The overall chemosensory activity results in/induces hyperventilation, 
stimulation of the sympathetic nervous system and modulation of arterial 
peripheral resistance and cardiac output  (Gonzalez et al., 1994). Figure 3 
summarizes the control of breathing from the peripheral to central regions to 
adjust PaO2 and PaCO2 to normal levels. 
 
 
Figure 3 - Chemoreceptor control of breathing. PaO2, PaCO2 and pH are tightly regulated by the organism 
though specific chemoreceptors located in peripheral and central nervous system. Changes in the arterial 
pressure of these gases (Panel A) activate peripheral chemoreceptors (carotid body, CB, Panel B) and central 
chemoreceptors (Panel C). CB senses primarily changes in O2 but also in CO2/pH (blue arrows, Panel B). Central 
chemoreceptors are the main CO2 sensors through activation by changes in pH or directly by CO2. Multiple CO2 
chemosensitive areas have been identified in the brainstem and are interconnected (chemoreceptor areas in full 
pink circles, and connection is red arrows, Panel C). The medulla also contains the respiratory neuronal groups 
(PRG, DRG and VRG) that control the neurons that activate the respiratory effectors (Panel C and D). PRG 
modulates DRG and VRG (Panel C). DRG contains primarily inspiratory neurons and VRG contains both 
inspiratory (rostral) and excitatory (caudal) neurons that depolarize the motor neurons to induce ventilation 
(Panel D).  Light blue lines represent inspiratory neuron; purple lines represent excitatory neurons.  
CO2, carbon dioxide; O2, oxygen; H2O, water; HCO3-, ion bicarbonate; PaO2, partial pressure of O2 in arterial 
blood; PaCO2, partial pressure of CO2 in arterial blood; CB, carotid body; LH, lateral hypothalamus; LC, locus 
coeruleus;, nucleus tractus solitarius; RTN, retrotrapezoid nucleus; PBS, pre-botzinger complex; VRG, ventral 

































Chemotransduction mechanisms for O2 and CO2 in carotid body 
 
 Mammalian organisms have evolved exquisite mechanisms to detect and 
respond to changes in O2 and CO2 levels. The first part of this introduction was 
focused on the integration of O2 and CO2 peripheral and central chemoreceptors 
to ultimately induce ventilation.  This second part is mainly focused on the known 
cellular transduction mechanisms that occur in the CB in response to stimuli.  
  Type I cells of the CB sense changes in O2 and CO2 through sensors that 
are likely to trigger different cellular events (at the level of the transduction 
cascade), but all evoke, although in a different extend, discharge of the CSN.  
Even though differences between species and developmental stage occur, in the 
adult cat, the discharge of the CSN is initiated when PaO2 decreases from 100 to 
70-75 mmHg (for a review  (Gonzalez et al., 1994)). The maximum CSN 
discharge occurs when the PaO2 decreases to 10-15 mmHg; below a PaO2 of 10 
mmHg the activity of the CSN is maintained at a constant level or decreases (for a 
review  (Gonzalez et al., 1994)). The threshold for CO2 excitation of the cat CB is 
25 mmHg (Eyzaguirre and Lewin, 1961) and the CSN discharge tends to plateau 
at a PaCO2 greater than 100 mmHg (Lahiri and Forster, 2003). The CSN 
responses to CO2 in rats, as compared to cats, are smaller with no apparent 
developmental maturation (for a review (Donnelly, 2005)). The O2-induced 
responses in the CSN increase throughout development until full maturity is 
reached after 2 weeks of age in rats (for a review (Donnelly, 2005)).  When low O2 
(hypoxia) and high CO2 (hypercapnia) are applied together, the response (CSN 
discharge) in the adult rat is greater than the sum of these two stimuli when 
applied separately (multiplicative interaction) (Pepper et al., 1995).   
 The following sections are devoted to the cellular mechanisms that occur 
in type I cells in response to different O2/CO2 concentrations, to induce the 
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O2 sensing mechanism 
 
 Although different chemotransduction hypotheses have been proposed 
for O2 sensing in the CB (membrane and mitochondrial hypothesis, for a review 
see Gonzalez et al., 2010 and Gonzalez et al., 1994), the general consensus for 
the O2-sensing mechanism is that hypoxia inhibits O2 sensitive K+ channels (a 
Ca2+ and voltage dependent K+ channel (BrCa) and a non-voltage dependent “leak 
channel” (TASK)), which depolarizes the membrane of type I cells (Peers, 1990, 
Lopez-Barneo et al., 1988, Gonzalez et al., 2009). Type I cell membrane 
depolarization activates Ca2+ channels, with a consequent increase of Ca2+i 
(Buckler and Vaughan-Jones, 1994a),and release of neurotransmitters (Figure 4).  
 As mentioned earlier (Peripheral chemoreceptors- Carotid bodies 
section), some of the neurotransmitters released initiate afferent CSN discharge 
(of note, the release of neurotransmitters is not essential for hypoxic 
chemotransduction, Donnelly, 1996). It has been proposed that ATP and 
acetylcholine (co-released) are the main excitatory neurotransmitters that induce 
CSN discharge in response to hypoxia through their ionotropic receptors present 
in the afferent terminals  (Zhang et al., 2000).  
 The response mediated by neurotransmitters that bind to ionotropic 
receptors is fast since it involves Ca2+ entry, which rapidly induces cellular 
responses. However, acetylcholine-ATP co-transmission does not entirely 
mediate all of the responses of the CB to hypoxia  (Reyes et al., 2007, Donnelly, 
2009). Adenosine receptors have also been identified on chemoafferents and 
recent data supports a key role of this neurotransmitter in hypoxic 

































Figure 4- Steps in O2 chemotransduction mechanim in CB type I cells. A decrease of PaO2 (1) inhibits K+ 
channels (2), with consequent depolarization of the cell membrane (3), and opening of calcium channels (4).  The 
levels of intracellular calcium increase (5) and bind to the vesicles containing neurotransmitters through 
synaptotagmin. The neurotransmitters released (6) can bind to ionotropic and metabotropic pos-sinaptic 
receptors in afferent CSN fibers (7) and/or pre-synaptic receptors in type I cells (8). The activation of 
metabotropic receptors modifies transmembrane adenylate cyclase, tmAC, activity and consequent production of 
cAMP.  
O2, oxygen; PaO2, partial pressure of O2 in arterial blood; CB, carotid body; K+, ion potassium, Ca2+, ion calcium; 
NTS, nucleus tractus solitarius; Vm, change in voltage, AC, adenylate cyclase; cAMP, cyclic AMP  
Adenosine (and other neurotransmitters) binds to pre- and pos-synaptic 
metabotrophic receptors, coupled to G-proteins (GPCR, G-protein coupled 
receptors) that modulate adenylyl cyclase (AC) activity and thus, cyclic AMP 
(cAMP) levels. The response mediated by neurotransmitters that bind to GPCR is 
slower than the one mediated by ionotropic receptors, since it modulates the 
production of the second messenger, cAMP, and consequent activation of cAMP-
signaling cascades. Thus, it has been suggested that the cAMP-signaling pathway 
mediates the hypoxic transduction mechanism in the CB (for a review (Gonzalez 
et al., 1994)), which will be discussed in more detail in the Role of cAMP in O2 and 
CO2 detection in the Carotid body section.  
 
CO2 sensing mechanism 
 
 The CO2 sensing mechanisms within the CB that mediates a 
hyperventilatory response are not completely understood. Under physiological 
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conditions, CO2 is in constant equilibrium with HCO3- and H+ through the reaction 
catalyzed by carbonic anhydrases in type I cells (CAH, Ridderstrale and Hanson, 
1984). CAH are divided in subgroups according to their cellular localization: 
cytosolic (CAH-I, CAH-II, CAH-III, CAH-VII, CAH-VIII, CAH-X, CAH-XI and CAH-
XIII), mitochondrial (CAH-VA and CAH-VB), secreted (CAH- VI), membrane-
bound (CAH-IV and CAH-XV) and transmembrane (CAH-IX, CAH-XII, CAH-XIV) 
(Supuran, 2008). Althought the precise localization of the CAH in the CB is 
controversial, there is evidence showing that type I and II cells, and nerve bundles 
are immunoreactive for CAH-I, II and III isoforms (cytosolic isoforms)  (Yamamoto 
et al., 2003). Inhibition of CAH depresses hypercapnia – induced response 
discharge in in vitro CB (Iturriaga et al., 1991).  Thus, increases in PaCO2 causes 
rapid diffusion of CO2 into the cytosol of type I cells, which increases H+ and 
HCO3- levels via CAH (Figure 5.1-2). A decrease in intracellular pH (increases in 
H+) inhibits K+ channels, with consequent membrane depolarization and voltage-
gated Ca2+ channel activation (Figure 5.3) (Buckler and Vaughan-Jones, 1994). 
The K+ channels (TWIK-related acid-sensitive potassium, TASK, channels) 
sensitive to acidic stimuli are also sensitive to hypoxia, and thus, it is a site of 
convergence for hypoxia and hypercapnia chemosensitive signaling in rat type I 
cells  (Buckler et al., 2000). It has also been demonstrated that acidosis can 
modulate pH regulatory transporters (Na+/H+ exchange, NHE), promoting the 
reversal of Na+/Ca2+ exchange, which results in elevated Ca2+i concentrations 
(Figure 5. 4) (Rocher et al., 1991). The acidic stimuli increases CSN firing rate, 
either by inducing release of neurotransmitters, or by activating directly the CSN 
endings or by making them more sensitive to neurotransmitters released from 
type I cells (Rigual et al., 1984). The type I cells also contain Na+ Cl-/HCO3- 
exchanger and HCO3- channels (Rocher et al., 1991).   
  From the neurotransmitters released, adenosine seems to enhance the 
response under hypercapnic conditions, a mechanism suggested to be mediated 
by adenylyl cyclases coupled to GPCRs inducing an increase in intracellular 
































release of ATP and acethylcholine from co-cultures of type I cells and petrosal 
neurons (Zhang and Nurse, 2004); these neurotransmitters bind to ionotropic 
receptors increasing Ca2+i.  
 
 
Figure 5 - CO2 chemotransduction mechanim in CB type I cells. Increases in PaCO2 (1) diffuse to the cytosol 
of type I cell where, by the action of carbonic anhydrase, CA (2) is converted in H+ and HCO3-. The protons inhibit 
potassium, K+, channels (3) with consequent cell depolarization, Vm, and opening of calcium channels (4). The 
intracellular calcium, Ca2+, levels increase in the cell (5) and induce neurotransmitter release (6-7). Some 
neurotransmitters activate metabotropic receptors (8-9) with activation of adenylate cyclase, AC and consequent 
increase in cAMP levels (10). Some authors propose that acidosis activate pH regulatory transporters (Na+/H+ 
exchange and Na+/ Ca2+ exchange) (4). It has also been suggested that HCO3- can activate soluble adenylate 
cyclase, sAC, increasing cAMP levels in the cell (11).   
CO2, carbon dioxide; PaCO2, partial pressure of CO2 in arterial blood, Vm, change in voltage, tmAC, 
trasnmembrane adenylate cyclase ; cAMP, cyclic AMP.  
 
There is also evidence for an independent CO2 effect: Summers and collegues  
(Summers et al., 2002) suggested that CO2 could activate Ca2+ currents directly 
leading to increased Ca2+I, through a cAMP and protein kinase A (PKA)- 
dependent pathway (Figure 5.5). Although it is unknown how molecular CO2 
could increase cAMP levels, this group suggested that this mechanism could be 
mediated by a particular type of enzymes involved in the synthesis of cAMP that 
are activated by intracellular HCO3- (soluble adenylyl cyclase, sAC) (Figure 5.11).  
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 There are many similarities between cellular signaling mechanisms 
involved in central CO2 chemosensitive neurons and type I cells: in both types of 
cells, acidosis inhibit K+ currents with consequent membrane depolarization. 
Some central chemoreceptors are believed to be directly sensitive to CO2, such as 
LC and VLM, activating L-type Ca2+ channels (Filosa and Putnam, 2003), a similar 
finding that has been also observed in the type I cells (Summers et al., 2002). 
More recently, it has been demonstrated that central CO2 chemosensitive regions 
are coupled to each other and to glial cells by gap junctions and recent work has 
demonstrated a role of connexin 26 in CO2-dependent release of ATP in the 
central chemosensitive cells (Huckstepp et al., 2010).  
 
Role of cAMP in O2 and CO2 detection in the carotid body 
 As mentioned above, neurotransmitter release increase in hypoxic and 
hypercapnic conditions, modulating cAMP levels in the CB mainly through 
adenosine A2a and A2b receptors (Monteiro et al., 1996, Chen et al., 1997, 
Conde and Monteiro, 2006a, Conde et al., 2006b), ß-adrenoceptor activity  (Mir et 
al., 1984) and dopamine D2 and D1 receptors (Mir et al., 1984, Almaraz et al., 
1991, Batuca et al., 2003). Thus, it has been proposed that cAMP could be 
mediating the O2/CO2 sensing transduction mechanism in the CB. However 
experiments aimed to answer this question were controversy. 
While some investigators have observed increases in cAMP levels with 
hypoxia/hypercapnia, others have not been able to confirm the role of cAMP in the 
transduction mechanism (Table 1 in attachment for more details). The small size 
of the CB, low levels of cAMP detected (in the order of pmol/CB), inter- 
experiment variability, species and ages differences, dissection methods, different 
preparations, the intensity of O2 and CO2 stimuli, incubation times and cAMP 
detection methods, have been credited for the discrepancies found in the 
literature. These differences are summarized in Table 4 (also table 1 in 



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Spec, species; Anes, anesthesia; Prep, preparation; Inc, incubation; Ref, reference; R.A., room air; RIA, 
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 The experimental studies included in this dissertation sought to better 
understand the role of cAMP-signaling pathway in the chemotransduction 
mechanism of the rat CB. The specific characteristics of the cAMP signaling 




 cAMP was discovered by Earl W. Sutherland and Theodore Rall in 1958 
(Sutherland and Rall, 1958). The levels of cAMP within the cells are tightly 
regulated by adenylyl cyclases (AC) and phosphodiesterases (PDE). Activation of 
one single AC isoform can originate many cAMP molecules, and amplification of 
the signal can be achieved rapidly. cAMP diffuses throughout the cell, binding and 
modulating the activity of three types of effectors: protein kinase A (PKA), cyclic 
nucleotide gated ion channels and exchange proteins activated by cAMP 
(EPACs). Although there are only three types of effectors that translate its signal, 
cAMP is able to elicit highly specific cellular effects in response to external stimuli.  
One of the reasons for this high specificity seems to be the compartimentation of 
the cAMP in pools in the cells. These pools are maintained by nearby PDE, which 
are enzymes that hydrolyze cAMP and, thus, regulate and restore basal cAMP 
levels, and by scaffolding proteins such as AKAPs that are located in the cytosol 
of the cells or within specific organelles such as nucleus and mitochondria (for a 
review,  Carnegie et al., 2009). Intracellular cAMP levels can also change due to 
other distinct cellular mechanisms: diffusion from one cell to another through gap 
junctions  (Bevans et al., 1998) or transport to the extracellular milieu (for a review  
Bankir et al., 2002).  
 
cAMP Pathway- Adenylyl Cyclases 
 Adenylyl cyclases (E.C.4.6.1.1) catalyze the synthesis of cAMP through 
































of adenylate cyclases: the classic transmembrane (tmAC) and the more recently 
described soluble adenylyl cyclase (sAC) (for a review Kamenetsky et al., 2006). 
The former (tmAC) mediates intracellular changes due to extracellular signals 
(e.g. neurotransmitters, hormones) that bind to GPCR (metabotropic receptors). 
These receptos comprise seven membrane-spanning -helices that are linked by 
extracellular and intracellular loops; the largest intracellular loop interacts with the 
G-protein. The G-protein contains three subunits ,  and . When a GPCR is 
activated, occours a conformational change in the cytoplasmatic domain of the 
receptor, which dissociates G from the  subunit and from the receptor. Then, 
Gs activates tmAC. TmAC is also sensitive to forskolin (Hacker et al., 1998), 
Ca2+ signaling pathway (Halls and Copper, 2011) and CO2 (Townsend et al., 
2009; Cook et al., 2012). On the other hand, sAC is regulated by HCO3- and Ca2+ 
ions, in a pH independent manner  (Jaiswal and Conti, 2003, Chen et al., 2000). 
 The mammalian tmAC has been well characterized and the structural 
information is very well documented. However, structural information for sAC is 
lacking. The only existing information available for mammalian sAC is derived 
from the homolog CyaC, an AC from the cyanobacterium Spinulina platensis, 
which contains 26% of protein sequence identity and includes all conserved key 
amino-acids implicated in catalysis in mammalian sAC enzymes  (Steegborn et 
al., 2005). Both tmAC and sAC are composed of two cytoplasmic regions also 
termed cyclase homology domain (CHD, or C1a and C2a, Figure 6 and Figure 
7). These two CHD domains must heterodimerize with each other to create a 
hydrophobic pocket allowing the ATP and co-factors to bind and activate the 
enzyme (the catalytic core, Figure 6B and Figure 7B). In addition, tmAC contains 
an N-terminal (N) domain, a short C-terminal (C2b) domain, and two 
transmembrane regions (TM1-6 and TM7-12), consisting of six hydrophobic 
transmembrane spanning α-helices each, anchoring the enzyme to the plasma 
membrane (Figure 6 A)  (Tesmer et al., 1997). The TMs contain extracellular N-
glycosylation sites that may be important in the regulation and catalytic activity of 
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the AC. The two TMs and C1a domains are joined by a linker termed C1b, which, 
depending on the tmAC isoform type, contains different regulatory sites for G-
proteins (which influences the relative orientation of the catalytic domains (Topal 
et al., 2012), Ca2+/ CaM (calmodulin) and protein kinases (Figure 6 A). The small 
differences in the amino acid sequences of the catalytic core (CHD heterodimer) 
and C1b domain (Tesmer et al., 1997) among the 9 tmAC isoforms have been 
counted for the specific regulation of each isoform, tissue distribution, and specific 
roles in mediating physiological responses (Fig.8,Table 1.2 in attachment).  
sAC differs from tmAC by lacking the transmembrane domains; in 
addition to the 2 CHD, sAC contains a large cytoplasmic domain (ca. 1150 
residues) present in the full length isoform (sACfL) but removed by alternative 
splicing in the short length form of sAC, sACsL (Figure 7). The absence of the 
large cytoplasmatic domain may be essential for sAC activation. 
 
 
Figure 6- Transmembrane adenylyl cyclase structure. Molecular architecture and mechanism of tmAC 
activity. (A) tmAC is represented by NH2 terminus, a first transmembrane cluster (TM), a cytoplasmic region 
comprising C1a and C1b domains, a second transmembrane cluster (TM) with extracellular N-glycosylation sites 
and a second cytoplasmatic domain comprising C2a and C2b.  B) C1a and C2a dimerize to form the catalytic 
site, where FSK and ATP bind at opposite sites. FSK anneals the two cytoplasmatic domains by a combination of 
hydrophobic and hydrogen bonding interactions. tmAC, transmembrane adenylate cyclase ;CHD, cyclase 
homogy domain, FSK, forskolin. 
 
The characterization of tmAC and sAC is possible using pharmacological 
tools more specific/sensitive towards each type of enzyme. P-site inhibitors, such 
































competitively or uncompetitively to the ATP binding site. Since tmAC has more 
affinity for ATP than sAC (Km is 30-400 µM vs 1-16 mM), P-site inhibitors are 
more selective towards tmAC. MDL-12,330A is an irreversible inhibitor, but the 
mechanism of action is not completely known (Guellaen et al., 1977). Although it 
is considered to be more selective for tmAC, there is no information regarding its 
selectivety towards sAC.  
 
 
sAC is specifically inhibited by KH7, identified in a small molecule screen 
with an unknown mechanism of action (Hess et al., 2005), and by catechol 
derivatives of estrogen, which inhibit sAC by chelating the Mg2+ in the active site 
of the enzyme (Steegborn et al., 2005b). Although adenylyl cyclases are 
ubiquitously expressed in the organism, the expression and characterization of the 
isoforms in the CB has never been performed. Evidence supporting the presence 
of these enzymes in the CB has been demonstrated by activity measurements  
(Mir et al., 1984) or by the effect of specific neurotransmitter/ neuromodulators 
Figure 7- Soluble adenylyl cyclase (sAC) structure. Molecular architecture and representation of sAC structure 
and mechanism of activity. (A) sAC is composed by two cytoplasm domains C1a and C1b. ATP binds to the open 
state. (B) Instead of the Asp residue characteristic of the substract binding domais of tmAC, sAC has a Thr, which 
allows HCO3- to bind (Cann et al., 2003). HCO3- closes the dimmer and moves the catalytic residues into a 
favorauble arrangement for cyclization of ATP. Ca2+ promotes its activity by increasing the affinity for ATP  
(Steegborn et al., 2005a). Mg2+ ion is also required in the catalytic site of the enzyme to coordinate binding and 
cycling of ATP. First, ATP with Ca2+ bound to its -phosphate, coordinates with specific residues in the catalytic 
center, leaving the CHD dimmer open (open sAC state, Figure 7A). Then, HCO3- binding recruits a Mg 2+ ion that 
binds to the -phosphate of the ATP, closes the dimmer (closed state) and moves the catalytic residues into an 
arrangement more favorable for cyclization of ATP (esterification of the -phosphate with the ribose in adenosine 
and the concomitant release of the - and -phosphates), Figure 7B (Steegborn et al., 2005a).  
sAC, soluble adenylyl cyclase, CHD, cyclase homology domain, HCO3-, bicarbonate ion, Mg2, magnesium ion. 
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that bind to receptors positively or negatively coupled to this enzyme  (Gonzalez 
et al., 1994). One of the aims of this work was to characterize adenylyl cyclase 
isoforms in the rat CB and study whether O2/CO2 could affect their expression and 
activity. 
 
Figure 8- Regulation of adenylate cyclase isoforms.   
General patterns of activation (+) and inhibition (-) of the different isoforms. Adapted from (Dessauer, 2009). 
CAM, calmodulin; FSK, forskolin; tmAC, transmembrane adenylate cyclase; sAC, soluble adenylate cyclase; 
PKC, protein kinase C; CNG, cyclic nucleotide-gated channel; RGS2, regulator of G protein signaling; PAM, 
protein activator od myc; PI3K, phosphatidylinositol-3-kinase.  
cAMP Pathway- Phosphodiesterases 
 Phosphodiesterases (PDEs, E.C. 3.1.4.1) catalyze the hydrolysis of the 
3’- cyclic phosphate bonds of adenosine 3’ 5’-cyclic monophosphate to AMP, 
terminating the cAMP-signaling cascade. There are 11 PDE families, derived from 
separate gene families, which differ in their amino acid sequences, endogenous 
and exogenous regulators and pharmacological properties (Table 1.3 in 
attachments) (Bender and Beavo, 2006). Many of these PDE families have 
distinct isoforms and splice variants (Bender and Beavo, 2006) (Table 1.3 
attachemnt). There are over 50 PDE isoforms resulting from the 21 PDE-coding 
































the same family are functionally related to each other through similarities in amino 
acid sequences, specificity and affinity for cGMP and cAMP, inhibitor specificity, 
and regulatory mechanisms (Table 1.3 attachemnt). PDEs are present 
ubiquitously in the cell: in the cytosol, plasma membrane, cytoskeleton, and 
nucleus (Houslay and Adams, 2003) (Table 1.3, in attachment). In most cells, 
PDE3 and 4 are the main players for cAMP hydrolysis.  
 The general structure of these enzymes consists of two distinct domains: 
a regulatory domain located at the N-terminus of the protein and a catalytic 
domain located at the C-terminus (Figure 9) (Thompson, 1991). The N-terminal 
domain contains unique motifs that regulate PDE expression and activity. These 
motifs are responsible for dimerization, phosphorylation, binding of modulators 
such as cGMP or Ca2+/calmodulin, interaction with regulatory proteins, and 
subcellular localization of the PDE isoforms. Thus, the catalytic activities of the 
PDEs are highly regulated by these motifs, which are inputs from many different 
pathways. The integration of these signals plays an important role in determining 
the intensity and duration of the cellular response to external stimulis. This 
regulatory domain can vary in length and it is a site for alternative splicing, which 
explains the variety of PDE isoforms that exist (Bender and Beavo, 2006).  
 
Figure 9- Cyclic nucleotide phosphodiesterase (PDE) structure. PDE have the carboxic domain with the 
catalytic domain and the regulatory domain. The regulatory domain of the PDE contains unique motifs involved in 
the regulation of protein expression and enzyme activity. The catalytic domain contains a conserved glutamine 
(G) that is involved in the nucleotide binding. Adapted from  (Menniti et al., 2006). GAF, cGMP-specific 
phosphodiesterases, Adenylyl cyclases and FhIA domain; URC, upstream conserved region; PAS, Period 
circadian protein.  
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 The catalytic domain is highly conserved across all isoforms. The 
molecular mechanisms for specific binding or hydrolysis of the phosphodiester 
bond are not full understood. The six-member phosphodiester ring of cAMP or 
cGMP and the purine moiety are critical for the binding with PDEs. The 
phosphohydrolase reaction involves the nucleophilic substitution of a solvent 
hydroxyl at the phosphate, disrupting the P-O bond at the 3’oxygen of the ribose 
(Francis et al., 2001). The catalytic core contains two consensus divalent cation 
(Zn2+ or Mg2+)-binding. The cyclic nucleotide binding specificity (either specific to 
cAMP, cGMP or both) is determined by the orientation of a conserved glutamine 
in the catalytic pocket (so-called Glutamine switch). In case of a dual-substrate 
isoform, this glutamine is free to rotate to adapt either orientation (Zhang et al., 
2004).  
 Changes in cAMP levels contribute to many disease states. By 
degrading cAMP, PDEs are important modulators of cAMP levels, preventing the 
uncontrolled diffusion of cAMP through the cell and consequently contribute to the 
formation of localized pools or gradients of cAMP within the cell.  Potent and 
selective PDE inhibitors have been developed as targets for a variety of 
pathologies, such as pulmonary hypertension, chronic obstructive disease and 
asthma  (Houslay et al., 2005).   
In the CB, the activity of cAMP- specific PDE was characterized for the 
first time by Hanbauer (Hanbauer and Lovenberg, 1977). At that time, two forms 
of PDEs were identified in the CB: a low KM enzyme (2.8X10-6) and a high KM 
enzyme (4.0X10-5). Exposing rats to 5%hypoxia for 30 min with consequent 
determination of PDE Km after 45 min, only identified the low km enzyme (the 
high Km enzyme could not be measured under these conditions) (Hanbauer and 
Lovenberg, 1977). IBMX, a non-specific PDE inhibitor, has been widely used in 
experiments aimed at measuring cAMP levels at rat. There are PDE that are 
IBMX-insensitive (or whose sensitivity to IBMX is unknown: PDE8, PDE10 and 
PDE11 and the cGMP specific PDE5 and PDE6) but these isoforms can be 
































characterization of the specific PDE isoforms has never been performed in the 
peripheral chemoreceptors. 
cAMP Pathway- Effectors 
 
 cAMP produced in the cell by AC and regulated by PDE binds to target 
proteins to activate the signaling cascade and produce a cellular effect. cAMP 
binds to protein kinase A (PKA), to the exchange protein activated by cAMP 
(EPAC) and/or cyclic nucleotide gated ion channels (CNG and HCN channels) 
(Figure 10 ).   
 
Figure 10- cAMP effectors. cAMP can bind to protein kinse A (PKA, A), exchange protein activated by cAMP 
(EPAC, B) and cyclic nucleotide gated ion channels (CNG and HCN channels, C). A) The binding of cAMP to the 
regulatory subunits of PKA releases the active catalytic subunits, resulting in the phosphorilation of ion channels, 
CREB and A-kinase anchoring proteins (AKAPs).  B) cAMP binds to the regulatory subunit of EPAC, unfolding 
the protein and allowing the of GDP to GTP on Rap 1,2. C) CNG channels are regulated by the binding of cAMP 
to their cytoplasmic tail, modulating the influx of Ca2+ and Na+.  
PKA, protein kinase A; EPAC, exchange protein activated by cAMP (EPAC), CNG, cyclic nucleotide gated ion 
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PKA is a holo-tetrameric serine/threonine kinase composed of two 
regulatory and two catalytic subunits. Four cAMP molecules bind to the regulatory 
subunits, each with two cAMP binding sites. The cAMP binding promotes the 
dissociation of the catalytic subunits that bind ATP to become catalytically active 
and phosphorylate serine and threonine residues in intracellular targets such as 
A-kinase anchoring proteins (AKAPs) and ion channels. 
AKAPs tether PKA to particular cellular organelles and to the plasma 
membrane confining the PKA signaling to a small pool within the cell (Beene and 
Scott, 2007). In the nucleus, PKA can phosphorylate transcription factors, such as 
cAMP response element binding protein (CREB), and thus regulate gene 
expression (Figure 10A). PKA activity has been demonstrated in the CB through 
the effects modulated by the PKA antagonist H89 and Rp-cAMPs  (Xu et al., 
2007, Xu et al., 2006, Wang et al., 1999, Summers et al., 2002). In this tissue, 
PKA phosphorylates Ca2+ channel protein, enhancing L-type Ca2+ currents with a 
consequent increase of intracellular Ca2+  (Summers et al., 2002). Epac is a 
guanine nucleotide exchange factor (GEF) for the Ras GTPase homologues, 
Rap1 and Rap2. Epac is composed of two regions: an N-terminal regulatory 
region containing a cAMP-binding site and a C-terminal catalytic region, with GEF 
activity   (de Rooij et al., 1998) (Figure 10B). It has been suggested that in the 
inactive conformation, Epac is folded and the regulatory domain functions as an 
auto-inhibitory domain. cAMP binding unfolds the protein, allowing Rap to bind (for 
a review (Gloerich and Bos, 2010)). Rap GTPases cycle between an inactive 
GDP-bound and an active GTP-bound state, with GEFs mediating the exchange 
of GDP for GTP. At the end, GTPase-activating proteins convert Rap to the 
inactive form (Bos, 2003). The activated Rap-GTP activates a variety of different 
mechanisms in the cell: promotes integrin-mediated cell adhesion, gap junction 
formation and ERK1/2 MAPK-mediated protein phosphorylation, stimulates 
phospholipase C-epsilon which hydrolyzes PIP2 to generate diacylglycerol (DAG), 
































Rocher and co-workers  (Rocher et al., 2009) have identified Epac in CB type I 
cells through the effects of the Epac activator (8-pCPT-2’-O-Me- 
cAMP) and inhibitor (brefeldin) on the release of catecholamines induced by 
hypoxia. These authors suggest that the effectors of Epac in these cells would be 
the exocytotic machinery and K+ channels.  
 cAMP can also directly bind to cyclic nucleotide-gated (CNG) and 
hyperpolarization-activated cyclic nucleotide-modulated (HCN) ion channels 
(Figure 10C).  These channels belong to a superfamily of voltage-gated cation 
channels, thus binding of cAMP to these channels are translated into changes in 
membrane potential and influx of Ca2+ and Na+. The presence of these channels 
in the rat CB has been suggested by the work of Stea and co-workers  (Stea et 
al., 1995); however, other works have observed that cAMP analogs do not affect 
Ca2+ currents in type I cells  (Lopez-Lopez et al., 1993). The direct characterization 
of these channels has never been characterized in this tissue.  
Extracellular and intercellular cAMP signaling 
 
 cAMP can be exported out from a variety of cell types and tissues (for a 
review (Bankir et al., 2002)). The cAMP transport moves against a concentration 
gradient, it is temperature dependent, is unidirectional and requires energy  
(Rindler et al., 1978). The efflux of cAMP is believed to be mediated by organic 
anion transporters (OAT) and multi-drug resistance proteins (MRP)  (Sekine et al., 
1997, van Aubel et al., 2002). The latter belongs to the superfamily of ATP binding 
cassette (ABC) proteins, specifically the ABCC subfamily (Figure 11). In 
particular, MRP4, MRP5 and MRP8 have been identified as cyclic nucleotide 
transporters (Kruh and Belinsky, 2003). AC was also suggested to be involved in 
cAMP extrusion due to the structural similarities that it shares with the classic 
ATP-driven transporters (Krupinski et al., 1989).  
 One of the proposed functions of the extracellular cAMP is to regulate 
extracellular adenosine (ADO) levels. Extracellular cAMP can be metabolized by 
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ecto-phosphodiesterases to adenosine monophosphate (5’-AMP), and then by 
ecto-5’-nucleotidases to ADO (Figure 11). The contribution of extracellular cAMP 
to ADO production has never been investigated in the CB and cAMP released 
from the CB has never been quantified. 
 
 
Figure 11- Extracellular cAMP pathway. cAMP synthetized by AC intracellularly can be transported to the 
extracellular mileu by ABC transporters. Once in the interstitial space, cAMP can be degraded by ecto-
phosphodiesterases to AMP and consequently to ADO, by the action of ecto-nucleotidases. cAMP is known to 
bind to cAMP receptors, cAR, but evidences in mammalian cells are lacking.  
tmAC, transmembrane adenylyl cyclase; ABC, ATP-binding cassete, ecto-PDEs, ecto-phosphodiesterses; Ecto-
5’-N, ecto-nucleotidases; ADO-R, adenosine receptors; cAMPR, cAMP receptors 
 The targets to extracellular cAMP have been well studied in the amoeba 
dictyostelium discoideum and used as a model for cellular migration and 
chemotaxis. In this organism, extracellular cAMP binds to cAMP receptors (cAR1, 
cAR2, cAR3, cAR4) that belong to the superfamily of GPCR (Bankir et al., 2002). 
































pathways and a variety of effects that are showed in Figure 11  (Aubry and Firtel, 
1999, Caterina et al., 1995, Milne et al., 1997). Although the effects of 
extracellular cAMP have been reported in several mammalian cells, no 
mammalian homologs of the cAR have been identified thus far.  
Intracellular cAMP can diffuse intercellularly through gap junctions  
(Bevans et al., 1998). These gap junctions are located in the membrane of the 
cells and consist of intercellular channels, each resulting from the association of 
two hemi-channels or connexons. Each connexon is located in one of the adjacent 
cells and is composed by six subunits termed connexins (Figure 12).  
 
 
Figure 12- Intercellular cAMP pathway. Gap junctions between two adjacents type I cells in the CB. Each cell 
membrane contains a connexon, constituted by six connexins. The two connexons connect to each other, 
forming a channel, allowing the passage of ions and small molecules, such as cAMP, Ca2.+ Once in adjacent cell, 
cAMP can mediate a variety of cellular and molecular effects. 
These connexins are arranged in a hexagonal shape around an axis 
perpendicular to the plane of the plasma membrane, forming a channel. These 
channels allow the passage of not only cAMP, but also ions and other small 
molecules up to 1.2 kDa  (Bennett et al., 1991).   
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Type I cells and type II cells and carotid nerve terminals in the rat CB are 
linked through gap junctions, which mediate intercellular communications and 
transporte of small molecules and ions (Abudara and Eyzaguirre, 1996). 
Junctional conductance and gap junction formation and connexin expression are 
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Pharmacological manipulation of cAMP signaling is currently used as a 
therapeutic target to treat respiratory pathologies: asthma, pulmonary 
hypertension, chronic obstructive pulmonary disease, obstructive sleep apnea 
(OSA) (Houslay et al., 2005). These pathologies have in common the imbalance 
of O2/CO2 and consequent CB activation. Thus, our overall hypothesis is that 
the CB activity could be manipulated with drugs that interfere with cAMP-
signaling pathway. The general aims of the work present in this thesis are 1) 
to study how specific is cAMP-signaling pathways in the CB mainly in 
different CO2 conditions and 2) how O2 concentrations alter/drives the 
manipulation of cAMP signaling in the CB.  
The O2/CO2 sensing mechanism of the CB is not fully understood, but an 
involvement of cAMP in this mechanism has been proposed. The experimental 
studies included in this doctoral thesis sought to investigate the role of cAMP in 
the rat CB chemotransduction mechanisms and to determine whether the 
enzymes that participate in cAMP signal transduction in the CB are regulated by 
O2/CO2.  
Specific aims: 
1)  to determine the effects of PDE inhibitors on cAMP signaling pathways in 
peripheral chemoreceptors; 
2)  to characterize PDE isoforms in O2 chemosensitive and non-
chemosensitive tissues;  
3)  to determine potential tissue specific modulation of PDE inhibitors in 
hypoxia-related disease conditions; 
4)  to determine whether the effects of PDE inhibitors are translated into 
apparent changes in PKA activity in primary SCG neurons 
5)  to characterize sAC and its putative role in the CB and non-
chemosensitive related organs.  
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6)  to determine the relative contribution of sAC and tmAC on cAMP 
signaling in response to hypercapnia in peripheral and central 
chemoreceptors, mainly the CB, PG and LC.  
 
 The relevance of this work is to study and potentially identify new 
molecular targets  (sAC, subtypes of tmAC, PDE isoforms) that could be used to 








































































The experiments were conducted on two different strains of rodents: 
Sprague-Dawley (SD) rats at postnatal day (P) 5-9, 16-17 and at 3 months, and 
Wistar rats at 3 months. All animal care and experimental procedures were carried 
out according to the European Union directives (Wistar rats) and by the guidelines 
of Animal Use Committee at the Johns Hopkins University School of Medicine (SD 
rats). SD rats of both sexes, P5-9 and P16-17, were obtained from Charles River 
Laboratories (Wilmington, MA). Wistar rats of both sexes, at 3 months of age, 
were obtained from Faculty Medical Science animal house (Portugal).  
Dissection of the biological preparations 
Different surgical procedures were performed on SD and Wistar rats, due 
to the different age and size of the animals.  
SD rats were briefly anesthetized with isoflurane (Abbott Laboratories, 
Inc., Abbott Park, Illinois) and immediately decapitated. Heads were mobilized 
ventral side up using sterile syringe needles. Dissection involved a cervical 
midline incision, exposing a mass of glandular, adipose, and lymphoid tissue 
(Figure 1A). This mass of tissue was removed, exposing the omohyoid muscle 
(Figure 1B), which was carefully removed, exposing the carotid artery (Figure 
1C-D). The carotid bifurcation, including the carotid body (CB), superior cervical 
ganglia (SCG), and the nodose/petrosal ganglion (NG/PG) complex, was cleaned 
of surrounding connective tissue and transferred en bloc (Figure 1E) to a 
dissecting petri dish coated with agar and containing ice-cold phosphate buffered 
saline buffer (PBS in mM: NaCl, 137; KCl, 2.7; Na2HPO4, 4.3; KH2PO4, 1.47; 
adjusted to pH 7.4). Under a dissecting microscope, the SCG was carefully 
removed, exposing the CB. Subsequently, the CB, the PG, and NG were quickly 
dissected from the carotid artery, free of connective tissue and fat, and prepared 
as mentioned in Preparations and Methodologies.   
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Figure 1- Dissection of peripheral chemo- and non-chemoreceptor tissues from a rat.  A) A vertical midline 
incision in the skin with lateral incisions to the left and right, was made at the level of the clavicles and the 
mandibles. Skin flaps were retracted laterally, exposing a mass of glandular, adipose, and lymphoid tissue. (B) 
The tissue was removed, exposing the sternohyoid and thyroid, sternocleidomastoid and omohyoid muscles. (C) 
The thin omohyoid muscle was carefully removed, exposing the carotid artery. (D) Details of the carotid artery 
exposure (A-D adapted from Fedoroff and Richardson, 2001). (E) Bifurcation of the carotid artery from SD rat at 
P10, exposing the carotid body (CB), nodose and petrosal ganglia (NG/PG), internal carotid artery (ICA), external 
carotid artery (ECA), ninth and tenth cranial nerves, and carotid sinus nerve (CSN) (Gauda and Lawson, 
2000) and Fedoroff and Richardson, 2001. 
The central chemoreceptor regions were obtained from the brainstems of 
SD rats. Dissection involved a longitudinal incision from the neck to the snout. The 
skull was cut longitudinally and anteriorly starting at the cisterna magna, by 
making 1 medial and 2 lateral cuts, on each side. The cranial nerves were cut and 
the brain was removed with a spatula and placed in ice-cold PBS to quickly micro-
dissect the central chemosensitive tissues of interest: medullary raphé nuclei 
(RN), ventrolateral medulla (VLM) and the locus coeruleus (LC) (Figure 2). Cortex 
(Cx) was included as a non-chemosensitive region. As previously described by 
Wang and co-workers (Wang et al., 1998) transverse cuts were made through the 




































immediately caudal to the union of the vertebral arteries near the spinomedullary 
border. Two longitudinal cuts were also made along the middle of both pyramids. 
A micro-knife was used to remove the pre-cut wedge of tissue with its base at the 
ventral surface and borders along the previously made cuts, and its apex in the 
midline approximately half way towards the dorsal surface of the medulla. The 
micro-dissected region captured the raphé pallidus, raphé magnus, a segment of 
the raphé obscurus, and tissue immediately adjacent to these nuclei (Figure 2A). 
Similarly, the ventrolateral medulla (VLM) was micro-dissected using a slightly 
modified approach, as described by Johnson and co-workers  (Johnson et al., 
2008, Johnson et al., 2001). The brainstem was sliced manually in ~500 μm 
increments with a micro-knife to capture a transverse slice containing the VLM.  
Tissue samples were taken from a slice where the inferior olive (IO), midline 
raphé, pyramids, and semi-compact division of nucleus ambiguus (NA) were 
visualized and used as identifying landmarks. A longitudinal cut was made 
immediately lateral to the midline raphé, diagonally above the IO complex, and a 
transverse cut was made slightly dorsal to the NA (Figure 2.2B). Finally, LC 
samples were obtained from pontine slices at the level of the 4th ventricle and the 
tract of 7th cranial nerve. The LC and adjacent tissue was bilaterally excised from 
the slice (Figure 2.2 C).  
The testicular tissue was removed from SD rats at P16-17 and at 3 
months of age. This tissue was used as a positive control organ to study soluble 
adenylyl cyclase (sAC) expression and activity since this enzyme is highly 
expressed in this tissue (Braun, 1991). The dissection of testes involved an 
incision through the scrotal wall and cremasteric fascia, exposing the scrotal sac 
where the testes were located. The testes were removed by cutting the excretory 
efferent ducts. The testicular capsule was teased off gently and the testes were 
incubated in “baskets” containing the incubation medium under study conditions. 
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Figure 2- Representation of the CO2 central chemoreceptor tissues from a rat. A) Dorsal surface of the 
medulla containing the raphe, B) Slice containing the VLM, and C) Slice containing the LC. LC, locous 
coeruleous, VLM, ventro lateral medulla. Figure adapted from  (Golanov et al., 2000, Kiyashchenko et al., 
2001). 
Wistar rats were anesthetized with sodium pentobarbital (60 mg.Kg, i.p.).  
The dissection involved a longitudinal incision in the middle cervical skin, followed 
by a tracheostomy to allow spontaneous breathing during the surgical procedure. 
Retractors were used to expose the carotid arteries and remove the connective 
tissue.  Under a dissection scope (Nikon SMZ-2B) with a cold light (Wetzlar 
LFQ150), the CBs, SCG and carotid arteries were gently dissected and 
immediately placed in ice-cold incubation medium in preparation for in vitro 
incubation experiments. The animals were killed by an intracardiac injection of a 






































 In this work, whole organs, slice tissue and single cells preparations were 




 Whole organs were dissected from the rodents as described previously in 
Surgical Procedures, and either processed directly according to the technique to 
be used or incubated in vitro to study the effect of experimental 
conditions/parameters (O2, CO2, bicarbonate ion (HCO3-), phosphodiesterase 
(PDE) inhibitors, adenyly cyclase (AC) activators and inhibitors) on gene 
expression (quantified by qRT-PCR) or on total cAMP levels (quantified by 
ELISA). The advantages of the use of whole organs, as oppose to cells, is that 
this model preserves cell-cell interactions. The isolated CBs are no longer 
influenced by blood flow changes or efferent nerve discharge; although it still 
responds to decreases in PO2 in a similar way to the in vivo CBs (Delpiano and 
Acker, 1980), and along with the small size of this organ, is a well-established 
model to elucidate O2-chemoreception  (Delpiano and Acker, 1991, Iturriaga et al., 
1992, Batuca et al., 2003, Monteiro et al., 2011).  
 A limitation on using a whole organ approach is the contribution of all the 
organ components (different cell types, blood vessels, nerve terminals) in the 
overall response to the stimulus in study.  However, a comparison between whole 
CB and non-chemosensitive related tissues allow us to identify specific properties 
of the CB chemosensitivity cells.  
Dissociated primary cell cultures 
 
 Dissociated primary cells from the CB and SCG were used to study the 
regulation of PKA activity using FRET-based imaging. Dissociated primary cells 
are a good model to study cellular and molecular mechanisms of specific cell 
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types, and have been widely used to understand chemotransduction mechanisms 
in the CB type I cells.  
 
 
Primary cultures of carotid body cells  
  Carotid bodies from SD rats at P6-9 were isolated and dissociated enzymatic and 
mechanically according to the protocol described by Carroll and co-workers  
(Carroll et al., 2005). Briefly, CBs were removed from rats as described in Surgical 
Procedures section, placed in ice-cold low-Ca2+, low Mg2+ PBS and transferred to 
an enzyme mixture consisting of trysin and collagenase (0.5 mg/ml) in low 
Ca2+/Mg2+ PBS. After 25 min, CBs were mechanically dissociated using a fire 
polished Pasteur pipette. The enzymatic reaction was stopped by addition of 
growth medium Ham’s F-12 Medium (Gibco, Invitrogen), supplemented with 10% 
fetal bovine serum (Gibco, Invitrogen), glucose (23 mM, Sigma), L-glutamine (2 
mM, Cellgro, Mediatc), penicillin–streptomycin (10 kunits, Cellgro, Mediatc) and 
insulin (3 μg ml−1, Sigma). The dissociated CBs were then centrifuged for 4 min at 
∼6000 rpm (∼2000 g,). The supernatant was removed and warm supplemented 
Ham’s F12 Medium was added to the cells to gently resuspend the pellet. This step 
was repeated to remove all traces of the enzymes. Hemocytometer-based trypan 
blue dye exclusion assay was used to determine a cellular viability of 75.5  3.3%. 
Dead cells took up the dye and appeared blue under the miscroscope, while 
living/viable cells excluded the dye and appeared white. The final cell suspension 
was handled differently according to the objectives of the experiment. For FRET 
experiments 10 µl aliquots were plated on small glass-bottomed cell culture dishes 
(Mat-Tek Corporation) coated with poly-L-lysine (PDL, 100g/ml, Sigma). Cells 
were incubated at 37°C/5%CO2 and after 50 min were fed with warm growth 
medium culture.   
  For studies on morphology/ characterization/ immunostaining of cells, 




































with PDL (Millicell® EZ slide, Millipore), which were then placed in a10 cm Petri 
dish. After one hour of incubation, enough CB growth medium was added to cover 
the slides. 
  Figure 3 shows the identification of type I cells from a CB cell culture. 
Type I cells were identified with tyrosine hydroxylase (TH) and fluoresceinated 
peanut agglutinin staining.  
CB primary cells were plated on slides pre-coated with PDL, fixed with 4% 
paraformaldehyde and treated with 0.4% Triton X-100 (Fisher) in PBS.  Cells were 
then blocked with 5% BSA (Sigma) in PBS, for an hour, to prevent specific or non-
specific background staining. Cells were labelled with anti-TH polyclonal rabbit 
antibody (1:50, sc-14007, Santa Cruz) in 1% BSA in PBS, overnight, at 4oC, 
followed by washes with PBS (3x5min) to remove unattached primary antibodies. 
Type I cells are enriched with TH, the rate-limiting enzyme in catecholamine 
biosynthesis. TH positive cells were detected using rhodamine donkey anti-rabbit 
secondary antibody (1:100, sc-2095, Santa Cruz) in 1% BSA in PBS for 2 hours at 
RT, in the dark. After 3x5 min washes with PBS, coverslips were mounted in DAPI-
containing Vectashield mounting medium (Vector lab, Burlingame, CA) and the 
slices were observed under fluorescent microscope. As shown in Figure 3A1, type 
I cells labeled with TH appeared in clusters, but TH did not labeled all CB cells, as 
shown in Figure 3A2 with DAPI staining.  
  Fluoresceinated peanut agglutinin (PNA) binds to the outer membrane of 
cells originating from the neural crest and can be used as a good marker to identify 
live type I cells in primary cultures of CB  (Kim et al., 2009). To confirm that PNA-
bound CB cells were exclusively TH positive type I cells, CB cells were previously 
treated with Rhodamine-PNA (Rhod-PNA, 30g/ml, Vector, CA) in supplemented 
Ham’s F-12 grow Medium for 1 hour, at 37oC. Then, the cells were fixed, 
permeabilized, blocked as described above and incubated with anti-TH mouse 
monoclonal primary antibody (1:50, sc-25269, Santa Cruz) in 1% BSA in PBS, 
overnight. Type 1 cells were detected by FITC goat anti-mouse secondary antibody 
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(1:100, sc-2010, Santa Cruz) in 1% BSA in PBS (Figure 2.3B1). As observed in 
Figure 2.3B1 and Figure 2.3B2, TH positive type I cells were PNA labeled.  
 
Primary cultures of superior cervical ganglia neurons  
 
  Superior cervical ganglia isolated from SD rats at PND 6-10 were 
transferred to sterile Leibovitz’s L-15 medium (Gibco, Invitrogen) and dissociated 
enzymatic and mechanically to obtain primary neuron cultures. The ganglia were 
teased apart and incubated in a mixture of trypsine and collagenase in Leibovitz’s 
L-15 medium at 37oC for 1 hour. At the end of the enzyme treatment, the ganglia 
were rinsed in fresh Leibovitz’s L-15 medium for 30 min at 37oC, followed by 3 
washes in L-15 and once in Neurobasal-A medium (Gibco) with supplements: 
nerve growth factor (NGF, 100g/ml, Sigma), L-glutamine (0.6 mM), 
penicillin/streptomycin (10 kunits) and B27 (Gibco Invitrogen). The ganglia was 
gently triturated with a pasteur pipette and washed 4 times through a 30-70 µm 
Figure 3- Primary culture of cells dissociated from CB from SD rats at P10. 
A1) Identification of type I cells by tyrosine hydroxylase (TH) immunostaining. Type I cells 
were stained with anti-TH polyclonal rabbit antibody (1:50) and detected using rhodamine 
donkey anti-rabbit secondary antibody (1:100). A2) Nuclei of CB cells were stained with 
DAPI. 400 fold magnification B1-B3) Identification of CB type I cells byfluoresceinated 
peanut agglutin (PNA) and TH co-staining B1) TH staining (1:50, mouse monoclonal TH 
antibody visualized using FITC goat anti-mouse antibody, 1:100), B2) PNA staining (30g/ml 
in cell culture media for 1hrvisualized by TRITC filter after incubation with of RHO-PNA in cell 
culture media during 1 hr, 37
o
C. B3) DAPI staining showing more than type I cell in the CB 





































pore cell strainer (Falcon). Cells were centrifuged for 6 min at 2000g and 
ressuspended in Neurobasal-A. Cellular viability was measured (82.34.5%). Cells 
were plated in petri dish pre-coated with PDL and laminin (25g/ml, Invitrogen) and 
after 30 min, 2 ml of Neurobasal-A with supplements was added to the cell culture.  
In the following day, the antimitotic cytosine arabaninoside (Ara-C, 10µM, Sigma) 
was added to prevent the growth of dividing non-neuronal cells. Neurofilaments 
(NF) and TH are neuronal markers for sympathetic ganglia (Ahonen, 1991). NF are 
proteins found specifically in neurons and constitute the main structural elements of 
neuronal axons and dendrites. Figure 4 shows the identification of the neuronal 
ganglia in the SCG cell culture. SCG primary neurons were plated in slides pre-
coated with PDL and laminin, fixed with 4% paraformaldehyde and permeabilized 
with 0.4% Triton X-100 in PBS. After blocking (5% BSA in PBS) for one hour, cells 
were labeled with two primary antibodies: anti-TH polyclonal rabbit antibody (1:50, 
sc_14007, Santa Cruz, Figure 2.4A) and anti NF-68kDa mouse monoclonal 
antibody (1:100, ab78159, abcam, Figure 2.4B), both in 1% BSA/PBS, overnight, 
4oC and visualized with rhodamine donkey anti-rabbit secondary antibody (1:100, 
sc_2095, Santa Cruz, Figure 4A) and FITC- conjugated goat, anti-mouse IgG 
secondary antibody (1:100, sc_2010, Santa Cruz, Figure 2.4B) in 1%BSA/PBS for 
2 hours at RT. After the washing step (3x5min in PBS), the coverslips were 
mounted with DAPI-containing Vectashield mounting medium and slices were 
observed under fluorescent microscope (Figure 4A-D).  
 
Figure 4- Primary cultures from superior cervical ganglia from SD rats at P10. 
A) SCG neurons labeled with anti-Tyrosine hydroxylase (TH) polyclonal rabbit antibody (1:50 in 1%BSA/PBS, 
overnight at 4oC) and detected using rhodamine donkey anti-rabbit antibody (1:100). B) SCG neurons labeled 
with neurofilament 68kDa (NF-68) mouse monoclonal antibody (1:100) and visualized by FITC goat anti-mouse 
antibody (1:100), C) Merged imaged showing co-staining of TH and NF-68 in SCG neurons. D) DAPI staining 
showing more than SCG neurons in the culture. 400 fold magnification. 
A B C D 
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Organotypic slice cultures 
 
 Organotypic slice cultures of CB/SCG were used to investigate the effect 
of PDE inhibitors on PKA activity by FRET. Organotypic slice culture is an 
advantageous in vitro model, allowing the maintenance of fiber projections 
between cells and avoiding enzymatic and mechanical dissociation of the tissue 
(as in dissociated cell cultures), which results in better preservation of the cellular 
physiology and morphology and minimal disruption of type I cell-type II cell 
contacts. 
  CB attached to the SCG were isolated from SD rats at P6-8, cleaned of 
connective tissue and transferred to sterile ice-cold Leibovitz L-15 medium 
(Figure 5A).  The tissue complex was then embedded in 3% low melting point 
agar (Sigma Chemical Co, St Louis, MO). The embedded tissues were mounted 
on the specimen disc of the vibratome (Vibratome, Ted Pella, Inc, Redding, CA). 
The disc was then mounted on to the vibratome in a tray filled with ice-cold 
Leibovitz L-15 and 40µm thick SCG-CB slices were sectioned.  2-3 slices were 
placed on a Millicell-CM cell culture inserts (Millipore, Bedford, MA) in a six-well 
plate containing 1 mL of Neurobasal-A medium with supplements (0.3% L-
glutamine, 2% B-27 and 1% Pen-Strept).  The inserts are porous membrane filter 
that allow the slices to remain well oxygenated without drying out and with 
adequate nutrition. The slices were maintained in a CO2 incubator, at 37oC, and 
the culture Neurobasal-A medium was changed every 2 days.  Figure 5B shows 
an organotypic slice of SCG/CB after 24 hours in culture.  As it can be observed 
by the close up image (Figure 5C), sections showed intact morphology with round 





































Figure  5- Culture of organotypic SCG/CB slices 
A) SCG/CB tissue complex after dissection from SD rat at P6. B) 40 m SCG/CB organotypic slice after 24 
hours in culture, 100 fold of magnification C) Amplification of the area of the SCG in the SCG/CB organotypic 
slice, 400 fold of magnification. SCG, superior cervical ganglia, CB, carotid body. 
 
 The viability of the slices was evaluated using propidium iodide (PI), a 
fluorescent membrane impermeant dye that intercalates between the bases of the 
DNA of nonviable cells (Jones and Senft, 1985) and the nuclei which appear 
bright orange-red nuclei when observed with a fluorescent microscope (rhodamine 
filters, Figure 6). Slices cultured for 24 hours were transferred to microscope 
slides. A positive control was prepared with incubation in 0.3% Triton X-100 in 
PBS for 10 min, 37oC, before addition of PI (500nM, Figure 6A). PI (500nM) was 
added to the slices at RT for 5 min (Figure 6B). Coverslips were mounted with a 
drop of glycerol/Tris media and observed under the microscope using rhodamine 
filters (Figure 6).  
 
Figure  6- Evaluation of cell death in slice culture 
A) Slices incubated with 0.3% Triton X-100 in the presence of PI (500 nM), showing a majority of death cells 
andB) minimal cell death observed in the slices cultured for 24 hours. Fluorescent intensity is depicted in each 
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 Identification of the neuronal SCG in the organotypic slices and the 
integrity of the slice were done by imunostaining with TH and neurofilament 
antibodies, using the same protocol described above for SCG cells (Figure 7).  
 
Figure 7- Identification of SCG neurons in organotopyc slices from rat at P6.  
A) SCG neurons labeled with anti-Tyrosine hydroxylase (TH) polyclonal rabbit antibody (1:100 in 1%BSA/PBS, 
overnight at 4oC) and detected using rhodamine donkey anti-rabbit antibody (1:100). B) SCG neurons labeled 
with neurofilament 68kDa (NF-68) mouse monoclonal antibody (1:100) and visualized by FITC goat anti-mouse 
antibody (1:100). D) DAPI staining showing more than SCG neurons in the slice culture. 400 fold magnification. 
Methodologies 
 
General in vitro whole tissue (organ) experimental conditions 
 
 Tissues were placed into an incubator chamber (1.5 ml eppendorf) 
containing 1 ml of Krebs modified medium (KMM) containing (in mM): NaCl 135; 
KCl 5; CaCl2 2; MgCl2 1.1, HEPES 10, glucose 5.5, in the presence or absence of 
HCO3- 24, at pH 7.4 and 37oC (Perez-Garcia et al., 1990) and continuously 
bubbled with the percentages of O2 and CO2 of interest. According to the aim of 
the experiment, incubation was done in the presence or absence of PDE and/or 
AC inhibitors. After 15-30 min of pre-incubation, tissues were replaced in fresh 
KMM in the presence or absence of PDEs and ACs inhibitors and activators (also 
see table 1.4 in attachments for reagents information) and equilibrated with 
different percentages of O2 and CO2 for 30-60 min (Figure 8). Changes in CO2 
were followed by changes in HCO3- to maintain a constant pH, according to the 
Henderson-Hasselbalch equation: pH= (6.1+log [HCO3-])/0.03xPCO2, and 
osmolarity was adjusted with NaCl. At the end of the intended period, tissue was 






































Figure  8- Set up for in vitro experiments  
A) Dissection microscope. B) Water bath and gas incubation. C) Detail of the incubator chamber bubbled with 
gas (O2/CO2), at 37C in a water bath.  
 













































Cyclic nucleotide extraction and quantification by EIA 
 
 At the end of the in vitro incubation experiments, tissues were collected 
and immersed in cold 6% (w/v) trichloroacetic acid (600 µL, Sigma) for 10 min.  
Tissues dissected from adult animals (Wistar, 3 months) were weighed in an 
electrobalance (mc 215 Sartorius, Madrid, Spain) to express the amount of cAMP 
per weigh of tissue. The tissues from younger animals (SD, P16-17) were not 
weighed but processed for protein quantification to express the amount of cAMP 
per µg of protein, as described bellow. Tissues were homogenized using a potter 
glass homogenizer at 2-8oC and centrifuged at 12 000 g for 10 min at 4oC.  The 
pellet was stored for protein assay. The supernatants were washed 4 times with 3 
ml of water saturated with diethyl ether solution (50:50), collected for lyophilization 
(Christ Alpha 1-2 B. Brawn, Biotech International, Melsungen, Germany) and 
stored at -20oC until cAMP quantification by commercial enzyme immunoassay 
(EIA) kit according to the manufacturer’s instructions (RPN 2255 GE Healthcare 
Bio-Sciences AB, Uppsala, Sweden). The EIA assay is based on the competition 
between unlabelled cAMP (present in the sample) and peroxidase- labelled cAMP 
for a number of cAMP-specific antibody binding sites. The standard and the 
unknown samples (both with unlabeled cAMP) are mixed with specific antiserum 
rabbit antibody and incubated in a 96 well microplate coated with capture 
antibody. The antiserum binds to the antibody of the plate and the cAMP from the 
samples and standards binds to the antiserum. Then cAMP-peroxidase conjugate 
is added to the wells and binds to the anti-cAMP antiserum that is not occupied by 
unlabeled cAMP. Therefore, the amount of cAMP conjugated that binds to the 
antibody, is inversely proportional to the concentration of cAMP in the sample. 
The wells are washed with detergent and the substrate of the cAMP-peroxidase 
conjugate (TMB) is added. If there is little cAMP pesent in the sample, more 
substrate will bind to the antiserum-peroxidase conjugate. Protein pellets were 
stored at -80°C until protein quantification. Samples from all tissues, except from 
the CB, were quantified by standard Bradford Protein Assay (Bio-RAD). CB 
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protein was quantified by a fluorescence detection kit, Molecular Probes’ 
NanoOrange Protein (Invitrogen, Eugene, OR), which offers an accurate detection 
of proteins with a higher level of sensitivity and lower protein-to-protein variability 
than the Bradford assay. cAMP levels were expressed in femtomoles per 
microgram of protein (fmol/µg protein).    
Western Blot 
 
 The presence of sAC protein was determined by Western blot using 20 
µL of protein from crude homogenates of CB, SCG (SD rats at P16-17) and testis 
(SD rat at 3 months old). The tissues were homogenized in buffer containing 20 
mM Tris-HCL (Sigma), 5mM ethylene glycol tetraacetic acid (EGTA, Sigma), 
10mM Benzamidine (Sigma), 0.1 mM phenylmethylsulfonyl fluoride (Sigma, 
PMSF) and 1mM ethylenediaminetetraacetic acid (EDTA, Sigma), 10% sucrose 
(Sigma) and complete protease inhibitor (Roche Molecular Diagnostics 
Pleasanton, CA, 1 tablet/50mL buffer).  The samples were diluted 2:1 (v/v) in 
loading buffer containing 0.125 M Tris –HCl pH 6.8 (Sigma), 4% sodium dodecyl 
sulfate (Sigma), Dl-dithiothreitol (Sigma), 20% (w/v) glycerol (Sigma), 0.004% 
bromophenol blue (Sigma) and 10% 2-mercaptotehanol (Sigma), boiled for 5 min 
and loaded on 10% sodium dodecyl sulfate polyacrylamine gel electrophoresis 
(SDS-PAGE). Protein was transferred to nitrocellulose membrane using standard 
electroblotting procedures and confirmed by Ponceau S. Nitrocellulose membrane 
was blocked with 5% nonfat dry milk in 0.1% Tween-Tris Buffered Saline (TTBS, 
Quality Biological Inc). Blots were incubated with monoclonal anti-sAC R21 
antibody (1:500, provided as a generous gift from Dr. Buck and Dr. Levin) or with 
the protein loading control goat anti-mouse monoclonal β-actin (1:10000, Sigma 
Chemical), overnight, at 4oC. The R21 monoclonal antibody was raised against 
amino acids 203-216 of human sAC encompassing the catalytic regions (C1 and 
C2) (Zippin et al., 2003). After exposure to the primary antibody, the membrane 




































conjugated secondary antibody (1:10,000, Bio-Rad) for 1 hour at RT. 
Immunoreactivity was detected with enhanced chemiluminescence using 
SuperSignal kit (Thermo Scientific, Wilmington, DE) and densitometric analysis 
(optical density OD) was done with IP Lab Gel H softaware (Signal Analytics) 
adjusted for background. Protein levels were expressed as adjusted OD levels 
corrected for loading.  
Quantitative Real-time Polymerase Chain Reaction (RT-PCR) 
 
 The comparison of the levels of gene expression of adenylate cyclases 
and phosphodiesterase and their regulation was done by quantitative real Time-
PCR (qRT-PCR) experiments. These experiments were divided into three steps: 
tissue collection, homogenization and total RNA isolation; cDNA synthesis; and 
real Time-PCR.  
 Tissues were collected in RNAse free eppendorf tubes and quick-frozen 
on dried ice and stored at -80oC. On the day of the experiment, the tissues were 
thawed on ice and processed to obtain total RNA according to the manufacturer’s 
instructions (Micro-to-Midi Total RNA Purification, Invitrogen). DNase treatment 
(PureLink DNase, Invitrogen) was performed during RNA purification, to avoid 
contamination with genomic DNA. RNA yield was measured by spectrophotometry 
at 260 and 280 nm: conventional UV spectrophotometer (Beckman Du 530) was 
used to measure OD260/OD280 of the RNA samples from all the tissues, except 
from the CB, where a NanoDrop spectrophotometer (Thermo Scientific) was used. 
Only RNA samples with an optical density ratio (OD260/OD280) between 1.8 and 2.0 
were used.  
 Total RNA (about 1 µg) was used for first-strand cDNA synthesis using 
an iSCRIPt cDNA synthesis kit (Bio-Rad Laboratories, Hercules, CA). 
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Table 2 Sequences of primers 
Gene Sequence (5’-3’) size 
sAC1 
       Sense:     CATGAGTAAGGAATGGTGGTACTCA;                                                      
Antisense:   AGGGTTACGTTGCCTGATACAATT 
111 
AC12 
































































             Sense:CACGGCAAGTTCAACGGCACAGTCA;                        
Antisense: GTGAAGACGCCAGTAGACTCCACGAC       
152 
-actin 
Sense: GGCCAACCGTGAAAAGATGAC;                                                                     
Antisense: GCCACGCTCGGTCAGGATCTT 
253 




































Suitability of primers for RT-PCR amplification was tested by amplifying 
the product from cDNA in a conventional PCR reaction using Phusion DNA 
polymerase (New England Biolabs). The absence of non-specific PCR products 
was confirmed by a single band product by electrophorese separation of the 
products in 2% ethidium bromide staining agarose gel.  A master mix was 
prepared containing 0.5µM anti-sense primer, 0.5µM sense primer, 10% template 
CB cDNA, 1X of 5X Phusion Buffer, 200µM of each dNTP and 0.02U/µl Phusion 
DNA polymerase and the cycling conditions were denaturing 2 min at 98°C, 
followed by 30 cycles at 98°C for 20 sec, 62°C for 20 sec, 72°C for 5 sec and a 
terminal extension period at 72°C for 5 min. The products were run in a 2% 
agarose gel (Figure 9). 
          Real Time-qPCR was performed with a MyiQ iCycler RT-qPCR system 
(Bio-Rad) with the SYBR Green detection system.  The intensity of the dye SYBR 
Green is proportional to the amount of PCR product. Each qPCR reaction 
consisted of 1 µl of cDNA and 3.5 µl of 300 nM primers diluted in DEPC-H2O and 
10µl of SYBR Green Supermix (Bio-Rad) for a final volume of 20 µl. We 
performed triplicates for each sample. qPCR conditions for sAC gene expression 
and regulation were: denaturing 8 min at 95°C, followed by 40 cycles at 95°C for 
1 min, 60°C for 30 sec, 72°C for 45 sec, and a terminal extension period (72°C, 
10 min). RT-qPCR conditions for AC (tmAC and sAC) expression and regulation 
were: denaturing 5 min at 95°C, followed by 40 cycles at 95°C for 20 sec, 62°C 
for 20 sec, 72°C for 20 sec, and a terminal extension period (72°C, 10 min). We 
analyzed the specificity of the RT-qPCR product by performing melting curves 
with 0.5oC increments in temperature. Product formation during the exponential 
phase of the reaction was analyzed for semi-quantification of relative expression 
in the specific tissues using the Pfaffl method (Pfaffl, 2001) or relative 
quantification to reference gene based on the threshold cycle (CT) for 
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Figure 9- Specificity of the primers. Visualization of thePCR amplification products in 2% agarose gel using 
different primer setsas indicated. No template cDNA was added to the negative control lanes (-). A) Adenylate 
cyclase primers: 1) AC1, 2) - AC1, 3) AC2, 4) -AC2, 5) AC3, 6) -AC3, 7) AC4, 8) -AC4, 9) AC5, 10) -AC5, 11) 
AC6, 12) -AC6, 13) Marker, 14) AC7, 15) -AC7, 16) AC8, 17) -AC8, 18) AC9, 19) -AC9, 20) sAC and 21) -sAC.  
B) Phosphodiesterases 3 and 4 (PDE3a-b and PDE4a-d) primers: 1) PDE3b, 2) -PDE3b, 3) Marker, 4) PDE4a, 
5) - PDE4a, 6) PDE4b, 7) P- PDE4b, 8) PDE4d, 9) - PDE4d, 10) G6PDH, 11) - G6PDH, 12) Marker, 13) Marker, 
14) PDE4c, 15) - PDE4C, 16) PDE3a, 17) - PDE3a.   
 
The reference gene used was the glucose-6-phosphate dehydrogenase 
(G6PDH). We also validate our results using two other different reference genes: 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and beta-actin (-actin). 
We evaluated the expression of the three reference genes in all the studied 
tissues and conditions using a website that combined 4 different algorithms used 
to determine the stability of the reference genes: geNorm, Normfinder, Bestkeeper 
and comparative Ct method (http://www.leonxie.com/referencegene.php?type=reference). 
We found that GAPDH is the most stable gene across our experiments, but the 
gene expression levels normalized with this reference gene showed the same 




































Fluorescence resonance energy transfer (FRET) 
 
 The FRET-based imaging technique was performed in the laboratory of 
Pharmacology, Department of Pharmacology at Johns Hopkins University, under 
the supervision of Dr. Jin Zhang.  The aim of this collaboration was to investigate 
the effect of PDE inhibitors and AC activators and inhibitors on cAMP downstream 
effectors such as PKA, using FRET-based imaging in primary cell cultures and 
organotypic slices of CB and SCG. 
 Primary cells (CB and SCG) and organotypic slices were infected with 
adenovirus to express the third generation of protein kinase A (PKA) activity 
reporter, AKAR3. AKAR3 is composed by a substrate peptide for PKA, a 
phosphorylation recognition domain, a cyan florescent protein (CFP) and a yellow 
florescent protein (YFP) (Zhang et al., 2001). PKA, when activated, is able to 
phosphorylate the substrate peptide sequence, whereupon the phosphorylation 
recognition domain forms an intracellular complex with the phosphorylated 
peptide. This conformational change alters the distance and or relative orientation 
between the two fluorescent proteins, generating a FRET change.  A 
dephosphorylation of the peptide by phosphatases reverses the FRET signal  
(Zhang et al., 2001). 
 Cells/slices were infected with AKAR3 virus in cell culture medium, 37oC, 
5%CO2, for 24 hours and viral infection was confirmed. Figure 10 confirms 
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Figure 10- PNA-labeled type I cells expressing A-Kinase Activity Reporter (AKAR3). A) AKAR3 
expression, visualized with the FITC channel. B) Type I cells labeled with Rho-PNA (30ug/mL) visualized with 
TRITC channel. C) Co-localization of AKAR3 and Rho-PNA, confirming the infection of type I cells with AKAR3. 
400 fold magnification. 
Figure 11 confirms, by immunostainig, the expression of AKAR3 on TH-positive 
SCG neurons, a specific marker for these cells, as mentioned above in SCG 
primary cultures.  
 
Figure 11- Primary superior cervical ganglia (SCG) cells expressing A-Kinase Activity Reporter (AKAR3) 
can be identified by expression of tyrosine hydroxylase (TH, a specific marker of these cells). A) Immunostaining 
of SCG cells labeled with anti-TH (1:50) and visualized with Rhodamine secondary antibody (1:100). B) 
Expression of AKAR3 in SCG cells, as visualized by FITC channel. C) Co-localization of AKAR3 and TH (1:50) in 
SCG cells.  400 fold magnification. 
Figure 12 confirms the expression of AKAR3 in organotypic SCG slices.  
 
Figure 12- Figure 2.12- Expression of A-Kinase Activity Reporter (AKAR3) visualized by FITC channel in 
organotypic slices from rat at P7, infected with AKAR3 for 48 hours after 2 days in culture. A) AKAR3 
expression in slices containing CB and SCG cells. B) AKAR3 expression in SCG organotypic slices. 200 fold 
magnification.  
 
A B C 
SCG 
CB 




































 Figure 13 shows the set up for FRET imaging. The cells were imaged on 
a Zeiss Axiovert 200M microscope (Carl Zeiss) with a 40X oil immersion objective 
and a cooled charge-coupled device camera (Roper Scientific) controlled by 
Metafluor 6.2 software (Molecular Devices). Dual emission ratio imaging used a 
420DF20 excitation filter, a 450DRLP dichroic mirror and two emission filters 




Figure 13- Perfusion system for FRET imaging.  Solutions containing PDE inhibitors and AC activators and 
inhibitors were warmed up in the water bath (1), equilibrated with different % of O2/CO2 (2). The solution passed 
through a pump (3; 2 ml/min) connected to a perfusion chamber (4) containing a petri-dish tightly closed with 
parafilm and containing the cells/slice. The perfusion chamber was placed next to the lens of an inverted 
fluorescent microscope Zeiss Axiovert (5) for image acquision.  The microscope setup uses an external light 
source (6) and a filter control (7) to excite the cyan fluorescent protein (CFP) and yellow fluorescent protein 
(YFP) of the FRET sensors. Fluorescent intensities were recorded by a digital CCD camera (8), controlled by 
Metaflour 6.2 software (9). 
 Exposure time was 50-500ms and images were acquired every 20 sec. 
Background correction of the fluorescence images was performed by subtracting 
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curves were normalized by setting the emission ratio at baseline (before the 
addition of any drugs) as equal to one. 
 In one set of experiments SCG neurons were placed on the heating 
stage of a Zeiss Axiovert 20M microscope with a 40X oil immersion objective lens, 
and sequentially were treated with rolipram (ROL, specific PDE4 inhibitor, 1µM), 
milrinone (MIL, specific PDE3 inhibitor, 10µM), IBMX (non-specific inhibitor, 
100µM), Forskolin (FSK, transmembrane adenylyl cyclase activator, 50µM) and 
H89 (PKA inhibitor, 10µM). 
 In another set of experiments, the imaging dishes containing SCG or CB 
or slice cultures were placed into a perfusion chamber (Warner Instruments) to 
allow perfusion of the cells with a constant flow rate of 2 ml/min (Ismatec pump, 
Cole Parmer Instruments) with Krebs modified solution in the presence or 
absence of different PDE and AC activators and inhibitors, equilibrated with 
different % of CO2/O2. Figure 14 shows the effect of the PDE inhibitors on PKA 
activity on SCG organotypic slices expressing AKAR3. These slices showed high 
basal activation of PKA, which did not allow us to observe changes between the 
different inhibitors.  
To test the contribution of tmAC and sAC in PKA activity in the CB type I 
cells, we performed two sets of experiments: CB cells were incubated in the 
presence of 1) tmAC and sAC activators, forskolin (50 µM) and HCO3-/CO2 (0/0-
44/10 mM/%), respectively, and 2) in the presence of tmAC and sAC inhibitors, 
MDL 12,330A (500 µM) and KH7 (50 µM), respectively. In both set of 





































Figure 14- SCG organotypic slices expressing AKAR3 contain high basal PKA activity. A) Pseudocolor 
images of SCG slices expressing AKAR3. B) Average time-course response of AKAR3 showing no change in 
emission ratio in response to rolipram (Rol), milrinone (Mil), IBMX and forskolin (FSK). Addition of H89 10 uM 
decreased emission ratio by 15%. 
Intracellular pH measurements 
 
 Two different approaches were considered to evaluate changes in 
intracellular pH in CB cells: iridium oxide pH sensor microelectrodes and 
fluorescent pH sensitive fluorescent dye. 
Iridium oxide pH sensor microelectrodes 
 
 Iridium oxide microelectrodes were developed and tested as a pH sensor 
in the Analytical and Bioanalytical Chemistry Institute, University of Ulm, 
Germany, under the supervision of Dr. Cristine Kranz. The aim of this 
collaboration was to develop a pH sensitive microelectrode to investigate changes 
in intracellular pH when the CB was exposed to Krebs modified solution (KMS) 
containing different concentrations of HCO3-/CO2.   
 Iridium oxide pH sensor microelectrodes were used instead of the typical 
glass pH sensor microelectrodes, since they have higher stability over a wide pH 
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range, are more rigid thus less breakable, compared to other electrodes. 
Microelectrodes were prepared as described in Marzouk and co-workers  
(Marzouk et al., 1998). Briefly, a platinum wire was placed inside of a borosilicate 
glass capillary tube, and the tip of the glass broken to expose the wire. Insulated 
copper wire was connected with the platinum wire. The pH sensor was prepared 
by electrochemical IrCl4 deposition producing an iridium oxide film. A microscope 
(Nikon) was used to estimating the diameter of the tip of the iridium 
microelectrode and the formation of the oxide film. The diameters of the 
microelectrodes tested ranged from 11-35 µm. Cyclic voltammetry and pH 
measurements were measured using a potentiostat consisting of an 
electrochemical workstation, a faraday cage and a CHI program (CH Instruments 
Inc, Austin, Tx) (Figure 15A). The electrochemical cell was a three-electrode 
setting with an Ag/AgCl reference electrode, a platinum wire as a counter 
electrode and the working microelectrode (Figure 15B).  
Titration curves were done to characterize the pH responses. The 
microelectrodes were calibrated measuring their potential response (mV) with 
respect to the reference electrode and comparing with the potential (mV) and pH 
value measured by a glass commercial pH meter, in a series of phosphates’ buffer 
solutions in the pH range from 2 to 10. The buffers were prepared by dropwise 
addition of 1M of HCl and NaOH to the solutions. As observed in Figure 16A, a 
linear relation between the potential (mV) and pH was observed, following the 
Nernst equation: E = E0 + (2.303RT/ nF) x pH (E= total potential (in mV) 
developed between the sensing and reference electrodes, Eo= a constant 
characteristic of the particular working/reference electrode pair, (2.303RT/ nF)= a 
slope of the straight line plot of mV vs pH). This linear relation was parallel with 
the response obtained with glass commercial electrode. The sensitivity of the 
microelectrode was assessed under relevant conditions to the work presented in 
this thesis. The effects of pH measurement in Krebs modified solution (KMS) were 
evaluated by comparison with commercial pH glass electrode and no differences 





































Figure 15- Potentiostat system   
A) Potentiostat system consists of a 1) Picoamp boster and faraday cage, used to lower the noise, make 
relatively fast measurements of small currents and eliminate electrical interference, a 2) electrochemical 
workstation and the 3) CH program version 8.10. All the equipment is from CH Instruments Inc, Austn, Tx. B) 
Electrochemical cell inside the faraday cage: 4) Ag/AgCl reference electrode, microelectrode the potential of 
which remains constant throughout the experiment, 5) working electrode (behind the reference electrode), 
microelectrode the potential of which varies with the experiment and 6) platinum counter electrode which simply 
serves to conduct electricity from the signal source though the solution.   
 
However, when KMS in the presence of 24mM HCO3- was equilibrated 
with 60%O2/5%CO2, no linear relation between potential and pH was obtained 
using the iridium oxide microelectrode (Figure 16C). Measurements of potential 
(mV) by iridium oxide microelectrodes were very unstable in the presence HCO3- 
/CO2/O2, which are critical/essential parameters/conditions for the experiments of 
this thesis.   Thus, other approach was performed to measure intracellular pH.  
 
Figure 16 - Calibration curves of the iridium oxide microelectrode and commercial glass electrode. 
Potentiometric responses of the same iridium oxide microelectrode (pink) and commercial glass pH electrode 
(blue) to pH changes in different medium solutions: A) phosphate buffer, B) Krebs modified solution and C) Krebs 
modified solution in the presence of 24mMHCO3-/5%CO2/60%O2.  Except for graph C), iridium oxide 
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Fluorescent intracellular pH measurement  
 Intracellular pH (pHi) was measured using the pH-sensitive fluorescence 
dye, 2’,7’-bis(2-carboxyethyl)-5(6)-carboxyfluoresceinacetoxy methyl ester  
(BCECF-AM (Molecular Probes, Eugene, OR) using a protocol previously 
described by Iturriaga and co-workers  (Iturriaga et al., 1992).  The carotid 
bifurcation with the CB was dissected from the rats, incubated with trypsin (0.02%, 
Sigma) and collagenase (0.01%, Sigma) for 30 minutes, and rinsed in PBS.  
Then, the CB was cleaned of connective tissue and fat, remaining attached to the 
carotid artery. The complex was then incubated with BCECF-AM (5 µM) at 37oC 
for 1 hour and washed to remove excess of dye.  The complex was placed in a 
perfusion chamber and the detection of labeled cell clusters allowed identification 
of CB type I cells in the whole CB. These regions were selected as regions of 
interest (ROI) to analyze changes in BCECF-AM fluorescence intensity while the 
whole organ was superfused with different concentrations of oxygen solutions. All 
solutions were titrated to pH 7.4 as described above. Fluorescent images were 
examined with a fluorescent microscope (Nikon Eclipse E-400, Nikon Instruments, 
Melville, NY) captured at 400x with an attached charge-coupled device (CCD) 
camera (Hamamatsu, Photonic ItSystems, Bridgewater, NJ). The BCECF dye was 
excited at 495 nm, and emission was recorded at 519 nm. The images were 
captured over a period of 200 frames corresponding to 2.38 minutes and analyzed 
by Ivison (BioVision Technologies, PA).  To avoid photobleaching, the intensity of 
light was controlled by Exfo X-cite 1200PC (0.12 intensity, Exfo Photonic 
Solutions, Ontario, Canada). Cells were superfused with the nigericin (10 
µM)/high K+calibration solutions of pH 6.5-8.0 (KCl 140mM, MgCl2 1.1 mM, CaCl2 
2.2mM, nigericine 10µM and Hepes 5 mM, titrated to the desired pH). Nigericin 
acts as both potassium and proton ionophore. By raising external potassium to 
140 mM the membrane potential should be reduced to around 0 mV and pHi 
should become equal to extracellular pH (pHo). The pHi is then controlled by 




































ensure that dye intensity corresponded to changes in intracellular pH  (Buckler et 
al., 1991). NH4Cl initially increased the fluorescence (alkaline), which was followed 
by a reduction of the sign (acid).  The initial increase in pH was due to the 
increase concentration of NH3 in the cell. After NH4Cl withdrawal, acidification was 
produced by the exit of NH3, leaving H+ in the cells. Changes in BCECF-AM 
fluorescence intensity were measured while the whole organ was superfused with 
oxygenated KMS containing increasing concentrations of HCO3-/CO2 and pHi 




 Statistical analysis were obtained using Graph Pad prism. Data are 
presented as means ± standard error of the mean and p<0.05 was considered 
significant. Specific analyses for each group of experiments are described in the 
results chapter.   
Methods- Diagram 
 
Figure 17- Diagram of the methods used in the work presented in this thesis   
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Chapter 1 is devoted to the experiments performed in CB and related non-
chemosensitive strutures to characterize PDE4 and the effects of O2 in its activity. 
The results obtained in this part of the work originated 1) one book chapter and 2) 
one publication in the British Journal of Pharmacology. The main findings are 
listed bellow:  
1) Functional characterization of phosphodiesterases 4 in the rat carotid 
body: effect of oxygen concentrations. 
Nunes AR, Batuca JR, Monteiro EC. Adv Exp Med Biol. 2009; 648:113-9. 
 
a) PDE 4 inhibitors induced an increase in cAMP levels in both normoxic and 
hypoxic conditions in CB, consistent with the presence of PDE4 activity in this 
tissue. Fig.1, page 78. 
b) In normoxia, only high levels of inhibitors caused clear effects on cAMP levels 
while hypoxia increased the effects of the inhibitors at a lower range. Fig.1, page 
78.  
c) Acute hypoxia increased efficacy and potency of the inhibitors. Emax obtained 
for all inhibitors (PDE4 inhibitors and non-selective PDE inhibitor, IBMX) were 
similar in hypoxia and higher than in normoxia, suggesting a higher contribution of 
PDE4 in the hydrolise of cAMP in this tissue. – Figure 1 and table 1, page 78 and 
79; 
2) Acute hypoxia modifies cAMP level induced by inhibitors of 
phosphodiesterase-4 in rat carotid bodies, carotid arteries and superior 
cervical ganglia 
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a) cAMP levels did not change significantly between pre-incubations of either 
95%O2 (hypercapnic conditions) or 20%O2 (normocapnic conditions) in CB, SCG 
and carotid arteries in the presence of IBMX- Fig 1 page 86; 
b) Hypoxic conditions (5%O2) did not modify cAMP concentrations in the rat CB, 
SCG and carotid arteries comparatively with basal (20%O2) – Fig 2,page 86; 
c) IBMX (0.3-500uM), rolipram (0.1- 100 uM) and ro 20-1724 (0.1-100 uM) 
increased cAMP content in CBs in a concentration-response manner in normoxia, 
and hypoxia shifted the concentration-response curves to the left. This shift was 
statistically significant for IBMX (>50 uM) and rolipram (<100 uM). Fig 3 and table 
1, page 87 e 88; 
d) IBMX (0.3-500uM), rolipram (0.1- 100 uM) and ro 20-1724 (0.1-100 uM) 
increased cAMP content in carotid arteries in hypoxic conditions, specially at low 
concentrations of Ro 20-1724 and IBMX and high concentrations of rolipram. Fig 
4, page 88. 
e) In the SCG, both PDE4 inhibitors, IBMX and PDE2 inhibitor, EHNA, increased 
cAMP levels in normoxic conditions. Hypoxia induced a significant decrease in 






























Functional characterization of phosphodiesterases 
4 in the rat carotid body: effect of oxygen 
concentrations  
 
A.R. NUNES, J.R. BATUCA AND E.C. MONTEIRO 
 
Department of Pharmacology, Faculty of Medical Sciences, New University of Lisbon, Campo 





 The non-specific cAMP phosphodiesterase (PDE) inhibitor 
isobutylmethylxanthine (IBMX) has been used to manipulate cAMP levels in 
carotid body (CB) preparations but the characterization of different PDE 
isoforms in CB has never been performed. PDE4 is one of the PDE families 
that uses cAMP as a specific substrate and changes its activity and affinity for 
drug inhibitors according to the degree of its phosphorylation. We 
investigated the effects of hypoxia on cAMP accumulation induced by 
different PDE4 inhibitors in the CB based on the hypothesis that acute 
changes in O2 could interfere with their affinity.  
 Concentration-response curves for the effects of the PDE4 selective 
inhibitors, rolipram and Ro 20-1724 and IBMX on cAMP were obtained in 
CBs, removed from rats and incubated in normoxia (20%O2) or hypoxia 
(5%O2). 
 No differences were found between cAMP concentrations in 
normoxic and hypoxic conditions in the absence of PDE inhibitors. In both 
conditions, the Emax calculated for IBMX was similar to that of the specific 
PDE4 inhibitors. Hypoxia shifted the concentration response curves to the 
left with the following rank order of potency IBMX> RO 20-1724=rolipram 
and increased Emax by about 25%.  
 This pharmacological approach supports the hypothesis that there is 
PDE4 activity in CBs that is enhanced by acute hypoxia although the low 
potency of the PDE4 inhibitors to increase cAMP do not support an important 
role for PDE4 activation in the O2-sensing machinery at the CB.  
 
Key words: Carotid body; Hypoxia; phosphodiesterases; cAMP; 
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 cAMP is an ubiquitous intracellular second messenger common to 
metabotropic receptors coupled to transmembrane adenylate cyclase and 
hydrolysed by cyclic nucleotide phosphodiesterases (PDE). cAMP 
concentrations in the CB are regulated by the stimulatory effects of adenosine 
mediated by A2A and A2B receptors (Chen et al. 1997;Conde et al. 
2006;Monteiro et al. 1996), by beta-adrenoceptor activity (Mir et al. 1984) 
and by dopamine D2 and D1 receptors (Almaraz et al. 1991;Batuca et al. 
2003;Mir et al. 1984). Some evidence also suggests a modulatory role for 
cAMP in the O2-sensing machinery in the CB (Gonzalez et al. 1994) but it 
has also been shown that cyclic nucleotides alone do not modify K
+
 current 
inhibition by hypoxia in isolated type I carotid body cells (Hatton et al. 
1996). 
 The non-specific cAMP phosphodiesterase (PDE) inhibitor 
isobutylmethylxanthine (IBMX) has been used to manipulate cAMP levels in 
CB preparations but the characterization of different PDE isoforms in CB, 
has never been performed. Eleven kinetically distinct PDE isoform families 
that differ in their affinity for subtracts (cAMP and/or cGMP), 
pharmacological inhibitors and their response to modulators have so far been 
identified (Bender et al. 2006).  
 PDE4 is one of the PDE families that uses cAMP as a specific 
substrate, its activity is not regulated by Ca2+ but changes its activity and 
affinity for drug inhibitors according to the degree of its phosphorylation 
(Bender et al. 2006). Chronic hypoxia (several days) regulates PDE4 activity 
in pulmonary arteries (Millen et al. 2006) as well as the activity of cAMP-
PDE in rat blood (Spoto et al. 1998) but little is known about the effect of 
acute hypoxia. Increases in the activity of a Ca2+-dependent PDE in CBs of 
rats submitted in vivo to 40 min of hypoxia have been reported (Hanbauer et 
al. 1977). 
 We investigated the effects of hypoxia on cAMP accumulation 
induced by different PDE4 inhibitors at the CB based on the hypothesis that 
acute changes on O2 could interfere with their affinity.  
 
 
2. METHODS  
 
2.1. Surgical procedures 
 
 The experiments were performed on CBs, isolated from adult (3 
months old) male and female Wistar rats. Rats were obtained from the 
Faculty of Medical Sciences animal house, kept at a constant temperature 
(21ºC) with a regular light (08-20h) and dark (20-08h) cycle, with food and 
water ad libitum. Experiments were carried out in accordance with the 
Portuguese regulations for the protection of the animals. Surgical procedures 

































































































Hypoxia and PDE4 inhibitors at the carotid body            135 
least one order of magnitude higher than adenylate and guanylate cyclases in 
all tissues (see e.g. (Bender et al. 2006)).  
 Acute hypoxia increased the efficacy as well as the potency of the 
inhibitors suggesting that probably an increase in both PDE activity and drug 
affinities are involved. Complex cAMP driven mechanisms through protein 
kinase A and extracellular signal regulated kinase mediated phosphorylation 
can modify PDE4 specific isoforms activity and subsequently alter sensitivity 
to selective inhibitors (Bender et al. 2006). The hypothesis that acute hypoxia 
may cause PDE4 activation by PKA- or ERK mediated phosphorylation 
could be advanced. 
 In conclusion, this pharmacological approach supports the 
hypothesis that there is PDE4 activity in CBs that is enhanced by acute 
hypoxia although the low potency of the PDE4 inhibitors to increase cAMP 
do not support an important role for PDE4 activation in the O2-sensing 
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Chapter 2 is devoted to the effect of O2 on PDE3 and PDE4 and PKA activity in 
the superior cervical ganglia. The results obtained in this part of the work 
originated one book chapter. The main findings are listed bellow: 
 
Effect of oxygen on phosphodiesterases (PDE) 3 and 4 isoforms and PKA 
activity in the Superior Cervical Ganglia.  
Nunes A.R., Sample V., Xiang Y.K., Monteiro E.C., Gauda E.B. and Zhang J. In 
Arterial chemoreceptors: From Molecules to systems, 758; 287-294. C.A. Nurse et 
al (eds.), Springer, Netherlands, 2012. 
 
a) Using FRET-based imaging, PDE inhibitors were able to increase PKA activity 
in SCG neurons. Fig 39.1, page 98. 
b) Different patterns of PDE activities were observed: some SCG neurons 
presented high PDE4 activity, others high PDE3 activity and others both PDE3 
and PDE4 activity. Fig 39.2, page 99. 
c) No differences were observed in the emission ratio (no differences in PKA 
activity) between normoxic and hypoxic conditions in SCG neurons, in the 
presence of IBMX 500µM. 
d) PDE3a-b and PDE4a-d are expressed in the rat SCG, being PDE3a, PDE4b 
and PDE4d the most expressed isoforms in this organ. Figure 39.3a, page 100. 
e) Hypoxic (5%O2), normoxic (20%O2) and hypercapnic (60%O2) conditions did 
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cyclase activator forskolin (FSK, 50  m M). Different PDE activity patterns were observed in different 
cells: high PDE4 activity (n = 3), high PDE3 activity (n = 3) and presence of activity of other PDEs 
(n = 3). Addition of PKA inhibitor H89 (10  m M) completely reversed the response. We further studied 









 ) induced a similar increase in the FRET emission ratio (14.5 ± 0.8 and 
14.7 ± 0.8, respectively). 
 PDE3a, PDE4b and PDE4d isoforms mRNAs were highly expressed in the whole SCG with no 
modulation by hypoxia. 
 CONCLUSION: Using a FRET-based PKA activity sensor, we show that primary SCG neurons 
can be used as a model system to dissect the contribution of different PDE isoforms in regulating 
cAMP/PKA signaling. The differential patterns of PDE regulation potentially represent subpopulations 
of ganglion cells with different physiological functions. 
 Keywords  Superior cervical ganglia (SCG) •  Phosphodiesterases (PDE) •  Cyclic AMP (cAMP) 
•  Hypoxia •  Protein kinase A (PKA) 
 39.1  Introduction 
 Cyclic AMP is a ubiquitous second messenger involved in synaptic transmission and signal transduction. 
The levels of cAMP are regulated by the synthetic activity of adenylate cyclases (AC) and by the 
hydrolytic activity of phosphodiesterases (PDE); the latter determines the intracellular concentration 
of cAMP (Bender and Beavo  2006 ) . Thus, PDEs have become important targets of study in the past 
years and have been pursued as therapeutic targets (Bender and Beavo  2006 ) . There are 11 PDE 
isoforms that differ in their af fi nity for cAMP and/or cGMP and inhibitors, and in their responses to 
modulators (Bender and Beavo  2006 ) . 
 Superior cervical ganglion (SCG) has a key role in the sympathetic nervous system and sends 
neuronal projections to the carotid body (CB) controlling the vascular tone. We have recently observed 
that acute hypoxia decreased cAMP levels induced by PDE inhibitors in these ganglia, an opposite 
effect to that observed in the CB (Nunes et al.  2010 ) . 
 The aim of this work is to characterize the role of PDE3 and PDE4 regulation on cAMP/PKA 
activity in the SCG under different oxygen concentrations. We also wanted to explore whether the 
effect of hypoxia observed in cAMP production induced by IBMX is translated into apparent changes 
in PKA activity in primary SCG neurons. 
 To answer these questions we investigated the effect of PDE inhibitors on the activation of PKA in 
dissociated SCG neurons using  fl uorescence resonance energy transfer (FRET)-based imaging 
and studied the expression of PDE3 and PDE4 and their regulation by oxygen in the whole SCG by 
quantitative RT-PCR. 
 39.2  Methods 
 39.2.1  Surgical Procedures 
 The experiments were performed using SCGs isolated from Sprague–Dawley rats (Charles River 
Laboratories, Wilmington, MA) of both sexes at postnatal days 5–9. The Animal Care and Use 
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The animals were anesthetized brie fl y with iso fl urane and immediately decapitated. The carotid 
bifurcation was isolated and the SCG dissected and cleaned of surrounding connective tissue under a 
dissecting microscope. The tissues removed were further prepared as follows. 
 39.2.2  Measurement of Protein Kinase A (PKA) Activity in Primary Superior 
Cervical Ganglia Neurons by FRET 
 SCGs were mechanically and enzymatically dissociated with an enzyme mixture consisting of trypsin 
and collagenase (~0.5 mg/ml). SCG cells were plated on poly-D-Lysine and laminin coated imaging 
dishes and cultured for 2–4 days in neurobasal-A supplemented with NGF and Ara-C (10  m M). To 
monitor PKA activity, we infected the SCG neurons with an adenovirus containing a 3 rd -generation of 
a genetically encoded A-Kinase activity reporter (AKAR3) for 24 h. 
 In one set of experiments we imaged the SCG neurons at 37 °C and sequentially treated them with 
rolipram (ROL, speci fi c PDE4 inhibitor, 1  m M), milrinone (MIL, speci fi c PDE3 inhibitor, 10  m M), 
IBMX (non-speci fi c inhibitor, 100  m M), Forskolin (FSK, transmembrane adenylyl cyclase activator, 
50  m M) and H89 (PKA inhibitor, 10  m M). 
 In another set of experiments, we placed the imaging dish into a chamber (Warner Instruments) to 
allow superfusion of the cells with a constant  fl ow rate of 2 ml/min (Ismatec, Cole Parmer instrument) 
with Kreb’s modi fi ed solution containing (in mM): NaCl 116, NaHCO 
3
 24, KCl 5, CaCl 
2
 2, MgCl 
2
 









 ) in the presence or absence of IBMX 
(100  m M). 
 The cells were imaged on a Zeiss Axiovert 200 M microscope (Carl Zeiss) with a 40X oil immersion 
objective and a cooled charge-coupled device camera (Roper Scienti fi c) controlled by Meta fl uor 6.2 
software (Molecular Devices). Dual emission ratio imaging used a 420DF20 excitation  fi lter, a 
450DRLP dichroic mirror and two emission  fi lters (475DF40 for cyan  fl uorescent protein (CFP) and 
535DF25 for yellow  fl uorescent protein (YFP)). Exposure time was 50–500 ms and images were 
acquired every 20 s. Background correction of the  fl uorescence images was performed by subtracting 
auto fl uorescent intensities of regions of the imaging dish with no cells. Graph curves were normalized 
by setting the emission ratio at baseline (before the addition of an y drugs) as equal to one. 
 39.2.3  PDE mRNA Gene Expression and Regulation 
 In one set of experiments we compared PDE3 and PDE4 gene expression levels in the whole SCG. 
The tissues were isolated (3 rats per condition; n = 3 independent experiments), quick-frozen on dry 
ice and stored at −80 °C. 
 In another set of experiments, we studied the effect of changes in oxygen tension on the expression 
of PDE3 and PDE4 in the whole SCG. Tissues were pre-incubated in a 37 °C shaker bath for 30 min 




 (normoxia). After the pre-incubation 









 ) for 60 min. Tissues were quick-frozen on dry ice and 
stored at −80 °C. 
 Frozen tissues were processed to obtain total RNA (about 1  m g, micro-to-Midi Total RNA 
Puri fi cation, Invitrogen) that was used for  fi rst-strand cDNA synthesis using an iSCRIPt cDNA 
synthesis kit (Bio-Rad Laboratories). The primer sequences used were: forward 5 ¢ - 
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for PDE3a, forward 5 ¢ -CGACCAATTCCTGGCTTACAGCAGC-3 ¢ and reverse 5 ¢ - GCAGGAATG-
TTTGAAGACAGGCAGCC-3 ¢ for PDE3b, forward 5 ¢ -CCTGCACGCAGCGGATGTGC-3 ¢ and 
reverse 5 ¢ -GGAACTGGTTGGAG-ACGCCAGG-3 ¢ for PDE4a, forward 5 ¢ -CCTGGCTGCCAT-
TTTTGCAGC-TGC-3 ¢ and reverse 5 ¢ -GAGCTTGAATCCCACAGCGAGGTG-3 ¢ for PDE4b, forward 
5 ¢ -CCAGGAGGAGCAGCTGGCTAAG-3 ¢ and reverse 5 ¢ - CACGTTGGAGTGGTAGTGCCCTTC-3 ¢ 
for PDE4c, forward 5 ¢ - GCG-GAGCTGTCTGGCAACCG-3 ¢ and reverse 5 ¢ - GACTGGACGACATCTG-
CAGCATGG-3 ¢ for PDE4d, and forward 5 ¢ - GATGGCCTTCTACCCG-AAGACACC-3 ¢ and reverse 
5 ¢ - GCCAGCTACATAGGAGTTACGGGC-3 ¢ for G6PDH. 
 qRT-PCR was performed with a MyiQ iCycler qRT-PCR system (Bio-Rad Laboratories) with 
Syber Green detection. qRT-PCR conditions were: 5 min at 95 °C, followed by 40 cycles at 95 °C for 
20 s, 60 °C for 20 s, 72 °C for 20 s, a terminal extension period (72 °C, 10 min) and a melting curve 
with 0.5 °C increments in temperature. Product formation during the exponential phase of the reaction 
was analyzed for relative quanti fi cation to the reference gene based on the threshold cycle (C 
T
 ) for 
ampli fi cation as 2 ( D CT) , where  D C 
T
 = C 
T,reference
 − C 
T,target
 . 
 39.3  Results 
 We investigated the role of PDE3 and PDE4 on the activation of PKA in primary SCG neurons using 
FRET-based imaging. Figure  39.1 shows a representative response in a SCG neuron induced by 
sequential addition of speci fi c and non-speci fi c PDE inhibitors. While ROL did not induce a change 
in emission ratio (∆ER), Mil induced an increase in ∆ER with no further changes with IBMX and 
FSK. Addition of H89 (10  m M) completely reversed the response. This pharmacological pro fi le sug-
gests that there is high PDE3 activity in this neuron. However, this pattern was not consistent in all 
SCG neurons. PDE inhibitors differentially modulated PKA activity, suggesting that there are 
subpopulations of SCG neurons with different PDE activity patterns. 
 Figure  39.2 shows the pro fi les of PDE3 and PDE4 activity in regulating PKA in different SCG 
neurons: 1) high PDE4 activity with 20.0 ± 0.4%  D ER in response to ROL with no further increase 
with MIL, IBMX and FSK (n = 3, Fig.  39.2a ), 2) high PDE3 activity with 1.9 ± 0.6%  D ER in 
response to ROL and 19.0 ± 7.2%  D ER to MIL with no further increase with IBMX and FSK (n = 3, 
Fig.  39.2b ), and 3) activity of other PDEs than PDE3/PDE4, with 1.6 ± 0.8%  D ER in response to 
ROL, 5.7 ± 1.1% in response to MIL and 18.7 ± 2.7% in response to IBMX and no further increase 
in the presence of FSK (n = 3, Fig.  39.2c ). Addition of H89 reversed the response in all neurons 
(Fig.  39.2 ). 
 To determine whether oxygen tension modi fi es PKA activity by affecting PDE activity, we per-
fused SCG neurons with Kreb’s modi fi ed solution in the presence and absence of IBMX (100  m M) 
equilibrated either with normoxia or hypoxia. 
 D ER increased as a consequence of perfusion with IBMX in normoxia and this effect was com-
pletely reversible after washout. No differences were observed in the ∆ER between normoxia and 
hypoxia in the presence of IBMX (14.5 ± 0.8 ∆ER and 14.7 ± 0.8 ∆ER, respectively, n = 10). 
 We further characterized the gene expression of the PDE3a-b and PDE4a-d isoforms in the whole 
SCG. Even though all isoforms were expressed in the SCG: PDE3a, PDE4b and PDE4d were the most 
abundant (Fig.  39.3 ). This pattern of expression was similar in SCG incubated with control oxygen 
concentrations (hypoxia, normoxia and hyperoxia) (Fig.  39.3b ) and those that were quick frozen without 
incubations (Fig.  39.3a ). Exposing SCGs with different percentages of oxygen did not signi fi cantly 
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 39.4  Discussion 
 In this work, we characterized the PDE3 and PDE4 expression in the SCG and investigated the role 
of these PDE isoforms in the activation of PKA in ganglion neurons. We demonstrated that FRET-
based imaging could be used to study the contribution of PDE isoforms in the regulation of cAMP/
PKA signaling in primary SCG neurons as a model system. We observed differential patterns of PDE 
regulation in subpopulations of SCG neurons, which can potentially represent those subpopulations 
with different physiological functions. The level of oxygen tension did not modulate PDE expression 
and did not change the effect of PDE inhibition in the PKA activity. 
 SCG contains subpopulations of sympathetic neurons (secreto-, pilo-, vasomotor neurons), which 
receive input from the cervical sympathetic pre-ganglionic nerve  fi bers and provides innervations of 
the neck and head structures (Asamoto  2005 ) . Each subpopulation of neurons projects exclusively to 
speci fi c targets (Li and Horn  2006 ) , which could explain the differences in PDE regulating PKA activ-
ity between SCG neurons described in our work. 
 We identi fi ed for the  fi rst time PDE3 and PDE4 mRNA expression patterns in the SCG. This 
 fi nding adds to the literature by identifying PDE3 isoforms in this ganglion and is consistent with 
previous reports that characterize PDE4 by the effects of their speci fi c inhibitors (Giorgi et al.  1994 ; 
Lakics et al.  2010 ; Li and Horn  2006 ; Nunes et al.  2010 ) . We found that PDE3a, PDE4b and PDE4d 
 Fig. 39.1  ( a ) Pseudocolor images (400X) and ( b ) representative response curve of AKAR3 to rolipram (Rol, 1  m M), 
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 Fig. 39.3  Effect of different oxygen concentrations on PDE3 and PDE4 isoform gene expression in the whole superior 
cervical ganglia (SCG). ( a ) PDE3a-b and PDE4a-d isoform expression levels and their ( b ) regulation by hypoxia 
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not translated into changes in PKA activity. No effect of oxygen tension on changes in PKA activity 
could be due to saturation of PKA activity under high levels of cAMP caused by the PDE inhibition. 
Further experiments will test whether changes in oxygen concentrations directly modify PDE 
activity. 
 The results suggest selective distribution of PDE3a, PDE4b and PDE4d isoforms in subpopulations 
of ganglion cells that potentially represent subpopulations with dif ferent physiological functions.  
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Chapter 3  
 
Chapter 3 is devoted to the characterization of sAC and tmAC isoforms in 
peripheral and central chemoreceptors and the effect of changes in HCO3-/CO2 in 
the activity of these enzymes. The results obtained in this part of the work 
originated 1) one book chapter and 2) and 3) manuscripts that are in submission 
and preparation for publication, respectively. The main findings are listed bellow:  
1) Bicarbonate-regulated soluble adenylyl cyclase (sAC) mRNA expression 
and activity in peripheral chemoreceptors 
Nunes AR, Monteiro EC, Johnson SM, Gauda EB. Adv Exp Med BIol 2009; 
648:235-41 
 
a) sAC is higly expressed in the CB comparatively to the SCG, PG and NG, 
except for the testis, the tissue control. Table 1, page 108. 
b) Increasing concentrations of HCO3/CO2 during 1 hr up-regulated sAC gene 
expression only in CB. Table 2, page 108. 
c) sAC protein is expressed in the CB, SCG and testis. Fig. 1, page 109. 
d) Changes from 0 to 24 mMHCO3-/5%CO2, in the presence of IBMX, PDE 
inhibitor, and MDL 12 330A, tmAC inhibitor, induced an increase in cAMP levels in 
the only in the CB. Table 3, page 109.  
2) Bicarbonate-sensitive soluble adenylyl cyclase (sAC) and transmembrane 
adenylyl cyclase in peripheral chemoreceptors. 
Nunes AR, Holmes APS, Sample V, Kumar P, Cann MJ, Monteiro EC, Zhang J 
and Gauda EB. J Physiol (Submitted).  
e) The amount of cAMP in the CB was dependent on the HCO3-/CO2 (0/0, 12/2.5, 
24/5, 44/10). cAMP levels were highest in 24 mM HCO3/CO2 (normocapnic 
conditions). Peripheral non-chemosensitive tissues did not change cAMP levels in 
the presence of different concentrations of HCO3-/CO2. Fig 1, page 123.  
Chapter IV 
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f) Changes of HCO3-/CO2 did not alter pHi in CB type I cells. Fig 3, page 125. 
g) Different HCO3-/CO2 concentrations did not change PKA activity in type I cells. 
h)The profile of expression of adenylyl cyclase isoforms was different between CB 
and PG. In the CB, the expression of tmAC 1, 3, 4, 6 and 9 were higher than sAC. 
Fig 5, page 129. 
i) There is a higher contribution of tmAC and sAC for cAMP accumulation in 
response to 12 mM HCO3/2.5CO2 than to normocapnic and hypercapnic 
conditions. Fig 7, page 131.  
j) The inhibitory effect of KH7 (sAC inhibitor, 10uM) and ddADO 100uM (tmAC 
inhibitor) was the same after 5 or 30 min of incubation in all the concentrations of 
HCO3-/CO2 tested. Fig 8, page 133. 
k) CSN discharge was increased by acidic but not isohydric hypercapnia. Inhbiton 
of tmAC but not sAC, decreased the basal discharge of the CSN and its response 
to acidic hypercapnia. Fig 9, page 133. 
3) Bicarbonate-sensitive soluble adenylyl cyclase (sAC) and transmembrane 
adenylyl cyclase in central CO2 chemoreceptors- a comparative study with 
the carotid body (in preparation) 
m) sAC mRNA wass expressed in the central chemoreceptors regions; expression 
levels in central chemoreceptors were lower than in the CB. sAC expression is 
upregulated by concentrations of HCO3/CO2 in the LC, but not in the other central 
regions. Fig 1, page 148. 
n) tmAC inhibitors blocked only 50% of the cAMP production in the LC. Fig 2, 
page 148.  
o) The amount of cAMP in the LC, VLM and RN, but not cortex, was dependent 
on concentrations of HCO3-/CO2. Fig 3, page 150. 
p) tmAC isoforms 1, 2, 3, 4, 6, 8 and 9 were more expressed than sAC in the LC. 
Fig 4, page 151. 
q) tmAC and sAC were partially active in the LC normocapnia, but in hypercapnia 
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Breathing is modulated by peripheral arterial chemoreceptors 
distributed in Type I cells in the carotid body (CB), which are sensitive to 
changes in pCO2/pH (for a review see (Gonzalez et al. 1994)). cAMP is an 
important mediator of O2-chemotransduction (for a review see (Gonzalez et 
al. 1994)) through activation of transmembrane adenylyl cyclase (tmAC), 
and hypercapnia increases cAMP levels in the CB (Perez-Garcia et al. 1990); 
however, the specific cellular mechanisms responsible for CO2 sensitivity in 
this organ are not well understood. Recently, a soluble adenylyl cyclase 
(sAC) that is activated and regulated by changes in HCO3
-
/CO2 has been 
characterized in testis and somatic tissues (Buck et al. 1999;Schmid et al. 
2007;Sinclair et al. 2000;Sun et al. 2003;Wang et al. 2005). Unlike tmAC, 
sAC is insensitive to G proteins or to foskolin, and is unique in its activation 
by HCO3
- (reviewed in (Kamenetsky et al. 2006)). In this study, we 
examined the role of sAC in chemotransduction and hypothesized that sAC 
mRNA will be expressed in the CB and that changes in CO2/HCO3
- levels 




2. METHODS  
 
 Sprague-Dawley rats at postnatal days 16-17 were used. Animals 
were anesthetized with isoflurane and decapitated. Carotid body (CB), 
superior cervical (SCG), petrosal (PG), nodose (NG) ganglia and testis were 
removed, and prepared for quantitative real-time polymerase chain reaction 
(qRT-PCR), immunoblotting or cAMP measurements. Experiments were 
approved by the Animal Care and Use Committee at the Johns Hopkins 
University School of Medicine. 
 
 2.1. sAC mRNA Gene Expression and Regulation 
 
We characterized sAC mRNA gene expression in the CB and non-
chemoreceptor tissues pooled from six rats from the same litter. The 
experiment was done in triplicate using a total of 18 animals from 3 different 
litters.  
 In order to study the effect of HCO3
-
 on sAC mRNA levels in the 
CB, SCG and testis, the tissues were pre-incubated in Krebs modified 
solution containing (in mM) NaCl 116; KCl 5; CaCl2 2; MgCl2 1.1; HEPES 
10; glucose 5.5, pH 7.40 (Perez-Garcia et al. 1990) with 0 mM HCO3
-/ 
0%CO2/60%O2, for 30 minutes. The tissues were then incubated in Krebs 
modified solution containing one of the following conditions: 1) 0 mM 
HCO3
-
/0% CO2/60% O2, 2) 24 mM HCO3
-
/5% CO2/60% O2, and 3) 44 mM 
HCO3
-
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Spearman's Rank-Order Correlation and by Kruskal-Wallis one-way 
ANOVA with the Dunnett’s post hoc test using GraphPad Prism (GraphPad 
Software, Inc., version 4, San Diego, CA) or SPSS (SPSS Inc., version 12, 





3.1. sAC mRNA Gene Expression and Regulation 
 
sAC mRNA expression was lower in SCG, PG and NG than in CB 
and testis removed from rats at postnatal days 16-17 (Table 1). 
 
Table 1 - sAC mRNA expression in peripheral chemoreceptors and non-chemoreceptors 






CB SCG NG PG testis 
% of CB. sAC 
expression 
(m±SEM) 
100 11.3±1.33 3.05±0.22 3.78±0.54 254±47.9 
 
 
Increasing concentrations of HCO3
- upregulated sAC gene expression only in 
the CB (p < 0.01; Spearman’s correlation), but did not affect sAC mRNA 
gene expression in other tissues, including testis (Table 2).  
 
Table 2- Effect of HCO3
-/CO2 on sAC mRNA relative gene expression (relative 
expression to 0mM HCO3
-
 for each tissue) 
HCO3
- 
 (mM) / CO2 (%) 
 
Tissues 0 mM / 0 % 24 mM / 5 % 44 mM / 10 % 
CB 1.00 ± 0.00 1.58 ± 0.15 2.12 ± 0.30 
SCG 1.00 ± 0.00 1.00 ± 0.14 0.90 ± 0.04 
testis 1.00 ± 0.00 0.67 ± 0.47 0.97 ± 0.23 
 
 
Western immunoblot was used to determine the presence of sAC protein 
detected with the monoclonal anti-sAC antibody, identified as R21 (Figure 
1). We detected an intense band at 50 kDa in the CB, SCG and testis 
corresponding to the sACt isoform. In the testis we also detected  




































































Figure 1- Immunoblot showing sAC protein expression in 









3.2. Bicarbonate-Regulated cAMP Levels 
 
The effect produced by increasing the concentrations of HCO3
- on 
cAMP levels in CB and non-chemoreceptor tissues (SCG, PG, testis) in the 
presence of IBMX (500 µM) and MDL-12,330A (500 µM) is shown in Table 
3. Previous experiments have demonstrated that MDL-12,330A (500 µM) 
was effective in blocking tmAC. In the CB, increasing HCO3
- 
concentrations 
from 0 to 24 mM significantly increased cAMP levels from 15.27 ± 3.22 to 
35.27 ± 6.04 fmol/µg protein (p<0.01). Exposing the CB to higher 
concentrations of HCO3
-/CO2 (44 mM HCO3
- with 10%CO2) did not produce 
any additional increase in cAMP levels in this tissue. Increasing HCO3
- 
concentrations did not increase cAMP levels in non-chemoreceptor tissues 
(SCG, PG and testis). These results suggest that sAC could be involved in 
chemoreception of HCO3
-/CO2 in peripheral arterial chemoreceptors. 
 
Table 3- Effects of changes in HCO3




 (mM) / CO2 (%) 
Tissues 
0 mM / 0 % 24 mM / 5 % 44 mM / 10 % 
CB 15.3± 3.22 (n=16) 35.3 ± 6.04 (n=14) ** 26.3 ± 2.83 (n=14)* 
SCG 31.6 ± 5.41 (n=9) 43.5 ± 14.8 (n=7) 36.06 ± 6.96 (n=8) 
PG 16.8 ± 6.125 (n=6) 15.9 ± 6.69 (n=6) 17.9± 8.09 (n=5) 
testis 9.21 ± 1.75 (n=10) 8.99 ± 1.49 (n=10) 9.32 ± 1.44 (n=10) 
 
* p<0.05 by one-way Kruskal-Wallis test with the Dunnett’s post-test corresponding to 
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4. DISCUSSION 
 
We describe the novel finding of increased sAC gene expression and 
regulation in the carotid body, which is sensitive to changes in pH/CO2.  
These results demonstrate that sAC gene expression occurs in both the CB 
and in non-chemoreceptor tissues: SCG, PG, NG. Unlike non-chemoreceptor 
tissues, sAC gene expression is greatest in the CB, where it is modulated by 
HCO3
-
 in a concentration-dependent manner.  
We identified several protein isoforms of sAC using homogenates of 
testicular tissue, CB, and the SCG that were consistent with the previously 
described truncated sAC isoform (sACt: 48 kDA) (Buck et al. 1999) reported 
for testicular tissue. Our data also show that other novel isoforms of sAC are 
expressed in the homogenates of the testis but the functions of these isoforms 
have not been characterized.  
We tested the role of HCO3
-/CO2 on sAC gene expression and 
activity in CB and SCG, PG and testis, and showed that increasing 
concentrations of CO2/HCO3
- increased sAC mRNA gene expression in a 
concentration-dependent manner and induced an increased in cAMP levels 
but only in the CB. We excluded the effect of external pH variations by 
maintaining the extracellular pH at 7.4, but the intracellular pH was not 
measured. However, it has been shown that when the extracellular pH 
maintains constant and pCO2 increases, there is little change in intracellular 
pH in Type I cells (Buckler et al. 1991) of the carotid body. Additionally, 
sAC activity is also independent of changes in intracellular pH (Chen et al. 
2000). Taken together, sAC gene expression in the CB is most likely 
regulated by changes in HCO3
-
 concentration. Yet, we can not be certain 
whether these findings are specific to Type I cells, since homogenates of the 
CB were used. Similar to other reports, we detected sAC gene expression in 
testicular tissue. However, in response to CO2/HCO3
-, we did not observe an 
increase in cAMP levels in this tissue, which could be explained by the fact 
that we used whole testis homogenates from younger animals than has been 
previously reported (Jaiswal et al. 2001). 
In this study, we describe for the first time that sAC gene expression 
and its activity differs between CB chemosensitive tissues and non- 
chemosensitive tissues (PG, NG, and SCG). The regulation of sAC gene 
expression and activity suggests different cellular roles for sAC in these 
tissues. Our results also suggest that in peripheral arterial chemoreceptors, 
sAC may mediate cAMP-dependent pathways, responding to changes in 
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BICARBONATE- SENSITIVE SOLUBLE AND TRANSMEMBRANE 
ADENYLYL CYCLASES IN PERIPHERAL CHEMORECEPTORS 
           A R Nunes1,2, A Holmes3, V Sample4, P Kumar3, M J Cann5, E C Monteiro2, J Zhang3  and 
E B Gauda1* 
1Pediatrics, 4Pharmacology and Molecular Sciences, Johns Hopkins Medical Institutions, Baltimore, MD; 2CEDOC, 
Pharmacology, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Portugal; 3School of Clinical and 
Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham, 5School 
of Biological and Biomedical Sciences, Durham University, U.K. 
 
Background and purpose: The CO2-sensing mechanisms in mammalian carotid body 
(CB) are not fully understood. As cAMP levels are associated with the chemotransduction 
mechanism, this study investigates if changes in HCO3-/CO2 modify chemodischarge 
through a HCO3/CO2 responsive – soluble adenylyl cyclase (sAC) and/or a 
neurotransmitter/ hormone responsive-transmembrane adenylate cyclase (tmAC) 
dependent mechanism. Experimental approach: We examined changes in sAC and 
tmAC mRNA expression (quantitative Real Time-PCR), cAMP levels (ELISA), activation of 
protein kinase A (PKA, FRET-based sensors) and carotid sinus nerve activity (in vitro 
nerve recordings) in the presence and absence of activators or inhibitors of sAC, tmAC, 
and PKA.   
Key Results: Increases in HCO3-/CO2 from 0/0% to normocapnia, in the presence of 
IBMX, a phosphodiesterase inhibitor, and MDL-12 330, a tmAC inhibitor, increased cAMP 
levels in the rat CB, but no further increases were observed in response to hypercapnia 
(44/10%). Forskolin, but not isohydric hypercapnia, increased PKA activity in type I cells of 
the CB. In the CB, the level of expression for tmAC1,4,6 and 9 isoforms was more highly 
expressed than sAC. Both sAC and tmAC inhibitors (KH7 10-50 µM, sAC inhibitor, and 
2’3’-ddADO 100 µM) decreased cAMP levels in CB in both normo- and isohydric 
hypercapnia, with a higher contribution of tmAC. However, sAC and tmAC inhibitors 
induzed a higher inhibitory effect on the cAMP levels under 12 mM HCO3/2.5%CO2 than 
normocapnia or isohydric hypercapnia. cAMP levels did not change significantly during 
different incubation times (5-30 min) in the presence of different concentrations of HCO3-
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/CO2, in the presence or absence of adenylyl cyclase inhibitors. CSN discharge was 
increased by acidic but not isohydric hypercapnia. Inhibition of tmAC, but not sAC, 
decreased the basal discharge of the CSN and its response to acid hypercapnia.  
Conclusions and Implications: sAC and tmAC are functional in peripheral 
chemoreceptors, and tmAC but not sAC, is envolved in setting the basal chemoafferent 
discharge and the response to acidic hypercapnia. Isohydric hypercapnia causes no 
change in cAMP, PKA and discharge frequency. Evidence supports a particular 
contribution of these enzymes in situations when low HCO3- concentrations occur. 
Collectively, these data support that transduction of CO2 requires an absolute change in 
pHi, which is dependent on cAMP deived from tmAC. 
Keywords: cAMP, cyclic adenosine monophosphate; CB, carotid body; sAC, soluble 
adenylyl cyclase; tmAC, transmembrane adenylate cyclase; peripheral arterial 
chemoreceptors; HCO3-/CO2, bicarbonate/ CO2. 
*Correspondence author: Estelle B. Gauda, M.D., Department of Pediatrics, Division of 
Neonatology, Johns Hopkins Medical University, 600 N. Wolfe Street, CMSC 6-104, 
Baltimore, MD 21287-3200 USA, egauda@mail.jhmi.edu 
Running title: sAC and tmAC in carotid body.  
 
Introduction 
     Peripheral arterial chemo-receptors 
located in the carotid body (CB) and 
central chemoreceptors located in the 
brainstem contain specialized cells that 
either depolarise in response to changes in 
PaO2  or in response to changes in 
CO2/H+. Type I (glomus) cells of the CB, 
the peripheral chemoreceptor units, are 
innervated by carotid sinus nerve (CSN) 
afferents, a branch of the 
glossopharyngeal nerve, which have 
somas in the petrosal ganglion (PG), and 
relay on to neurons in the nucleus tractus 
solitarius in the brainstem (Gonzalez et al., 
1994).Although peripheral chemoreceptors 
were believed to be the major O2 sensors 
while central chemoreceptors contributed 
predominantly to the CO2/pH ventilatory 
response, recent evidence suggest that the 
central and peripheral chemoreceptors 
interact with each other, and the latter can 
modulate the central sensitivity to CO2/pH 
(for a review see (Forster and Smith, 
2010)). The specific cellular CO2 sensing 
mechanisms that trigger hyperventilation in 
order to maintain metabolic demands are 
not fully understood although recent work 
has demonstrated a role for connexin 26 in 





























chemosensitive cells (Huckstepp et al., 
2010).  
     cAMP is an essential secondary 
messenger that activates a multitude of 
downstream effectors through protein 
kinase A (PKA), exchange proteins 
activated by cAMP (EPACs) and cyclic 
nucleotide gated ion channels (CNGs).  
Two types of adenylyl cyclase mediate the 
production of cAMP in mammalian cells: 
the family of transmembrane adenylyl 
cyclase (tmAC) isoforms and the soluble 
adenylyl cyclase (sAC).  In peripheral 
chemoreceptors, cellular cAMP levels are 
modulated by neurotransmitters/ 
neuromodulators that bind to G-protein 
coupled receptors (GPCRs) and alter 
tmAC activity (Gonzalez et al., 1994, Lahiri 
et al., 2006). At least nine specific tmAC 
isoforms have been identified in 
mammalian genomes, but they have not 
been characterized in this tissue. tmAC 
isoforms are sensitive to G proteins,  
forskolin, Ca2+- signaling pathway (Halls 
and Cooper, 2011), and CO2 (Townsend et 
al., 2009; Cook et al. 2012). sAC is 
activated by HCO3- and Ca2+ (reviewed by 
Kamenetsky et al., 2006). We have 
previously identified sAC mRNA and 
protein in the CB and related peripheral 
non-chemosensitive structures suggesting 
a functional role for sAC in this tissue 
(Nunes et al., 2009).  
     In this work, we explored whether 
isohydric hypercapnia increases 
chemodischarge through a HCO3-/CO2 
responsive-soluble adenylyl cyclase (sAC) 
and neurotransmitter responsive-
transmembrane (tmAC) dependent 
mechanism.  
 
Materials and Methods  
Surgical procedures 
     The Animal Care and Use Committee at 
the Johns Hopkins University School of 
Medicine approved all experimental 
protocols. CSN recording experiments 
were performed at the University of 
Birmingham and were approved by the 
Biomedical Services Unit.  
     Peripheral arterial chemoreceptors, as 
well as non-chemoreceptor tissues, were 
isolated from Sprague-Dawley rats (SD, 
Charles River Laboratories, Wilmington, 
MA) of both sexes at postnatal days (P) 16 
and 17. At this age CB hypoxic 
chemosensitivity is mature (Kholwadwala 
and Donnelly, 1992). The non-
chemoreceptor tissues included the 
superior cervical (SCG), petrosal (PG) and 
nodose (NG) ganglia.  Since sAC is highly 
expressed and has been well 
characterized in testicular tissue from rats 
at 3 months of age (Sinclair et al., 2000) 
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we included this tissue from this age 
animal as a positive control.  
     In one set of experiments, prior to tissue 
removal or dissection, the animals were 
anesthetized briefly with isoflurane and 
immediately decapitated. The carotid 
bifurcation, including the CB, SCG, and the 
NG/PG complex, was removed en bloc.  
Subsequently, tissues were isolated and 
cleaned of surrounding connective tissue 
under a dissecting microscope. In another 
set of experiments, we dissected CB for 
dissociation of type I cells from SD rats at 
P5-9. At this age dissociated cells were 
easier to obtain and no statistical 
differences in cAMP accumulation were 
observed between the whole CB from rats 
DOL 7 (23.5± 3.1 fmol/µg protein, n=6) 
and P17 (33.9± 4.6 fmol/µg protein, n=4) 
in normocapnic conditions. Lastly, CSN 
recording experiments were performed 
with tissues obtained from adult male SD 
rats (50-100g, Charles River UK Ltd, 
Margate, UK). CBs were harvested as 
described previously (Pepper et al, 1995). 
Briefly, anaesthesia was induced in an 
airtight induction chamber using 4% 
isoflurane in medical O2 administered at a 
flow rate of 1.5 – 3 ml/min. Surgical 
anaesthesia was continuously maintained 
through a nose cone with 1.5 – 2.0% 
isoflurane in O2, at a flow rate of 1.5 – 3 
ml/min. The carotid bifurcation along with 
the superior cervical ganglion, vagus 
nerve, glossopharyngeal nerve, carotid 
sinus nerve and the carotid body were all 
excised. The tissue was immediately 
placed in ice-cold bicarbonate buffered 
extracellular Krebs solution containing, in 
mM: 125 NaCl, 3 KCl, 1.25 NaH2PO4, 5 
Na2SO4, 1.3 MgSO4, 24 NaHCO3, 2.4 
CaCl2, 11 D-glucose, equilibrated with 95% 
O2 and 5% CO2. 
 
Effects of HCO3-/CO2 on cAMP levels 
     A control experiment was performed to 
confirm the efficacy of MDL-12,330A 
(Sigma) in blocking tmAC under our 
experimental conditions. PGs were pre-
incubated in Krebs modified solution in the 
presence of 24 mM HCO3- for 30 minutes 
followed by incubation in fresh Krebs 
modified medium, for 30 minutes, in the 
presence of 24 mM HCO3- plus forskolin 
(1-100 µM; Sigma) and 3-isobutyl-1-
methylxanthine (IBMX, 500 µM; Sigma), a 
phosphodiesterase (PDE) inhibitor. Based 
on the concentration-response curves for 
forskolin on cAMP levels, we divided CBs, 
PGs and testes into two experimental 
groups - one treated with forskolin (10 µM) 
in the absence of MDL-12,330A (500 µM) 
and the other treated with forskolin (10 
µM) in the presence of MDL-12,330A. 
     To study the effect of changes in HCO3-





























measurement of sAC activity, we pre-
incubated the CB and non-chemosensitive 
tissues (SCG, PG, testis and nodose 
ganglia) tissues in Krebs modified solution 
without HCO3-/CO2 and in the presence of 
MDL-12,330A (500 µM), a tmAC inhibitor 
(Delpiano and Acker, 1991).  After 30 
minutes, we incubated the tissues in fresh 
Krebs modified solution in the presence of 
MDL-12,330A (500 µM), and either 0 mM 
HCO3-/0 % CO2; 12 mM HCO3-/2.5% CO2; 
24 mM HCO3-/5% CO2; or 44 mM HCO3-
/10 % CO2 for 30 minutes, pH 7.4, 37°C.  
We modified the incubation buffer by 
changing CO2 and HCO3- concentrations, 
adjusting the osmolarity with NaCl. This 
approach allows the assessment of CO2 
effect, preventing major changes in pH.  
     All the experiments were conducted in 
the presence of a non-specific inhibitor for 
phosphodiesterase (PDE) IBMX (500 µM).  
To treat the testicular tissues, we also 
added dypiridamole (500 µM) to the 
incubation medium due to the elevated 
expression of PDE8 in this tissue, which is 
not inhibited by IBMX (Lugnier, 2006).  
Tissues were pooled from 2 animals from 
the same litter and the experiments were 
repeated using animals from different 
litters. Tissues were processed for cAMP 
extraction and the quantification was done 
as outlined below in cyclic nucleotide 
extraction and quantification. All the 
experiments were done in the presence of 
60%O2 since hypoxia has been known to 
increase the chemosensitivity response to 
CO2 (Fitzgerald and Parks, 1971). 
 
Contribution of sAC and tmAC to cAMP 
levels under different concentrations of 
HCO3-/CO2.  
     We tested the effect of the tmAC 
selective inhibitor, 2’5’-ddADO (100 µM, 
Sigma), or sAC inhibitor (KH7, 10-100 
µM), or both on the cAMP accumulation in 
the CB during 30 min and over time (0, 5, 
15, 30 min of incubation) under different 
concentrations of HCO3-/CO2. Control 
experiments were also performed to 
compare the effect of the tmAC inhibitors: 
MDL-12,330A (500 µM), ddADO (30-300 
µM) or SQ 22536 (200 µM). All 
experiments were conducted in the 
presence of IBMX (500 µM).  
 
Cyclic nucleotide extraction and 
quantification 
     cAMP was measured as previously 
reported (Batuca et al., 2003) and briefly 
described here.  We immersed tissues in 
cold 6% (w/v) trichloroacetic acid (TCA; 
600 µl) for 10 minutes, and then all the 
tissues were homogenized at 2 - 8ºC and 
centrifuged them at 12,000 g for 10 
minutes at 4ºC. The supernatants were 
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washed four times in 3 ml of water 
saturated with diethyl ether solution (50:50) 
and then lyophilized.  The sample was then 
stored at -20ºC until cAMP quantification 
by enzyme immunoassay (EIA, RPN 2255, 
GE Healthcare Bio-Sciences AB, 
Piscataway, NJ).  Protein pellets were 
stored at  -20°C until measured with the 
standard Bradford Protein Assay (Bio-
RAD) or by using a fluorescence detection 
kit, NanoOrange Protein (Invitrogen, 
Eugene, OR).  cAMP levels were 
expressed in femtomoles per microgram of 
protein (fmol/µg protein), which is more 
accurate than normalizing to grams of 
tissue, especially for small tissue samples, 
such as the CB. 
 
Intracellular pH measurement in carotid 
body 
     Intracellular pH (pHi) was measured 
using the pH-sensitive fluorescence dye, 
BCECF-AM (Molecular Probes, Eugene, 
OR) using a protocol previously described 
by Iturriaga and co-workers (Iturriaga et al., 
1992).  The isolated CB was incubated 
with trypsin (0.02%, Sigma) and 
collagenase (0.01%, Sigma) for 30 
minutes, and rinsed in phosphate buffered 
saline (PBS).  Then, the CB was incubated 
with BCECF-AM (5 µM) at 37oC for 1 hour 
and washed to remove excess dye.  Since 
type I cells, the sensors of the CB, appear 
usually in clusters, we selected these 
regions as the regions of interest (ROI) and 
analyzed the change in BCECF-AM 
fluorescence intensity while the whole 
organ was superfused with oxygenated 
solutions containing increasing 
concentrations of HCO3-/CO2.  All solutions 
were titrated to pH 7.4 as described above.  
Fluorescent images were examined with a 
fluorescent microscope (Nikon Eclipse E-
400, Nikon Instruments, Melville, NY) 
captured at 400x with an attached charge-
coupled device (CCD) camera 
(Hamamatsu, Photonic ItSystems, 
Bridgewater, NJ). The BCECF dye was 
excited at 495 nm, and emission was 
recorded at 519 nm. The images were 
captured over a period of 200 frames 
corresponding to 2.38 minutes and 
analyzed by Ivison (BioVision 
Technologies, PA). To avoid 
photobleaching, the intensity of light was 
controlled by Exfo X-cite 1200PC (0.12 
intensity, Exfo Photonic Solutions, Ontario, 
Canada).  A calibration curve for each CB 
was performed at the end of each 
experiment using the nigericin (10 
µM)/high K+ method (Thomas et al., 1976) 
to determine changes in fluorescence 
intensity versus pH (6.5-8.0).  Exposure to 
ammonium chloride (NH4Cl, 50mM) was 





























corresponded to changes in intracellular 
pH (Buckler et al., 1991).  
 
Changes in protein kinase A (PKA) 
activity in dissociated type I cells of the 
CB using FRET-based sensors 
 CBs isolated from SD rats P5-9 
were mechanically and enzymatically 
dissociated with an enzyme mixture 
consisting of trypsin and collagenase 
(~0.5mg/ml, Sigma) according to the 
protocol described by Carroll and co-
workers (2005).  CB cells were plated on 
poly-D-Lysine coated imaging dishes and 
cultured for 3 hours.  To monitor PKA 
activity we used a 3rd generation of a 
genetically encoded A-Kinase activity 
reporter dependent on FRET (AKAR3).  
AKAR3 consist of a fusion of a CFP, a 
phosphothreonine-binding domain, a PKA 
substrate, and the YFP variant venus 
(Allen and Zhang, 2006). When PKA is 
activated, the catalytic subunit of PKA 
phosphorylates the target in AKAR3, 
causing a conformational reorganization 
that increases FRET between CFP and 
YFP (Allen and Zhang, 2006). We obtained 
the adenoviruses expressing the AKAR3 
reporter by Yang K. Xiang’s laboratory and 
infected the CB type I cells for 24 hours.  
One hour before FRET imaging, CB type I 
cells were labeled with rhodamine PNA 
(Rho-PNA, 30 µg/ml) in complete CB 
medium at 37oC as previously described 
by Kim and co-workers (2009).  After an 
hour, we placed the imaging dish 
containing the cells infected with AKAR3 
and labeled with Rho-PNA into a chamber 
(Warner Instruments, Hamden, CT) to 
allow superfusion of the cells with a 
constant flow rate of 2 ml/min (Ismatec, 
Cole Parmer instrument CO, Vernon Hills).  
The cells were imaged on a Zeiss Axiovert 
200M microscope (Carl Zeiss, Thornwood, 
NY) with a 40X oil immersion objective and 
a cooled charge-coupled device camera 
(Roper Scientific, Trenton, NJ) controlled 
by Metafluor 6.2 software (Molecular 
Deices, Downingtown, PA).  Dual emission 
ratio imaging used a 420DF20 excitation 
filter, a 450DRLP dichroic mirror and two 
emission filters (475DF40 for CFP and 
535DF25 for YFP).  Exposure time was 50-
500 ms and images were acquired every 
20 sec.  Background correction of the 
fluorescence images was performed by 
subtracting intensities from regions of the 
imaging dish with no cells.  To test the 
contribution of tmAC and sAC in PKA 
activity we performed two sets of 
experiments: CB cells were incubated in 
the presence of 1) tmAC and sAC 
activators, forskolin (50 µM) and HCO3-
/CO2 (0/0-44/10 mM/%), respectively, and 
2) in the presence of tmAC and sAC 
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inhibitors, MDL 12,330A (500 µM) and 
KH7 (50 µM), respectively.  In both set of 
experiments, PDEs were inhibited by IBMX 
(10-100 µM). Graph curves were 
normalized by setting the emission ratio 
before drug addition equal to one.  
 
tmAC and sAC mRNA gene expression  
     The mRNA expression levels for sAC 
and the nine isoforms of tmAC in the CB 
and PG were compared. The tissues were 
isolated as mentioned in surgical 
procedure (4 rats per condition; n=3 
independent experiments), cleaned from 
surrounded tissue and quick-frozen on dry 
ice and stored at -80oC.  
     In independente experiments FSK, a 
tmAC activator, was used to investigate its 
effects on the regulation of sAC gene 
expression. The CB were pre-incubated in 
Krebs modified solution containing (in mM): 
NaCl 135; KCl 5; CaCl2 2; MgCl2 1.1; 
HEPES 10; glucose 5.5, pH 7.40 (Perez-
Garcia et al., 1990) with 24 mM NaHCO3 
and equilibrated with 5%CO2/60%O2. After 
30 minutes, we replaced the pre-incubation 
buffer with incubation buffer containing 24 
mM NaHCO3 and FSK (100 µM), 
equilibrated with 5%CO2/60%O2, for 1 hour 
at 37ºC, pH 7.4. Tissues were pooled from 
4 animals from the same litter and the 
experiments were repeated 4 times using 
animals from different litters. At the end, 
tissues were quick-frozen on dry ice and 
stored at -80ºC until further processing for 
RT-qPCR, as outlined below.  
 
Real time – quantitative PCR 
     Tissues used to study sAC and tmAC 
mRNA gene expression and regulation 
levels were processed to obtain total RNA 
(Micro-to-Midi Total RNA Purification, 
Invitrogen, Carlsbad, CA) according to the 
manufacturer’s instructions.  DNase 
treatment (PureLink DNase, Invitrogen) 
was performed to avoid genomic DNA 
contamination.  RNA yield and quality was 
measured at 260 and 280 nm by 
conventional UV spectrophotometer 
(Beckman Du 530) or NanoDrop 
spectrophotometer (for RNA from CB 
samples, Thermo Scientific, Wilmington, 
DE).  Total RNA (about 1 µg) was used for 
first-strand cDNA synthesis using an 
iSCRIPt cDNA synthesis kit (Bio-Rad 
Laboratories, Hercules, CA).  
     The respective primer sequences for 
each adenylyl cyclase isoform used are 
shown in Table 2, General Methods, 
quantitative RT-PCR section (Pastor-Soler 
et al., 2003b, Chang et al., 2003). Relative 
expression of AC genes between the 
tissues and conditions was standardized 
with levels of glucose-6-phosphate 
dehydrogenase (G6PDH) expression, the 





























results using two more different reference 
genes: glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) and Beta-actin 
(-actin) (Table 2, General Methods, 
quantitative RT-PCR section , Wang and 
Xu, 2010).  We evaluated the expression of 
the three reference genes in all the studied 
tissues and conditions using a web site 
that combined 4 different algorithms used 
to determine the stability of the reference 
genes: geNorm, Normfinder, Bestkeeper 
and comparative Ct method 
(http://www.leonxie.com/referencegene.ph
p?type=reference). We found that GAPDH 
is the most stable gene across our 
experiments, but AC gene expression 
levels normalized with this reference gene 
showed the same trend of results as 
shown when normalized with G6PDH.   
        RT-qPCR was performed with a MyiQ 
iCycler RT-qPCR system (Bio-Rad) with 
the SYBR Green detection system.  Each 
qPCR reaction consisted of 1 µl of cDNA 
and 3.5 µl of 300 nM primers diluted in 
DEPC-H2O and 10 µl of SYBR Green 
Supermix (Bio-Rad) for a final volume of 20 
µl.  We performed triplicates for each 
sample.  qPCR conditions for sAC gene 
expression and regulation were: denaturing 
8 min at 95°C, followed by 40 cycles at 
95°C for 1 min, 60°C for 30 sec, 72°C for 
45 sec, and a terminal extension period 
(72°C, 10 min).  qPCR conditions for AC 
(tmAC and sAC) expression and regulation 
were: denaturing 5 min at 95°C, followed 
by 40 cycles at 95°C for 20 sec, 62°C for 
20 sec, 72°C for 20 sec, and a terminal 
extension period (72°C, 10 min).  We 
analyzed the specificity of the RT-qPCR 
product by performing a melting curve with 
0.5oC increments in temperature.  Product 
formation during the exponential phase of 
the reaction was analyzed for semi-
quantification of relative expression in the 
specific tissues using the Pfaffl method 
(Pfaffl, 2001) or relative quantification to 
reference gene based on the threshold 
cycle (CT) for amplification as 2(ΔCT), where 
ΔCT = CT,reference − CT,target.  
 
Extracellular CSN recordings 
     The carotid bifurcation, along with the 
superior cervical ganglion, vagus nerve, 
glossopharyngeal nerve, carotid sinus 
nerve and the carotid body was pinned out 
in a small volume (ca 0.2 ml) dissecting 
chamber with a Sylgard 184 base (Dow 
Corning).  The tissue was continuously 
superfused with a bicarbonate buffered 
extracellular Krebs solution containing, in 
mM: 125 NaCl, 3 KCl, 1.25 NaH2PO4, 5 
Na2SO4, 1.3 MgSO4, 24 NaHCO3, 2.4 
CaCl2, 11 D-glucose, equilibrated with 95% 
O2 and 5% CO2. Connective tissue was 
removed and the superior cervical 
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ganglion, branches of the vagus nerve and 
the occipital artery were all individually 
excised.  The carotid sinus nerve was cut 
away from the glossopharyngeal nerve 
exposing the nerve endings. The whole 
tissue was partially digested by incubation 
in a bicarbonate buffered, equilibrated 95% 
O2 and 5% CO2 enzyme solution (0.075 
mg/ml collagenase type II, 0.0025 mg/ml 
dispase type I; Sigma) at a temperature of 
37°C, for 20 – 30 min, in a water bath at 
37°C (Grant W14, Grant Instruments 
Cambridge Ltd).  
     Extracellular recordings were made 
from the cut end of the CSN using glass 
suction electrodes pulled from GC150-10 
capillary glass (Harvard Apparatus). 
Voltage was amplified using an AC pre-
amplifier (NeuroLog NL104; Digitimer), 
then filtered between 50 Hz and 3 kHz 
(NeuroLog NL125; Digitimer) and amplified 
further with an AC amplifier (NeuroLog 
105; Digitimer).  Total amplification was 
x4000. Derived voltage was recorded using 
a CED micro1401 (Cambridge Electronic 
Design) and visualised on a PC with 
Spike2 (version 7.1) software (Cambridge 
Electronic Design). Offline analysis using 
Spike2 allowed for discrimination of single 
unit activity.  
     Flow meters with high precision valves 
(Cole Palmer Instruments) were used in 
order to gas the superfusate with a desired 
gas mixture. The superfusate PO2 was 
continuously measured using an O2 meter 
(OXELP, World Precision Instruments) and 
was maintained throughout at 300 mmHg. 
The superfusate PCO2 was increased from 
40 mmHg to 80 mmHg to monitor carotid 
body responses to acidic hypercapnia. In 
isohydric hypercapnia experiments, a 
PCO2 of 80 mmHg and a NaHCO3 
concentration of 44 mM were used to 
maintain pH. Here, osmolality was 
balanced by reducing the NaCl 
concentration. 
 
Data analysis and statistical procedures 
     The data are represented as mean ± 
SEM and differences between the 
experimental groups were determined 
using statistical software from GraphPad 
Prism (GraphPad Software Inc., version 4, 
San Diego, CA) or SPSS (SPSS Inc, 
version 12, Chicago, IL).  Statistical 




Bicarbonate-regulated cAMP levels 
     We had previously reported that, when 
tmAC is inhibited, increases in HCO3/CO2 
from 0/0 to 24/5 (mM/%) augmented cAMP 
levels in the CB but not in peripheral non-
chemosensitive tissues (Nunes et al., 
2009). In this work we explored the effects 





























(mM/%: 0/0, 12/2.5, 24/5, and 44/10) on 
cAMP production in peripheral chemo- and 
non-chemosensitive tissues as well as in 
testis from 3 month-old rats (control 
tissue). To differentiate between the 
activity of tmAC and sAC, we incubated the 
tissues with MDL-12,330A (500µM), an 
effective tmAC inhibitor in our preparations 
(Fig.1). In response to 10 µM of FSK (an 
effective concentration to induce increases 
in cAMP levels, Fig.1A), MDL-12,330A 
(500µM) blocked 95%, 81% and 91% of 
cAMP production in the CB (Fig.1B), PG 
(Fig.1C) and testes (Fig.1D). Experiments 
were performed in the presence of IBMX 
(500 µM), a non-specific PDE inhibitor.  
 
 
Figure 1 – Effect of a) Forskolin (1-100 µM) and MDL-12,330A (500 µM) on cAMP levels in b) carotid body 
(CB), c) petrosal ganglia (PG) and d) testicular tissue. ** p<0.01, *** p<0.001 Paired t- test corresponding to 
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Figure 2 - Concentration- response curves of HCO3-/%CO2 for effects on cAMP levels in the CB and non-
chemosensitive tissues. 0% increase was obtained with 0 mM HCO3/0%CO2:  17.8 ±2.9 fmol/µg protein (CB, 
n=21); 31.6±5.4 fmol/µg protein (SCG, n=9); 23.9 ±6.9 fmol/µg protein (PG, n=6); 8.7 ±2.9 fmol/µg protein (NG, 
n=3); 2.79 ±0.33 fmol/µg protein (testis, n=7).  
 
In non-chemosensitive tissues, 
concentrations of HCO3-/CO2 did not 
induce changes in cAMP levels, except in 
testicular tissues (Fig.2). Although sAC 
mRNA is highly expressed in testes, we 
had not been previously able to show sAC 
activity in testes from young animals 
(Nunes et al., 2009). In the present work, 
the results obtained using testes from adult 
rats support that sAC function increase 
with development in this tissue (Sinclair et 
al., 2000, Braun and Dods, 1975). 
The amount of cAMP in the chemo-
sensitive tissue, CB, was dependent on the 
concentration of HCO3-/CO2 
(0/0,12/2.5,24/5 mM HCO3-/%CO2, Fig.2). 
cAMP levels in the CB were highest in 
normocapnia (24 mM HCO3-/5%CO2); 
higher concentrations of HCO3-/CO2 (44 
mM HCO3- /10%CO2) had no additional 
effect on cAMP levels in this organ (Fig.2). 
These results suggested to us that when 
tmAC is blocked, sAC reached a maximal 
level of activity under physiological 
(normocapnic) conditions, 24 mM HCO3-
/5%CO2. 
     To determine whether the changes in 
cAMP levels in response to different 
concentrations of HCO3-/CO2 were 
mediated by a direct effect of bicarbonate 
or due to changes in intracellular pH (pHi) 





























sensitive fluorescence dye BCECF-AM.  A 
control experiment with NH4Cl showed that 
there was a distinct change in fluorescent 
intensity in the cells of the CB (Fig.3A,B). 
Furthermore, we observed incremental 
changes in fluorescent intensity associated 
with changes in extracellular pH (6.5-8.0), 
using the nigericin (10 µM)/high K+) 
method to construct calibration curves. We 
observed no variation in pHi 
associated with changes from 0mM 
HCO3- /0%CO2 to 44mM HCO3- 
/10%CO2 within each selected region 
of the whole CB (Fig. 3C,D). These 
results suggest that increases in 
HCO3-/CO2 with constant extracellular 





0 seconds, 0mM HCO3
-/ 0%CO2 130 seconds, NH4




Carotid body Carotid body 
Figure 3- BCECF dye fluorescent intensity representing changes in intracellular pH (pHi) in the 
superfused CB.  A) Representative photomicrographs of the CB showing changes in fluorescent intensity 
(pseudocolor) in the ROI captured prior to (left panel) or in response to exposure to NH4+Cl- (100 mM, right 
panel). Increased green pseudocolour and red areas in the ROI in the right photomicrograph represents 
increasing areas of fluorescent intensity corresponding to increased pHi. Tracing below photomicrographs was 
obtained prior to, during and after exposure to NH4+Cl- (100 mM).  C) Representative tracing from one 
experiment showing no change in mean fluorescence intensity (pHi) for the ROIs in the CB when the 
superfusate was changed from 0mM HCO3-/0%CO2 to 44mM HCO3-/10%CO2.  D) Composite data obtained 
from four different preparations, with a total of different 40 ROIs showing no change in mean fluorescence 
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Changes in protein kinase A (PKA) 
activity in dissociated type I cells of the 
CB  
 As the CB O2/CO2 sensors are 
located in type I cells, we explored whether 
the lack of effect of isohydric hypercapnia 
on cAMP accumulation observed in the 
whole CB was consistent with modulation 
of downstream targets of cAMP in isolated 
type I cells. Thus, we determined the effect 
of different concentrations of HCO3-/CO2 on 
PKA activity in type I cells of the CB using 
a genetically encoded AKAR3 reporter 
dependent on FRET. Preliminary 
experiments confirmed the co-localization 
of Rho-PNA with tyrosine hydroxylase (see 
General Method- FRET section), and co-
localization of Rho-PNA with AKAR3 virus 
expression in type I cells of the CB (see 
method section).  
 Cells were perfused with medium 
containing 0 mM HCO3-/0%CO2, followed 
by application of a sub-maximal 
concentration of IBMX (10 M) to avoid 
saturation of the reporter, which increased 
FRET emission ratio by 6 ± 4.8% (n=21 
cells). IBMX (10 M) was maintained 
through the experiment, and the perfusate 
medium was changed from 0 mM HCO3-
/0%CO2 to 24 mM HCO3-/5%CO2 or to 44 
mM HCO3-/10%CO2 with no observed 
change in FRET emission ratio.  Addition 
of FSK (50 M, tmAC activator) markedly 
increased the emission ratio to 7.4 ±1.1%.  
H89 (10 M, IC50= 50 nM, Rocher et al, 
2009), a PKA inhibitor, decreased the 
emission ratio by 14.6 ±1.4%(n=21, Fig.4). 
These results are consisitent with the 
measurments of cAMP in whole CB and 
suggest that isohydric hypercapnia does 
not increase PKA activity in type I cells. We 
can not exclude that changes in HCO3-
/CO2 concentrations could induce small 
changes in PKA activity that, together with 
the high PDE degradation rate (PDEs were 
not completely blocked by IBMX), were not 
measurable.  
We further studied the effect of 
sAC and tmAC inhibitors on PKA activity, 
perfusing type I cells either with MDL-
12,330A (100-500 μM, IC50= 250 µM, 
Guellaen et al, 1977) or KH7 (50 μM, IC50= 
2-5µM, Ramos et al 2008) in the presence 
of IBMX (100 μM) in normocapnic and 
hypercapnic conditions. KH7 is a specific 
sAC inhibitor and it is known to be inert 
towards tmACs in vitro at concentrations 
up to 300 µM (Hess et al, 2005). However, 
for concentrations up to 50 µM this 
inhibitor tends to precipitate, and, as 
observed by others, the precipitation is 
exacerbated by the continuous gas 
bubbling necessary during these 





























both conditions (normocapnia and 
hypercapnia) FRET emission ratio 
increased upon perfusion of type I cells in 
the presence of IBMX (100 μM).  The 
effect of the AC inhibitors was normalized 
to the effect on the emission ratio by IBMX.  
Perfusion with 100 μM of MDL-12,330A 
together with 24 mM HCO3-/5%CO2 did not 
change FRET emission ratio.  Perfusion 
with 500 μM of MDL-12,330A together with 
24 mM HCO3-/5%CO2 decreased the 
emission ratio by 108.9±5.3% (n=25).  
Perfusion with KH7 (50 μM) together with 
24 mM HCO3-/5%CO2 decreased emission 
ratio by 141.7± 31.1% (n=23).  Perfusion 
of type I cells with MDL-12,330A (500 μM) 
together with 44 mM HCO3-/10%CO2 
(hypercapnia) decreased the emission ratio 
by 198.2±27.7% (n=20), a higher inhibitory 
effect than the one observed in 
normocapnia (p<0.01, t-test).  Perfusion 
with KH7 (50 μM) decreased the FRET 
emission ratio in the same extent between 
normocapnia and hypercapnia conditions.  
In summary, the results showed that in 
type I cells, PKA activity depends in both 
sAC and tmAC activity. The highest 
inhibition on cAMP-dependent PKA activity 
mediated by MDL-12,330A in hypercapnia 
suggests that either tmAC has a role in 
CO2 sensitivity or raises a concern about 
the specificity of the inhibitor. To address 
these questions we studied the expression 
of tmAC and its involvement in CO2 
sensing in the CB, using different selective 
tmAC inhibitors.  
 
sAC and tmAC (I-IX isoforms) gene 
expression  
 mRNA levels for sAC and the 9 
tmAC isoforms were quantified in the CB 
and PG. As previously observed (Nunes et 
al, 2009), we confirmed that sAC 
expression was higher in the CB than in 
the PG (p<0.05, Paired t-test, Fig. 5). 
However, in the CB, gene expression for 
the isoforms: tmAC1 (Ca2+ and calmodulin 
stimulated), tmAC4 (G- protein G 
stimulated), tmAC6 (PKA, PKC and Ca2+ 
inhibited) and tmAC9 (Ca2+ inhibited) were 
significantly greater than sAC (p<0.001, 
two-way repeated measures ANOVA with 
Bonferroni’s comparison test, Fig.5). We 
observed that the CB and PG expression 
profile for the 9 tmAC isoforms differed 
(Fig.5); tmAC1 (Ca2+ and calmodulin 
stimulated),tmAC4(Gstimulated), and 
tmAC6 (PKA, PKC and Ca2+ inhibited) 
were higher in the CB than in the PG 
(p<0.001, Fig.5), while the levels of tmAC2 
(G and PKC stimulated) were lower 
(p<0.001, Fig.5). tmAC3 and tmAC8 
(calmodulin- Ca2+ stimulated), tmAC5 and 
tmAC7 (PKC-stimulated), and tmAC9  
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(Ca2+-inhibited) gene expression did not 
differ between tissues. These results 
demonstrated that even though sAC  
mRNA is higly expressed in the CB, it is 
much lower than of the level of expression 
















Figure 4- Effect of activators of sAC and tmAC on PKA activity in type I cells using FRET-based 
reporters.  A) RFP image showing PNA labeling in type I cells, YFP image showing the expression of the 3rd 
generation of A-Kinase activity reporter (AKAR3) and pseudocolor images showing the response of AKAR3 to 
different concentrations of HCO3-/CO2  (0/0-44/10), forskolin (FSK, 50 µM, tmAC activator) and H89 (10 µM, PKA 
inhibitor) in the presence of IBMX (10 µM, non-selective PDE inhibitor), 40X. B) Time course of representative 
response to HCO3-/CO2  (0/0-44/10 mM/%), FSK (50 µM) and H89 (10 µM) in the presence of IBMX (10 µM, 
n=14 cells).  C) Composite data showing that emission ratio increased by 1.6± 4.8% with addition of IBMX, did 
not significantly change with the addition of 24 or 44 mM HCO3-, markedly increased to 7.4 ± 1.1% with addition 
of FSK and decreased 14.6 ± 1.4% with H89 (n=21 cells).  Paired t-test ** p<0.01 and ***<0.001. 
Relative contribution of sAC and tmAC 
to cAMP accumulation in the carotid 
body  
           To investigate if these enzmes have 
a role in HCO3-/CO2 sensing in the CB, we 
first studied the effect of the tmAC 
inhibitors MDL-12,330A (500 µM, IC50=250 
µM, Guellaen et al, 1977),  2’5’-ddADO 
(30-300 µM, IC50=3-16 µM, Ramos et al, 
2008) and SQ 22536 (200 µM, IC50=20 
µM, Rocher et al, 2009), and sAC inhibitor 
KH7 (10-100 µM, IC50= 2-5µM, Ramos et 
al 2008) on cAMP production during 
isohydric hypercapnia. All the experiments  
were performed in the presence of IBMX 
(500 µM). MDL-12,330A (500 µM) 
inhibited all tmAC activity, blocking cAMP 












































































This result was not reproduced by other 
tmAC specific inhibitors, 2’5’-ddADO (100 
µM, 60.0±10.5% of inhibition, n=6, Fig.6) 
and SQ 22536 (200 µM, 63.0±3.5% of 
inhibition, n=3, Fig.6), suggesting that 
MDL-12,330A is not a specific tmAC 
inhibitor at the concentrations used in this 
work. KH7 blocked cAMP production in a 
concentration-dependent manner (10 µM 
of KH7 blocked cAMP levels by 
6.9±13.0%, n=9; 50 µM by 
60.7±13.0%,n=9; 100 µM by 
69.4±6.7%,n=8 Fig.6).  
      To investigate if these enzymes have a 
role in HCO3-/CO2 sensing in the CB, we 
incubated this tissue in the absence and 
presence of 2’5’-ddADO (100 µM) and 
KH7 (10-50 µM) or both, during 30 min, 
under different concentrations of HCO3-
/CO2 (mM/%, 12/2.5; 24/5 and 44/10).  We 
observed that at 12 mM HCO3-/ 2.5%CO2 
sAC was partially blocked by KH7 10µM 
(36.79.9% of inhibition, n= 6, Fig.7). 
Higher concentrations of KH7 (50µM) 
blocked 68.67.3% of cAMP production 
(n=4, Fig.7), a similar effect produced by 
2’5’-ddADO (100 µM, 73.13.1%, n=9, 
Fig.7) and by the presence of both 
inhibitors (2’5’-ddADO 100 µM + KH7 
Figure 5- sAC and tmAC mRNA expression in the carotid body (CB) and petrosal ganglia (PG) using 
qRT-PCR.  Two way repeated measurements ANOVA with Bonferroni’s comparison test: * p<0.05 and *** 
p<0.001 for comparison of the same AC isoform between different tissues and # p<0.05 and ###p<0.001 for 
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10µM, 73.12.6%, n=4 and 2’5’-ddADO 
100 µM + KH7 50µM, 67.91.8%, n=3, 
Fig.7). The inhibitory effect of 2’5’-ddADO 
under 12 mM HCO3/2.5%CO2 (73.23.1%) 
was more pronounced than in normocapnic 
(55.15.5%, n=8) and isohydric 
hypercapnic (55.36.7%, n=10) conditions 
(p<0.05, one way ANOVA, Fig.7). KH7 
(10µM) blocked sAC activity by 21.19.6% 
(n=6, Fig.7) and by 6.912.9% (n=9, 
Fig.7) under normocapnic and isohydric 
hypercapnic conditions, respectively.  
In summary, there is a higher contribution 
of tmAC and sAC for cAMP accumulation 
in response to 12 mM HCO3/2.5%CO2 than 
to normocapnia and isohydric hypercapnia 
conditions.  Although both enzymes are 
functional within the CB, tmAC contributes 
more to cAMP accumulation than sAC in 
normocapnia. The levels of depression in 
cAMP accumulation induced by sAC or 
tmAC inhibition does not change 
significantly between normocapnia and 
isohydric hypercapnia, suggesting that sAC 
or tmAC activity is not up regulated in 
response to isohydric hypercapnia, 
consistent with no global increase in cAMP 
levels in this condition.  
 Since sAC is directly activated by HCO3- 
while neurotransmitters released by the 
cells under these conditions bind to GPCR 
coupled to tmAC, we postulated that sAC 
could be activated earlier than tmAC.  We 
explored this hypothesis by determing the 
time courses of cAMP production during 
different concentrations of HCO3-/CO2. In 
the absence of sAC and tmAC inhibitor, 
cAMP levels did not change significantly 
during different incubation times and in the 
presence of different concentrations of 
HCO3-/CO2 (Fig.8). These results 
confirmed that sAC is not apparently 
involved in the production of cAMP under 
different concentrations of HCO3-/CO2, 
either after 5 or 30 min of incubation. The 
inhibitory effect induced by KH7 (10µM) 
and 2’5’-ddADO (100µM) was the same 
after 5 or 30 min of incubation in all the 
concentrations of HCO3-/CO2 tested. 
 
The impact of sAC and tmAC inhibition 
on the functional chemoafferent 
response to hypercapnia 
Initial experiments examined the 
functional impact of acidic and isohydric 
hypercapnia on the CSN chemoafferent 
discharge frequency. The single fiber 
frequency measured in normocapnia was 
significantly elevated in acidic but not 
isohydric hypercapnia (n=6, Fig. 9A-C), 
supporting the hypothesis that the CSN 
frequency response to raised PCO2 is 

































Figure 7- Effect of tmAC 2’5’-ddADO (100 µM), KH7 (10-50 µM) or both on cAMP production in response to 







Figure 6- Effect of tmAC inhibitors: MDL-12,330A (500 µM), SQ22356 (200 µM), 2’5’-ddADO (30-300 µM) 
and sAC inhibitor KH7 (10-100 µM) on cAMP production after 30 min of incubation in hypercapnia conditions 
(44mM HCO3-/10%CO2) in the carotid body.   
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Addition of 10 µM KH7 did not 
change single fiber chemoafferent 
frequency recorded in normocapnic or in 
acidic hypercapnic conditions, even after 
30 minutes of exposure (n=5, Fig. 10A-B). 
Accordingly, this absence of an effect was 
associated with no change in the 
calculated CO2 sensitivity (n=5, 
Fig,10C).Therefore, despite sAC inhibition 
attenuating cAMP generation in 
normocapnia, this did not translate in 
functional inhibition of CB chemoafferent 
discharge frequency. These data also point 
toward sAC dependent cAMP production 
not being central to the acidic hypercapnic 
stimulus excitation coupling in the CB.  
Inhibition of tmAC was targeret using SQ 
22536 (200 µM). Previous experiments 
had showed that SQ 22536 inhibits tmAC 
to the same extent as did 2’5’-ddADO (100 
µM; 59.6± 10.5% inhibitory effect induced 
by SQ 22536, n=6,versus 63.0± 3.5% 
inhibitory effect of 2’5’-ddADO, n=3, in the 
CB). Addition of SQ 22536 elicited an 
acute and marked reduction in single fiber 
discharge frequency under basal 
normocapnic conditions and depleted the 
absolute response to acidic hypercapnia 
(n=7, Fig. 10D-E). The calculated CO2 
sensitivity was also determined as being 
significantly attenuated in the presence of 
SQ 22536 (n=6, Fig.10F). Is it suggested 
therefore that cAMP generation through 
tmAC activity has an important role in 
mediating basal CB activity in normocapnia 
and in regulating the functional response of 
the CB to acidic hypercapnia. 
 
 Effect of tmAC on the regulation of sAC 
gene expression  
 Since sAC inhibition did not block cAMP 
levels during isohydric hypercapnia, we 
investigated whether cAMP produced by 
tmAC contributes to the regulation of sAC 
gene expression. We observed that, in 
normocapnic conditions, FSK (100 µM) 
increased sAC gene expression in CB 
(n=4) by 144%, supporting that sAC 
expression is dependent on tmAC activity.  
 
Discussion 
       The present results show that both 
sAC and tmAC contribute to the 
accumulation of cAMP in hypocapnia and 
normocapnia, with cAMP levels derived 
from tmAC being greater than those 
generated by sAC. Isohydric hypercapnia 
did not change sAC and tmAC activity, 
consistent with no change in observed 
cAMP levels, PKA activity or discharge 
frequency. Furthermore, our results 
demonstrate that for the CB discharge 
frequency to increase with CO2, it needs to 






























Figure 8- Effect of different concentrations of HCO3/CO2 (mM/%: 12/2.5, 24/5 and 44/10) on the levels of 
cAMP in the carotid body during 5-30 minutes of incubation, in the absence of AC inhibitors. The cAMP 
levels formed under 0 mM HCO3/0%CO2 during the different incubation times (0-30 min) were subtracted from 
the cAMP accumulated under 12/2.5, 24/5 and 44/10 mM/%. 
 
Figure 9- Acidic hypercapnia but not isohydric hypercapnia induces chemoafferent stimulation. A) 
An example extracellular recording showing raw carotid sinus nerve discharge (upper trace) and frequency 
interval histograms (lower trace) in 10s groups, recorded in control normocapnia, isohydric hypercapnia and 
acidic hypercapnia. The absence of a response in isohydric hypercapnic conditions was also apparent in the 
presence of the tmAC inhibitor SQ 22536. Overdraw action potentials are shown inset to demonstate the 
single fiber discrimination used to obtain the frequency histograms. B) Mean frequencies measured in 
normocapnia, acidic hypercapnia and isohydric hypercapnia. C) Concurrent increases in PCO2 (40-80 
mmHg) and [HCO3] (24-44 mM) did not significantly alter the superfusate pH. Data presented is from 6 
fibers from 3 animals for electrophysiology and pH measurments were analysed from superfusates from 3 
independent experiments. Error bars indicate mean ± SEM. * denotes P< o.o5 compared with normocapnic 
frequency, paired students t-test.  
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Figure 10- tmAC but not sAC modulates the basal normocapnic carotid body chemoafferent discharge 
frequency and the response to acidic hypercapnia. A) An example trace showing raw chemoafferent 
discharge (upper) and frequency interval histograms in 10s groups (lower) in normocapnia and acidic 
hypercapnia in the presence and absence of sAC inhibitor KH7. B) Grouped absolute frequencies measured in 
normocapnia and acidic hypercapnia in the presence and absence of KH7. C) Calculated CO2 sensitivity plots for 
control and KH7 determined by taking the difference in frequency per mmHg PCO2. D) Example trace showing 
the raw chemoafferent discharge (upper) and frequency interval histograms in 10s groups (lower) in normocapnia 
and acidic hypercapnia in the presence or absence of tmAC inhbitor SQ 22536. E) As in B but in the presence 
and absence of the tmAC inhibitor S!22536. F) As in C) but CO2 sensitivity was calculated for control and in the 
presence of SQ 22536. Data presented is from 5 fibers from 4 animals for KH7 and 7 fibers from 4 animals for 
SQ22536. Error bars indicate mean ±SEM. * denotes P<0.05 compared with control frequency, repeated 
measure ANOVA, Bonferroni pos hoc test, # denotes P<0.05 compare with control CO2 sensitivity.  
 
The CO2-sensing mechanism in 
the CB is not fully understood. CO2, H+ and 
HCO3- are intimately connected yet the 
nature of the primary stimuli remains 
uncertain. Some studies have 
demonstrated that in the CB this 
mechanism is mediated via decreasing 
intracellular pH (pHi), leading to a 
membrane depolarization, increasing 
intracellular calcium levels and 
neurotransmitter release (Buckler and 
Vaughan-Jones, 1994).  Acidosis can also 
activate Na+/H+ exchange promoting the 
reversal of Na2+/Ca2+ exchange, which 
results in elevated intracellular calcium 
concentrations (Rocher et al., 1991). Other 
studies report that molecular CO2 
(isohydric hypercapnia) is directly involved 
in the activation of calcium currents leading 
to an increase of intracellular Ca2+ 
(Summers et al., 2002).  Once in the cell, 





























and pH, through the reaction catalyzed by 
carbonic anhydrases (Ridderstrale and 
Hanson, 1984). Thus increases in CO2 
could lead to increases in HCO3- that could 
activate sAC (Chen et al, 2000) and 
consequently increase cAMP levels. 
Our group had previously 
identified the expression of sAC gene in 
the CB and suggested a functional role for 
sAC in this organ since: 1) sAC gene 
expression levels in the CB were at least 
10 times higher than in non-
chemoreceptors, except testis, a tissue 
where high levels of sAC have been 
observed; 2) sAC mRNA levels in the CB 
were up-regulated by HCO3-/CO2 and 3) 
sAC protein was present in the CB (Nunes 
et al, 2009).  Other than the CB, the role of 
sAC has been described in tissues where 
changes in HCO3-/CO2 are essential to 
their function. For instance in the testis, 
where sAC is highly expressed, sAC 
mediates sperm maturation and acquisition 
of motility, in kidneys it regulates recycling 
of V-ATPse, in airway epithelial cells sAC 
regulates the ciliary beat frequency, and in 
corneal endothelium it plays a role in the 
activation of the cystic fibrosis 
transmembrane conductance regulator, 
among others (Chen et al., 2000, Sun et 
al., 2004, Buck et al., 1999, Hess et al., 
2005, Pastor-Soler et al., 2003a, Schmid et 
al., 2007). The role of sAC in CO2 sensing 
has never been studied in the CB 
chemoreceptors.  
cAMP levels can also be 
synthesized by tmAC. Recently, it was 
demonstrated tmAC activity is modulated 
by CO2 (Townsend et al., 2009). Since it 
was been suggested that, in the CB, cAMP 
levels increase in response to acidic and 
isohydric hypercapnia (Perez-Garcia et al., 
1990; Summers et al., 2002), it was of 
interest to understand the role of tmAC and 
sAC in the CO2 sensing mechanism of the 
CB.  
We characterized for the first 
time the nine tmAC isoforms (tmAC1-9) in 
the CB and PG. Differences in the tissue 
distribution of the different isoforms were 
observed with a predominance of tmAC vs 
sAC in both tissues.  The information 
available in literature is not sufficient to 
allow a correlation between AC mRNA 
profiles and specific G-proteins and 
consequently specific G-protein coupled 
receptors.  Dopamine D2 and muscarinic 
M2 receptors, which inhibit tmAC have 
been identified in both PG and CB 
(Gonzalez et al., 1994, Alcayaga et al., 
1999, Bairam et al., 2006). Adenosine A2 
receptors and -receptors, which are 
positively coupled to tmAC, are described 
in the CB (Gonzalez et al., 1994, Gauda, 
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2002). While -adrenergic and D2 
dopamine receptors in heart and striatum 
are coupled to AC5 (Chern, 2000, Sadana 
and Dessauer, 2009), in the CB and PG 
these receptors would have to be coupled 
to a different tmAC isoform because we 
here demontrate that AC5 is not expressed 
in the PG and CB.  
Although tmAC and sAC were 
expressed and functional in the CB, the 
results presented here suggested that the 
increases in cAMP levels in response to 
isohydric hypercapnia described by others 
(Summers et al, 2002), could not be 
directly attributed to increases in sAC and 
tmAC activity mediated by CO2. sAC and 
tmAC inhibitors did not alter cAMP levels 
between normocapnia and isohydric 
hypercapnia. Also, in the absence of 
adenylyl cyclase inhibitors, cAMP levels 
did not increase in response to 
hypercapnic concentrations either after 5 
or 30 min of incubation. PKA activity did 
not change with isohydric hypercapnia. 
These results were not dependent on 
decreases in intracellular pH with CO2 
since we designed our experiments to 
maintain the extracellular pH constant at 
7.4 in all solutions and confirmed that 
exposure to different concentrations of 
HCO3-/CO2 did not modify intracellular pH. 
It is known that when extracellular pH 
remains constant minimal changes are 
observed in pHi of type I cells; when PCO2 
increases, pHi transiently decreases and 
then rapidly equilibrates to the extracellular 
pH (Buckler et al., 1991).   
Hornbein and Roos (1963) 
reported that bicarbonate and CO2 do not 
appear to affect pHi in Type 1 cells 
(Wilding et al., 1992). Furthermore, pH 
varying from 7.0 to 8.0 does not alter sAC 
mRNA expression (Sun et al., 2004).  sAC 
enzyme activity is also independent of pHi 
(Chen et al., 2000).  Perez-Garcia et al. 
(1990) described that increases in cAMP 
levels mediated by CO2 were associated 
with decreases in intracellular pH. In the 
present work, we also observed that a fall 
in pHi is essential for CSN discharge to 
increase in response to elevated CO2. We 
observed that tmAC tmAC-derived cAMP 
may be necessary but not essential to 
establish normal basal CSN activity and 
the increase in frequency observed in 
acidic hypercapnia.  
Although sAC and tmAC do not 
play a role in the detection of isohydric 
hypercapnia, we demonstrated that these 
enzymes seem to be important in the 
adaptation of hypocapnia to normocapnia, 
with an eventual saturation of the enzyme 
in normocapnia.  
 All together we propose that in 
hypocapnia and normocapnia there is a 





























sAC. In normocapnia this cAMP-
dependence does not translate into basal 
chemoafferent discharge. tmAC induce an 
increase in cAMP accumulation much 
greater and important in the generation of 
basal chemodischarge than sAC. For 
future experiments it will be necessary to 
acess the role of these enzymes in the 
response to hypocapnia in chemoafferent 
discharge. Isohydric hypercapnic causes 
no change in sAC or tmAC activity, which 
translates into no change in cAMP, PKA or 
discharge frequency. For the frequency to 
increase with CO2 it needs to be 
associated with a fall in pH. This increase 
in discharge is dependent on tmAC-derived 
cAMP. Thus, acid sensing leads to calcium 
dependent neurotransmitter release 
followed by K+ channel inhibition to cause 
autocrine activation of GPCR and further 
activation of tmAC.  
The interpretation of our data is 
limited by several factors that deserve 
discussion. First, we quantified mRNA 
levels, pHi and cAMP amounts in the whole 
CB, which preserves cell-cell interactions 
but does not enable determination of the 
specific contribution of chemo and non-
chemosensitive units within the CB. 
However, the results obtained measuring 
PKA activity using FRET based reporters 
in isolated type I cells were consistent with 
those in the whole CB. Second, high levels 
of sAC mRNA expression in the CB did not 
distinguish between the two sAC isoforms, 
truncated and full length, and thus we are 
not able to identify whether the increases 
in sAC gene expression correspond to the 
truncated active isoform. Third, we used 
44mM HCO3-/10%CO2 as a hypercapnic 
condition, and since this lies outside the 
physiologically relevant range, we can not 
exclude the possibility that the HCO3/CO2 
transport mechanism could be saturated or 
that the HCO3/CO2 sensor may no longer 
be sensitive to such supra-shysiological 
conditions.  Moreover, the different tmAC 
inhibitors used in this work allowed us to 
conclude that MDL-12,330 is not a good 
pharmacological tool to be used in 
experiments aimed to distinguish between 
tmAC and sAC activity. The effects of 
MDL-12,330A (500µM) on cAMP levels 
and PKA activity seemed to not be 
selective for tmAC and 100µM of this 
inhibitor abolished completely the CSN 
discharge. Furthermore, KH7, a selective 
sAC inhibitor does precipitate at 
concentrations higher than 50µM 
(Tresguerres et al, 2009), however, our 
results suggest that concentrations higher 
than 10 µM may not be selective for sAC 
in the CB.  
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 While these are limitations to our 
study design, we believe that our through 
approach of examining the contribution of 
sAC and tmAC on PCO2 transduction at 
multiple levels (mRNA, PKA regulation, 
cAMP production and integrated 
chemodischarge) using robust 
pharmacological and novel (FRET) 
approaches has contributed to our 
understanding of this basic signalling 
pathway in carotid chemoreceptors. Taken 
together our findings, and based in similar 
data on O2 sensing at the CB where 
highest levels of cAMP were observed in 
normoxic conditions (physiological 
conditions, Monteiro et al., 2011), and in 
this work, where sAC mRNA was up-
regulated by tmAC-induced cAMP 
production, we postulated that sAC and 
tmAC cooperate to maintain adequate 
cAMP levels in physiological conditions.  
In conclusion, we have shown 
that sAC and tmAC are active in the CB 
and postulate that they co-operate to 
maintain adequate cAMP levels in 
physiological conditions. In addition, we 
support the notion that a functional 
response to CO2 requires a decrease in 
pHi, and show, for the first tme, that this 
transduction mechanism is dependent 
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BICARBONATE-SENSITIVE SOLUBLE AND TRANSMEMBRANE 
ADENYLYL CYCLASES IN CENTRAL CO2 CHEMORECEPTORS – 
 A COMPARATIVE STUDY WITH THE CAROTID BODY 
A R Nunes1,2, E C Monteiro2, E B Gauda1*  
1Pediatrics, Johns Hopkins Medical Institutions, Baltimore, MD; 2CEDOC, Pharmacology, Faculdade de Ciências 
Médicas, Universidade Nova de Lisboa, Portugal 
 
Background and purpose: Changes in cAMP levels have been associated with the CO2-
sensing chemotransduction mechanism of the mammalian chemoreceptors. Two types of 
adenylyl cyclase (AC) are responsible for the production of cAMP: a soluble AC (sAC) 
activated by bicarbonate (HCO3-) /CO2 and a transmembrane AC (tmAC) regulated by 
neurotransmitters/hormones. In the carotid body (CB), these enzymes are both expressed 
and functional but do not play a role in response to isohydric hypercapnia (Nunes et al, in 
submittion).  The CB is sensitive to changes in CO2 but the main CO2 sensors in the 
organism are the central chemoreceptors.  Thus this work aims to determine if there are 
differences in the expression and activity of these enzymes between peripheral and 
central chemoreceptors. Experimental approach: We assayed for changes in sAC 
expression (RT-qPCR) in central chemoreceptors (locus coeruelus, ventrolateral medulla 
and raphe nucleus) and CB and investigated if changes in HCO3-/CO2 up-regulated sAC 
gene expression in the central chemoreceptors. We compared the expression of sAC and 
the 9 isoforms of the tmAC in the locus coeruleus and compared the effect of these 
enzymes on the cAMP levels (quantified by EIA), in the presence and absence of 
activators or inhibitors of sAC and tmAC. Key Results: sAC is expressed in central 
chemoreceptos, but in lower levels than in the CB. sAC mRNA and cAMP levels in the 
locus coeruleus augmented in response to increases in HCO3-/CO2 from 0/0% to 
normocapnia (24/5%). In this tissue, higher concentrations of HCO3-/CO2 had no additional 
effect on cAMP levels. While in the CB we had previously observed that tmAC  
contribute greater to cAMP accumulation than sAC, in both normocapnic and hypercapnic 
conditions (Nunes et al in submission), in the locus coeruleus tmAC had little effect in 
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cAMP accumulation in hypercapnic conditions. However, the expression of the 9 tmAC 
isoforms, except tmAC5 and 7, were higher than sAC mRNA in LC.  
Conclusions and Implications: sAC is ubiquitously expressed and functional in central 
chemoreceptors, and as demonstrated previously in the CB, it does not seem to play a 
role in response to hypercapnia conditions.  
Keywords: cAMP, cyclic adenosine monophosphate; CB, carotid body; sAC, soluble 
adenylyl cyclase; tmAC, transmembrane adenylate cyclase; peripheral arterial 
chemoreceptors; central chemoreceptors; HCO3-/CO2, bicarbonate/ CO2. 
*Correspondence author: Estelle B. Gauda, M.D., Department of Pediatrics, Division of 
Neonatology, Johns Hopkins Medical University, 600 N. Wolfe Street, CMSC 6-104, 
Baltimore, MD 21287-3200 USA, egauda@mail.jhmi.edu 




The central chemoreceptors 
located in the brainstem are the major 
CO2/pH sensors of the mammalian 
organism. Central chemosensitive cells are 
dispersed within distinct regions of the 
brainstem (reviewed by (Nattie, 1999)) 
including the locus coeruleus (LC), the 
retrotrapezoid nucleus, the ventrolateral 
medulla (VLM), and the medullary raphe 
(RN) (Filosa et al., 2002, Guyenet et al., 
2005, Richerson, 1995, Schlaefke et al., 
1970, Wang et al., 2002).  
 There is evidence suggesting 
that the central sensitivity to CO2/pH is 
modulated by peripheral chemoreceptors 
(for a review see Forster and Smith, 2010).  
As cAMP levels have been 
associated with the chemotransduction 
mechanism of the CB, we have recently 
investigated the effect of isohydric 
hypercapnia in the activity of HCO3-/CO2 
responsive-soluble adenylyl cyclase and 
neurotransmitter responsive-
transmembrane adenylyl cyclase (Nunes et 
al, in submission). A particular role of these 
enzymes in the response to isohydric 
hypercapnia in the CB was discarded 
(Nunes et al, in submittion).  
Since central chemoreceptors 
contribute apparently more to CO2 
sensitivity than CB, we hypothesized that 
tmAC and sAC could be more relevant in 
CO2-sensing in the central chemoreceptors 
than in the CB.  
Thus, this work aims to 
investigate the relative contribution of sAC 





























hypercapnia in central chemoreceptors, 
namely in the locus coeruleus (LC), a 
central chemoreceptor that is apparently 
more sensitive to CO2 than changes in pH 
(Filosa, 2003).  
 
Materials and Methods  
 
Surgical procedures 
The Animal Care and Use 
Committee at the Johns Hopkins University 
School of Medicine approved all 
experimental protocols. CB and central 
chemoreceptors tissues, were isolated 
from Sprague-Dawley rats (SD, Charles 
River Laboratories, Wilmington, MA) of 
both sexes at postnatal days (P) 16 and 
17.  Central chemoreceptor tissues used in 
the present work included: LC, RN and 
VLM. The non-chemoreceptor tissues 
included the cortex.  
Prior to tissue removal or 
dissection, the animals were anesthetized 
briefly with isoflurane and immediately 
decapitated. The CB was dissected as 
described in Nunes et al (in submission). 
Briefly, the carotid bifurcation including the 
CB, SCG and the NG/PG complex was 
removed en bloc and tissues were isolated 
and cleaned of surrounded connective 
tissue. The brainstem was removed en 
bloc and micro-dissected to obtain midline 
medullary RN, as previously described 
(Wang et al., 1998).  The micro-dissected 
region captured the raphé pallidus, raphé 
magnus, a segment of the raphé obscurus, 
and tissue immediately adjacent to these 
nuclei.  Similarly, the VLM was micro-
dissected using a slightly modified 
approach, as described by Johnson and 
co-workers (Johnson et al., 2008, Johnson 
et al., 2001). The brainstem was sliced 
manually in ~500 μm increments with a 
micro-knife to capture a transverse slice 
containing the VLM.  Tissue samples were 
taken from a slice where the inferior olive, 
midline raphé, pyramids, and semi-
compact division of nucleus ambiguous 
were visualized and used as identifying 
landmarks.  Finally, LC samples were 
obtained from pontine slices at the level of 
the 4th ventricle and the tract of 7th cranial 
nerve.  The LC and adjacent tissue was 
bilaterally excised from the slice.  
 
sAC and tmAC mRNA gene expression  
In one set of experiments, we 
compared sAC mRNA expression levels 
present in the central chemo- (VLM, RN 
and LC) and non-chemoreceptors (cortex) 
with the levels present in the CB.  In 
another set of experiments we compared 
mRNA expression levels between sAC and 
the nine isoforms of tmAC in the LC.  For 
both sets of experiments, the different 
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tissues were isolated as mentioned in 
surgical procedure (4 rats per condition; 
n=3 independent experiments), cleaned 
from surrounded tissue and quick-frozen 
on dry ice and stored at -80oC.  
To study the effect of HCO3-/CO2 
in the regulation of sAC gene expression, 
LC, VLM, RN and cortex were isolated and 
treated as described in Nunes et al (in 
submission). The tissues were pre-
incubated in Krebs modified solution 
containing (in mM): NaCl 135; KCl 5; CaCl2 
2; MgCl2 1.1; HEPES 10; glucose 5.5, pH 
7.40 (Perez-Garcia et al., 1990) without 
HCO3- and equilibrated with 
0%CO2/60%O2.  After 30 minutes, we 
replaced the pre-incubation buffer with 
incubation buffer containing one of the 
following HCO3-/CO2 concentrations: 1) 0 
mM HCO3-/0% CO2/60% O2, 2) 24 mM 
HCO3-/5% CO2/60% O2, and 3) 44 mM 
HCO3-/10% CO2/60% O2 for 1 hour at 
37ºC, pH 7.4.  We modified the incubation 
buffer by changing CO2 and HCO3- 
concentrations, adjusting the osmolarity 
with NaCl. This approach allows the 
assessment of CO2 effect, preventing 
major changes in pH.  Tissues were pooled 
from 4 animals from the same litter and the 
experiments were repeated 3 or more 
times using animals from different litters.  
 In a separate set of experiments, 
we also investigated the effect of forskolin 
(FSK), a tmAC activator, in the regulation 
of sAC gene expression in LC and cortex. 
The tissues were pre-incubated in Krebs 
modified solution containing 24 mM 
NaHCO3 equilibrated with 5%CO2/60%O2. 
After 30 minutes, we replaced the pre-
incubation buffer with incubation buffer 
containing 24 mM NaHCO3 and FSK (100 
µM), for 1 hour at 37ºC, pH 7.4.   
Tissues were quick-frozen on dry 
ice and stored at -80ºC until further 
processing for RT-qPCR, as outlined 
below.  
 
Quantitative Real time – PCR 
Tissues used to study sAC and 
tmAC mRNA gene expression and 
regulation levels were processed to obtain 
total RNA (Micro-to-Midi Total RNA 
Purification, Invitrogen, Carlsbad, CA) 
according to the manufacturer’s 
instructions.  DNase treatment (PureLink 
DNase, Invitrogen) was performed to avoid 
genomic DNA contamination.  RNA yield 
and quality was measured at 260 and 280 
nm by conventional UV spectrophotometer 
(Beckman Du 530). Total RNA (about 1 
µg) was used for first-strand cDNA 
synthesis using an iSCRIPt cDNA 
synthesis kit (Bio-Rad Laboratories, 
Hercules, CA).  
The respective primer sequences 





























are shown in Table 2, General methods -
RT-qPCR section (Pastor-Soler et al., 
2003b, Chang et al., 2003). Relative 
expression of AC genes between the 
tissues and conditions was standardized 
with levels of glucose-6-phosphate 
dehydrogenase (G6PDH) expression, the 
reference gene.  We also validate our 
results using more two reference genes: 
glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) and Beta-actin 
(-actin) (Table 2, General methods, RT-
qPCR section, Wang and Xu, 2010).  We 
evaluated the expression of the three 
reference genes in all the studied tissues 
and conditions using a web site that 
combined 4 different algorithms used to 
determine the stability of the reference 
genes: geNorm, Normfinder, Bestkeeper 
and comparative Ct method 
(http://www.leonxie.com/referencegene.ph
p?type=reference). We found that GAPDH 
is the most stable gene across our 
experiments, but AC gene expression 
levels normalized with this reference gene 
showed the same trend of results as 
shown when normalized with G6PDH.   
        RT-qPCR was performed with a MyiQ 
iCycler RT-qPCR system (Bio-Rad) with 
the SYBR Green detection system.  Each 
qPCR reaction consisted of 1 µl of cDNA 
and 3.5 µl of 300 nM primers diluted in 
DEPC-H2O and 10 µl of SYBR Green 
Supermix (Bio-Rad) for a final volume of 20 
µl.  We performed triplicates for each 
sample.  qPCR conditions for sAC gene 
expression and regulation were: denaturing 
8 min at 95°C, followed by 40 cycles at 
95°C for 1 min, 60°C for 30 sec, 72°C for 
45 sec, and a terminal extension period 
(72°C, 10 min).  qPCR conditions for AC 
(tmAC and sAC) expression and regulation 
were: denaturing 5 min at 95°C, followed 
by 40 cycles at 95°C for 20 sec, 62°C for 
20 sec, 72°C for 20 sec, and a terminal 
extension period (72°C, 10 min).  We 
analyzed the specificity of the RT-qPCR 
product by performing a melting curve with 
0.5oC increments in temperature.  Product 
formation during the exponential phase of 
the reaction was analyzed for semi-
quantification of relative expression in the 
specific tissues using the Pfaffl method 
(Pfaffl, 2001) or relative quantification to 
reference gene based on the threshold 
cycle (CT) for amplification as 2(ΔCT), where 
ΔCT = CT,reference − CT,target.  
 
Effects of HCO3-/CO2 on cAMP levels 
To study the effect of different 
concentrations in HCO3-/CO2 in cAMP 
levels, as an indirect measurement of sAC 
activity, we pre-incubated chemosensitive 
(RN, VLM and LC) and non-
chemosensitive (cortex) tissues according 
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with the protocol described in Nunes et al 
(in submission). The tissues were 
incubated in Krebs modified solution 
without HCO3-/CO2 and in the presence of 
MDL-12,330A (500 µM), a tmAC inhibitor 
(Delpiano and Acker, 1991).  After 30 
minutes, we incubated the tissues in fresh 
Krebs modified solution in the presence of 
MDL-12,330A (500 µM), and either 0 mM 
HCO3-/0 % CO2; 12 mM HCO3-/2.5% CO2; 
24 mM HCO3-/5% CO2; or 44 mM HCO3-
/10 % CO2 for 30 minutes, pH 7.4, 37°C.  
All the experiments were conducted in the 
presence of a non-specific inhibitor for 
phosphodiesterase (PDE) IBMX (500 µM). 
Tissues were pooled from 2 animals from 
the same litter and the experiments were 
repeated using animals from different 
litters.  Tissues were processed for cAMP 
extraction and the quantification was done 
as outlined below. 
 
Contribution of sAC and tmAC to cAMP 
levels in normocapnia and isohydric 
hypercapnia 
To study the contribution of tmAC 
and sAC on cAMP accumulation under 
normocapnia and isohydric hypercapnia, 
we pre-incubated LC tissues with Krebs 
modified solution containing 24 mM 
NaHCO3 and perfused with 60%O2/5%CO2 
in the absence or in the presence of MDL-
12,330A (500 µM) or KH7 (100 µM, a 
selective sAC inhibitor) or both.  After 30 
min we incubated the tissues in fresh 
Krebs modified solution containing either 
24mM NaHCO3/60%O2/5%CO2 or 44mM 
NaHCO3/60%O2/10%CO2, IBMX (500 µM), 
in the presence of absence of MDL-
12,330A (500 µM), KH7 (100 µM), or both, 
for 30 min at 37oC.   
 
Cyclic nucleotide extraction and 
quantification 
cAMP was measured as 
previously reported (Batuca et al., 2003) 
and briefly described here.  We immersed 
tissues in cold 6% (w/v) trichloroacetic acid 
(TCA; 600 µl) for 10 minutes, 
homogenized the tissues at 2 - 8ºC, and 
centrifuged them at 12,000 g for 10 
minutes at 4ºC.  The supernatants were 
washed four times in 3 ml of water 
saturated with diethyl ether solution (50:50) 
and then lyophilized.  The sample was then 
stored at -20ºC until cAMP quantification 
by enzyme immunoassay (EIA, RPN 2255, 
GE Healthcare Bio-Sciences AB, 
Piscataway, NJ).  Protein pellets were 
stored at -20°C until measured with the 
standard Bradford Protein Assay (Bio-
RAD). cAMP levels are expressed in 
femtomoles per microgram of protein 

































Data analysis and statistical procedures 
The data are represented as 
mean ± SEM and differences between the 
experimental groups were determined 
using statistical software from GraphPad 
Prism (GraphPad Software Inc., version 4, 
San Diego, CA) or SPSS (SPSS Inc, 
version 12, Chicago, IL).  Statistical 
significance was set at P<0.05.  
 
Results 
sAC mRNA gene expression and 
regulation 
We had previously identified sAC 
mRNA in the CB and related peripheral 
non-chemosensitive structures (PG, NG, 
SCG, Nunes et al, 2009). In the present 
work, we first investigated whether higher 
levels of expression were specific to the 
CB or to both peripheral and central CO2-
chemosenstive tissues. We observed that 
sAC mRNA was expressed ubiquitously in 
central chemo- (LC, VLM, RN) and non-
chemosensitive tissues (cortex). As 
observed in Fig.1A, sAC gene expression 
levels in the CB were at least 10 times 
higher than in the central chemo and non-
chemoreceptors.   
We next explored the effect of 
different concentrations of HCO3-/CO2 
(mM/%: 0/0, 24/5, 44/10) in sAC gene 
expression in central chemo- and non-
chemosensitive tissues.   We had 
previously observed that sAC gene 
expression was up-regulated by HCO3-
/CO2 in the CB (Nunes et al, 2009).  Here, 
we observed that increases from 0 mM 
HCO3-/0%CO2 to 24 mM HCO3-/5%CO2 
up-regulated sAC gene expression in the 
LC; no significant changes on the level of 
sAC mRNA gene were observed in RN, 
VLM and cortex (Fig.1B). These results 
suggested that sAC may be functional in 
some central chemoreceptors.  
 
Bicarbonate-regulated cAMP levels 
 We previously reported 
that sAC is functional in the CB, but not in 
non-chemosensitive tissues, under 
concentrations up to 24 mM HCO3/5%CO2 
(Nunes et al., in submission). In this work 
we investigated if sAC is functional in 
central chemoreceptors and whether the 
results obtained in the central 
chemoreceptors are similar to those 
obtained previously in the CB. For these 
experiments, we explored the effects of 
different concentrations of HCO3-/CO2 
(mM/%: 0/0, 12/2.5, 24/5, and 44/10) on 
cAMP production in central chemo- and 
non-chemosensitive tissues.  
To differentiate between the 
activity of tmAC and sAC, we incubated the 
tissues with MDL-12,330A (500µM) and 
IBMX (500 µM), a non-specific PDE 
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inhibitor. Although previous results had 
shown that MDL-12,330A was able to 
inhibit about 95% of the cAMP production 
induced by FSK in the CB (Nunes et al, in 
submittion), we observed that in the LC, it 
inhibited only 45.6±9.6% (n=6) (Fig.2A). 
Higher concentrations of MDL-12,330A 
(1000 µM) did not decrease the amount of 






Figure 1- A) sAC mRNA expression in carotid body and central chemoreceptors and non-chemoreceptor tissues. 
B) Effect of increasing HCO3- concentrations on sAC mRNA gene expression in central chemoreceptors and non-
chemoreceptor tissues using qRT-PCR.  0, 24, and 44 mM corresponds to 0 mM HCO3-/0%CO2, 24 mM HCO3-/5% 
CO2, and 44 mM HCO3- /10%CO2, respectively. CB, carotid body; LC, locus ceruleus; RN, raphé nucleus; VLM, 
ventrolateral medulla;  Cx, cortex. Non Parametric correlation (Spearman) ** p<0.01 
Figure 2- Effect of A) MDL-12,330A (500-1000 µM) and B) 2’5’-ddADO (3-300 µM) on cAMP production 
































We also investigated the effect of other 
specific tmAC inhibitor, 2’5’-ddADO (3-300 
µM), on cAMP production in the LC in the 
presence of FSK (Fig.2B).  2’5’-ddADO 
(300 µM) was able to inhibit 50.9±2.0% 
(n=7) of cAMP production induced by FSK 
in the LC (Fig.2B), an effect similar 
obtained with MDL-12,330A (500 µM). 
These results either raise concerns about 
the viability of the LC tissue or suggest a 
high concentration of α1 and α2-
adrenoceptor receptors negatively coupled 
to tmAC in LC. Considering a viability 
problem, we would expect a compromised 
response to different concentrations of 
HCO3/CO2 in this tissue. However, as 
observed in Fig.3, the amount of cAMP 
was dependent on the concentration of 
HCO3-/CO2 (0/0,12/2.5,24/5 mM HCO3-
/%CO2), not only in the LC, but also in VLM 
and RN. Higher levels of cAMP were 
obtained in normocapnia conditions. 
However, comparing with the results 
obtained previously in the CB (Nunes et al, 
in submission), normocapnia induced a 
lower effect on cAMP levels in the central 
chemoreceptors (82.0± 14.9 % increase in 
LC, 69.5± 22.2 % increase in RN and 
48.7± 11.6 % increase in VLM, Fig.3) than 
in the CB (158.4 ± 32.7 % increase). 
Higher concentrations of HCO3-/CO2 (44 
mM HCO3- /10%CO2) had no additional 
effect on cAMP levels in central 
chemosensitive tissues, an effect also 
observed previously in the CB (Nunes et 
al, in submission). In the cortex, higher 
concentrations of HCO3.-/CO2 did not 
induce changes in cAMP levels (Fig.3).  
These results suggested to us 
that when tmAC is blocked, sAC reached a 
maximal level of activity under 
physiological conditions, 24 mM HCO3-
/5%CO2 (normocapnia conditions) in the 
CO2 central chemoreceptors, a result that 
had been previsouly reported in the CB 
(Nunes et al, in submission). However, we 
can not exclude that tmAC may be 
affecting these responses.  
 
sAC and tmAC (I-IX isoforms) gene 
expression  
 
We characterized the 9 specific 
tmAC isoforms in the LC. As observed in 
Fig.4, except for tmAC5 and tmAC7 (PKC-
stimulated), the levels of expression for the 
tmAC isoforms were higher than sAC 
expression. 
Comparing the levels of tmAC 
isoforms expression in the LC with the 
ones previously observed for the CB 
(Nunes et al, in submission), we observed 
that the levels of expression for tmAC1 
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(Ca2+ and calmodulin stimulated, 
0.46±0.09 in CB vs 0.22±0.02 in the LC), 
tmAC4 (G stimulated, 0.51±0.09 in CB 
vs 0.05±0.00 in the LC), and tmAC6 (PKA, 
PKC and Ca2+ inhibited, 0.26±0.06 in CB 
vs 0.07±0.00 in the LC) were higher in the 
CB than in the LC, while the levels of 
tmAC2 (0.03±0.47 in CB vs 0.47±0.07 in 
the LC, G and PKC stimulated) were 
lower. The levels of expression for tmAC3 
and tmAC8 (calmodulin- Ca2+ stimulated), 
tmAC5 and tmAC7 (PKC-stimulated), and 
tmAC9 (Ca2+-inhibited) were not 
significantly different in the CB and LC. 
These results suggest that the expression 




Figure 3- Concentration- response curves of HCO3-/%CO2 for effects on cAMP levels in central chemo- and 
non-chemosensitive tissues.  0% increase was obtained with 0 mM HCO3/0%CO2: 22.5±3.4 fmol/µg protein 
(LC, n=13); 18.1±1.2 fmol/µg protein (RN, n=12); 15.1 ±3.9 fmol/µg protein (VLM, n=9); 10.1 ± 2.6 fmol/µg 



































Figure 4 - sAC and tmAC mRNA expression in the carotid body locus coeruleus (LC) using qRT-PCR.  
Figure 5- Effect of MDL-12,330A, a tmAC inhibitor and KH7, a sAC inhibitor, on cAMP levels in normocapnia 
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Relative contribution of sAC and tmAC 
to cAMP levels in LC  
To compare the levels of cAMP 
generated by sAC and by tmAC in 
normocapnia and hypercapnia, we studied 
the effect of MDL-12,330A (500µM) and/or 
KH7 (100µM) in cAMP production in LC 
using an enzyme immunoassay. KH7 
(IC50= 3-5 µM) is a specific sAC inhibitor. 
All the experiments were performed in the 
presence of IBMX (500µM). We observed 
that in the LC, the amounts of cAMP 
induced by hypercapnia decreases 
significantly from those observed in 
normocapnia (p<0.05, paired t-test, 30.6 ± 
1.8 fmol/ug protein, n=16, in normocapnia 
and 19.9 ±2,5 fmol/ug protein, n=8 in 
hypercapnia). In normocapnia the ACs 
were partially blocked by MDL-12,330A 
and KH7 (66.7 ±5.9%, n=7, Fig.5). We 
have used a higher concentration of MDL 
(1000µM) but no significant differences on 
cAMP levels were obtained in the presence 
of either 500 or 1000µM (p=0.7). In 
hypercapnia, MDL-12,330A apparently did 
not affect cAMP production and KH7 
inhibited cAMP production in the same 
magnitude between normocapnia and 
hypercapnia (p=0.5, paired t test, Fig.5). 
These results suggest that both tmAC and 
sAC are partially active in the LC in 
normocapnia but in hypercapnia, tmAC 
may not be functional.  
 
Effect of tmAC on the regulation of sAC 
gene expression  
         We have shown above that changes 
from 0 mM HCO3-/0%CO2 to 24 mM HCO3-
/5%CO2 up regulated sAC in LC. Here, we 
investigated whether cAMP produced by 
tmAC contributes to the regulation of sAC 
gene expression. We had previously 
observed that FSK up-regulated sAC gene 
expression by 144% in the CB (Nunes et 
al, in submission).  
        In the present work, we observed that 
in normocapnic conditions, FSK (100 µM) 
increased sAC gene expression in LC 
(n=9) by 57 %, respectively, but not in 
cortex (n=5, Fig.6) supporting that sAC 
expression is dependent on tmAC activity.  
 
Discussion 
The present results demonstrate for the 
first time that soluble AC is expressed in 
some CO2 central chemoreceptors and 
cortex. sAC mRNA was up-regulated with 
changes in HCO3/CO2 from 0mM/0% to 
24mM/5% in the LC. In this tissue 
increases from 0%CO2 to normocapnic 
conditions induced an increase in cAMP 
accumulation but no further increases were 































Figure 6 - Effect of foskolin (FSK) on sAC gene expression in locus coeruleus (LC) and cortex.  
Paired t-test * p<0.05. 
 
Our data, together with previous 
results obtained in the CB (Nunes et al, in 
submission), suggest that sAC plays a 
similar role in LC (central) and CB 
(peripheral chemoreceptors), and thus, it 
seems not relevant in the response to 
isohydric hypercapnia. 
The central chemoreceptors are found in 
many regions of the brainstem (VLM, LC, 
raphe, retrotrapezoid nucleus, 
PreBotzinger complex, and nucleus tractos 
solitarius (for a review see (Nattie, 1999)) 
but their specific location and cellular 
identity is controversial. Although the 
present work includes results in LC, VLM 
and RN regions we deeply explored the 
LC. 
Evidences in literature suggest 
that VLM and RN could be more sensitive 
to pH and LC to CO2, since direct CO2 
activation of central neurons through 
calcium channels has been shown only for 
LC (Filosa and Putnam, 2003). The 
experimental conditions of the present 
work were aimed to particularly investigate 
CO2 sensitivity.   
           The CO2 chemosensitivity of these 
tissues differ with age, which may affect 
sAC and tmAC function. In our model we 
used animals at the age of 16-17 days old. 
LC CO2 chemosensitivity appears to be 
well developed at birth but in RN it 
increases with postnatal development until 
the second week of life, in parallel with the 
hypercapnic ventilatory response in vivo 
(Stunden et al., 2001, Wang and 
Richerson, 1999). There is no direct link for 
CO2 maturation in VLM.  
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In the CB it has been suggested that CO2 
and O2 sensitivity increases during the first 
2 weeks after birth in the rat (Kholwadwala 
and Donnelly, 1992, Abu-Shaweesh et al., 
1999). Thus, the differences in sAC 
expression and function observed between 
the CB and central regions are not likely to 
be due to differences in chemoreceptor 
maturation.  
Characterization of tmAC 
isoforms in LC showed differences 
between LC and the CB. AC1 and AC8 
have been demonstrated in the LC 
(Zachariou et al., 2008), a tissue with 
predominance of 1 and 2 
adrenoreceptors. Although we have 
identified AC1 and AC8 mRNA in the LC, 
the most abundant mRNA isoform in the 
LC was AC2. The information available in 
literature is not sufficient to allow a 
correlation between AC mRNA profiles and 
specific G-proteins and consequently 
specific G-coupled receptors.  
The interpretation of our data is 
limited by several factors that deserve 
discussion. First, high levels of sAC mRNA 
expression in the CB did not distinguish 
between the two sAC isoforms, truncated 
and full length, thus we are not able to 
identify if the increases in sAC gene 
expression correspond to the truncated 
active isoform. Second, to distinguish 
between tmAC and sAC we used MDL-
12,330A, a tmAC inhibitor and KH7, a sAC 
inhibitor. We had recently reported that 
MDL-12,330A may not be a good 
pharmacological tool to distinguish 
between these two enzymes, since cross 
reactivity was observed in the CB (Nunes 
et al, in submission).  Although we do not 
exclude cross reactivity, the effect of these 
inhibitors was additive in normocapnia and 
hypercapnia. However, more experiments 
should be performed using more selective 
inhibitors. Third, we only studied the effects 
of these inhibitors after 30 min of 
incubation, excluding acute effects of these 
enzymes. However, we had previously 
observed in the CB that the relative 
contribution of tmAC and sAC is the same 
at 5 or 30 min of incubation (Nunes et al, in 
submission).   
Moreover, the effects of MDL-
12,330A on the cAMP production induced 
by FSK suggested the presence of 
adrenoreceptors negatively coupled to 
tmAC. Future experiments looking at the 
expression of these receptors should be 
considered. 
In conclusion, we have shown 
that sAC and tmAC are ubiquitously 
expressed in central chemoreceptors, and 
are not relevant to the CO2 sensing 
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Summary of findings  
 
     The work presented in this dissertation was aimed to establish how specific is 
cAMP-signaling pathways in the CB mainly in different CO2 conditions and how O2 
concentrations alter/drives the manipulation of cAMP signaling in the CB. The 
experimental studies included in this thesis sought to investigate the role of cAMP 
in the rat CB chemotransduction mechanisms and to determine whether the 
enzymes that participate in cAMP signal transduction in the CB are regulated by 
O2/CO2. We characterized the enzymes involved in the cAMP-signaling pathway 
in the CB (sAC, tmAC, PDE) under different O2/CO2 conditions. Our results 
demonstrated that many of these enzymes are involved in CO2/O2 sensing and 
while they may be useful in treating conditions with alterations in CO2/O2 sensing,  
they will not be specific to chemoreception within the CB: 1) PDE4 is ubiquitously 
expressed in CB and non-chemoreceptor related tissues and their affinity to 
inhibitors change with O2 tensions in both CB and carotid arteries, and 2) sAC and 
tmAC are expressed in peripheral and central chemo- and non-chemoreceptor 
tissues and their effect on cAMP levels do not change between normocapnic and 
isohydric hypercapnic conditions. Our results provide evidence against a specific 
role of cAMP as a mediator for O2 and CO2 chemotransduction in the rat CB and 
emphasized the role of pH in CO2 sensitivity of the CB. Furthermore, our results 
demonstrate that cAMP levels are maintained higher under physiological 
conditions, supporting recent finding from our lab, which all together suggests that 
cAMP has a homeostatic function in this organ.  
 
     First of all, using a pharmacological approach, we characterized PDE4 in the 
CB and non-chemoreceptor related tissues (chapter 1 and 2). PDEs are important 
in the regulation of cAMP levels and have been considered good therapeutic 
targets. According to the basic pharmacological principle, the regulation of 
degradation of a second messenger can often make a faster and larger 
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percentage change in concentration than comparable rates of synthesis (Bender 
and Beavo, 2006). Also, the PDE inhibitors compete effectively with the low 
concentration of cAMP in the cells (in microMolar range) and up to 50 different 
PDE isoforms with different regulation and inhibition properties (Bender and 
Beavor, 2006) are available. The results obtained demonstrate that, although 
PDE4 is apparently a good therapeutic target in the CB, its activity is non-specific 
for this tissue and hypoxia changed the affinity of the inhibitors to this enzyme.  
Specifically hypoxia potentiated the effects of PDE inhibitors on cAMP levels in 
the CB and carotid arteries and decreased in superior cervical ganglia. These 
findings should be considered when these inhibitors are used clinically and 
suggest that the effects of PDE inhibitors should be more intense in situations of 
acute hypoxia. Also, because of the lack of tissue-specificity, the vasodilation 
caused by PDE4 inhibitors can decrease the CB activity and compensate for the 
CB-mediated hyperventilatory response induced by the release of 
neurotransmitters in response to increases in cAMP. Moreover, the lack of tissue-
specificity suggests that PDE regulation/affinity by O2 tension is not apparently a 
specific characteristic of chemoreceptor tissues.  
     We also observed a differential pattern of PDE regulation within the cell bodies 
of superior cervical ganglion neurons. This finding suggests that each of these 
different subpopulations of superior cervical ganglion (or SCG) neurons may 
innervate different targets. For instance, the subpopulation with high PDE3 activity 
(high PKA activity induced by PDE3 inhibitors) could project to the heart, since 
PDE3 is the isoform more highly expressed in this organ (Lakics et al., 2010). 
SCG is a sympathetic organ that pos-synaptically modulates type I cell activity. 
Thus our findings may also suggest that a specific supopulation of SCG neurons 
may synapse with type I cells that have a similar PDE profile.  
     Next, we characterized the cAMP synthesis pathway in the CB (chapter 3), 
specifically focusing on soluble adenylyl cyclase, a novel adenylyl cyclase that is 
activated by HCO3-/CO2. Since CB is also sensitive to changes in CO2, we 






























dependent on HCO3- and thus, cAMP could mediate hypercapnia transduction. 
Furthermore, we also characterize the 9 tmAC isoforms and compared the relative 
contribution of both sAC and tmAC to the cAMP accumulation at different 
concentrations of CO2. We observed that sAC and tmAC expression and function 
were not specific to the CB but these enzymes were also expressed in central 
chemoreceptors and non-chemoreceptors and high CO2 levels (isohydric 
hypercapnic conditions) did not change the cAMP levels produced by these 
enzymes. These results suggested that these enzymes are not good/specific 
therapeutic targets under isohydric hypercapnia, however they may be important 
in hypocapnic conditions (respiratory alkalosis; hypocapnia is common in several 
diseases: early asthma, high altitute pulmonary edema, lung injury, for a review 
Curley et al 2010).  
     We determined the role of CO2 chemosensing in the carotid body at a constant 
pH. Although we are aware that changes in PCO2 are routinely accompanied by 
changes in pH in vivo, this approach allowed us to delineate the role of PCO2 from 
pH in carotid body sensitivity; our data supports that the CB is not directly 
sensitive to CO2 but is to changes in pH.  
 
How our results integrate with what has previously been published   
  
     One of the goals of this work was to investigate the role of cAMP as a specific 
mediator of chemotransduction in the rat CB. As mentioned in the Introduction, 
changes in pH are important for CB chemosensitivity, through a mechanism that 
involves inhibition of K+ channels with consequent cell depolarization, activation of 
Ca2+ channels, and increase of intracellular Ca2+ and release of neurotransmitters. 
It has also been demonstrated that molecular CO2, independent of its effects on 
pH, activates L-type Ca2+ channels through PKA activation (Summers et al. 2002). 
As a consequence of increases in CO2/pH, cAMP levels in the CB increase 
(Perez-Garcia et al., 1990, Summers et al., 2002). One of our questions was to 
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understand the mechanism by which cAMP increases. Both pH and molecular 
CO2 induce increases in intracellular Ca2+ and release of neurotransmitters that 
bind to GPCR coupled- tmACs, modifying cAMP levels in the CB. Furthermore, 
molecular CO2 can also be converted into intracellular HCO3- through the activity 
of carbonic anhydrase, activating sAC, an enzyme that has never been 
characterized in the CB. Here, we characterized for the first time the expression of 
sAC and the nine tmAC isoforms in peripheral and central chemo- and non- 
chemoreceptors. These enzymes were ubiquitously expressed in all the tissues 
studied, however, their levels of expression varied between each tissue. In 
contrast to the findings of others who observed that changes in cAMP levels were 
induced by increases in CO2 (Summers et al., 2002, Perez-Garcia et al., 1990), we 
observed that increases in HCO3-/CO2 from 24mM HCO3/5%CO2 (normocapnia) to 
44mM HCO3/10%CO2 (isohydric hypercapnia) did not change cAMP levels nor 
PKA activity, in the presence or absence of tmAC and sAC inhbitors. Besides 
species-related differences, the dissimilarities between these works and ours 
suggest that increases in cAMP levels, in hypercapnia, only occur in the presence 
of an acidic stimulus. We confirmed this supposition by showing that CSN 
discharge increases in response to hypercapnia acidosis, but not to isohydric 
hypercapnia, through a mechanism mediated by cAMP. In agreement with our 
findings, Buckler’s et al (Buckler et al, 1991) showed that changes in PCO2 at 
constant extracellular pH caused rapid transient changes in intracellular pH in the 
CB that was not correlated with sustained activation of the glomus cell. However, 
acidosis (changing PCO2 at constant HCO3-) caused a sustained increase in CB 
activity (Buckler et al, 1991).   
    Taken together, we propose that the mechanism for hypercapnia sensing in the 
CB depends on the enzymatic conversion of CO2 into H+, thereby inhibiting the K+ 
channels which leads to depolarization, increase in calcium entry and consequent 
release of neurotransmitters that bind to GPCR and modulate cAMP levels. Since 
tmAC inhibitors seem to cause a greater reduction in cAMP levels than sAC 






























suggests that tmAC contributes more to cAMP levels than sAC. Also, we can not 
exclude the hypothesis that molecular CO2 can regulate tmAC. In fact, it has been 
recently described that in mammalian recombinant G-protein-activated adenylyl 
cyclase and in the related Rv1625c adenylyl cyclase of Mycobacterium 
tuberculosis, CO2 increases the affinity of the enzyme for the metal co-factors, 
suggesting that while sAC is responsive to HCO3-, and consequently CO2, G-
protein-regulated tmAC are responsive to CO2 (Townsend et al., 2009). 
Furthermore, molecular CO2 increases steady state cytoplasmatic Ca2+ 
concentrations via IP3 receptor signaling leading to low cAMP levels (Cook et al., 
2012). It is unclear how CO2 causes Ca2+ release through IP3 receptor signaling 
and how elevated intracellular Ca2+ levels reduce cAMP levels. Either CO2 direclty 
interacts with adenylyl cyclase or there is an alternative signaling pathway which 
impacts on cAMP levels. The identification of such CO2 target could be relevant 
for the chemotrasduction mechanism of the carotid body.  
       Mammals have multiple CO2 sensory systems including the peripheral and 
central chemoreceptors. Understanding molecular mechanisms for CO2 
chemoreception in the different cells increases fundamental knowledge of a 
process that is essential in health and disease. For example, Chandrashekar et al. 
(2009) identified carbonic anhydrase 4 (CAH4) as a CO2 receptor in the taste 
cells. CAH4 is anchored at the surface of gustatory cells in the mammalian 
tongue, where it produces protons that may acidify the immediate extracellular 
environment. The amygdala has been considered as a chemosensor that detects 
CO2 and acidosis to elicit fear behavior throught the acid-sensing ion channel 
(ASIC) 1a (Ziemann et al., 2009). Also, TRPA1, by sensing intracellular 
acidification, constitutes an important component of the nociceptive response to 
CO2 (Wang et al., 2010). Futhermore, increases in CO2 suppress genes involved 
in the regulation of innate immunity and inflammation, through decrease of NF-kB 
family of transcriptors factors activity (for a review Taylor and Cummins, 2011). 
The signaling cascade proposed for CO2 detection by the olfactory system 
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involves soluble CAH II activation with production of HCO3- that activates guanylyl 
cyclases. The consequent increases in cGMP lead to CNG channel opening and 
causing cell depolarization (Luo et al., 2009). The mechanisms by which CO2 is 
detected in other systems may contribute for the to our understanding of CO2 
chemotransduction mechanism in the CB.  
     We also observed that sAC and tmAC had a particularly compensatory role to 
return cAMP levels to the “homeostatic set point”: tmAC and sAC inhibitors were 
more efficient under 12-24 mM HCO3-/2.5-5% CO2 in the presence of a PDE 
inhibitor. Situations of low CO2 (hypocapnia) may activate Na+- Cl+/HCO3- 
exchanger and Na+-HCO3- co-transport resulting in the increase of intracellular 
HCO3- that directly activates sAC. In rat hippocampal slices, HCO3- is needed for 
the recovery of synaptic transmission from anoxia, an effect independent of the 
effects of HCO3- on pHi or pHo (Roberts et al., 2000). HCO3- levels can be 
modified by glutamate uptake transporter in astrocytes (Judd et al., 1996), a 
mechanism that seems to be dependent in the ability of HCO3- to reduce free 
radical production by promoting the binding of iron to transferrin (Katsura et al., 
1994). HCO3- levels can be also modified by the activation of GABAA receptors, 
resulting in an efflux of HCO3- (selectivity for HCO3-/Cl- of 1:5) (Kaila et al., 1993). 
Our results also suggest that sAC may regulate tmAC activity until cAMP reaches 
a maximal level, which corresponds to levels measured under physiological 
conditions (normocapnia conditions).  
 
 Higher levels of cAMP can occure during normoxia as reported by 
Monteiro et al. (2011). Monteiro and co-workers (Monteiro et al., 2011) report that 
in the rat CB, the highest levels of cAMP occur during normoxia when compared 
to hyperoxia 95-100%O2. We found that cAMP levels obtained from whole CB 
from rat during hypoxia are in agreement with the ones obtained by Monteiro et al 
(2011). In both works, absolute cAMP values obtained in the presence of IBMX, 
did not change significantly between hypoxic and normoxic conditions, with a 






























al. (2011). We attribute this slight difference to the way the cAMP levels were 
normalized: we normalized the levels of cAMP per weight of each CB, while in 
Monteiro et al.  (Monteiro et al., 2011), all the levels of cAMP were normalized per 
the same mean value of CB weight. 
 The effect of different oxygen tension on cAMP levels in the rat CB 
differs from what has been reported for the rabbit and cat CB, where the highest 
levels of cAMP were observed in hypoxia (0-10%O2) (Wang et al., 1989, Perez-
Garcia et al., 1990, Chen et al., 1997, Delpiano and Acker, 1991, Cachero et al., 
1996, Delpiano and Acker, 1984, see also table 5 and table 1 in attachement). 
These data imply that differences may be species-related. The release of 
catecholamines during hypoxia is greater in rat than in rabbit CB (Vicario et al., 
2000, Fidone et al., 1982). Since dopamine binds to D2 receptors, which are 
negatively coupled to adenylyl cyclase, cAMP levels are then expected to be 
lower in rat CB.  
 The higher levels of cAMP in physiological (normoxic) conditions in the 
CB support a homeostatic and adaptator role for this second messenger in this 
organ. In fact, in the CB, cAMP induces a variety of cellular and molecular effects 
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Table 1 - Effects of cAMP in the carotid body  
Effects of cAMP Preparation Technique Agents that 
increase cAMP 
Reference 
Short and long term regulation of 
rat CB gap junctions:  
-modulation of junctional 
conductance, increased electrical 
coupling and enhanced gap 
junction formation 









Regulation of TH gene expression 
Whole CB from 
adult rats 
RT-PCR 
FSK (10uM), 3 hrs, 
in hypoxia (10%O2 
vs control 100%O2) 
Chen et al, 
1995 
Do not inhibit K+ currents and Ca2+ 
currents were not altered 
Type I cells 










(50uM), all in the 
presence of IBMX 
Hatton and 
Peers, 1996 
Activates Cl- currents 









Long term modulation/regulation 
of currents- increase in Na+ and 
Ca2+ inward currents and 
capacitance 
Type I cells 




(0.2-1 mM) and FSK 
(10uM),  
9-14 days 
Steal et al, 
1995 
Induce Na+ channels and causes 
hypertrophy of type I cells  
Type I cells of 







Stea et al, 
1992 
Inactivate K+ channels 
Do not modify Ca2+ currents 









Potentiates (30%O2 in N2)-evoked 
CA release and CSN discharge 
(versus no effect of FSK on CSN 
under 100%O2) 









Wang et al, 
1991 
Increases hypoxia (5%O2/95%N2)-
evoked release of DA (control 
100%O2) 
Whole adult 












cAMP mimick the effect of acidic 
hypercapnia (20%O2/10%CO2) on 
Ca 2+ currents 
 
Type I cells of 




for 10 min 
Summers et 
al, 2002 
Increases GAP-43 expression, 
stimulated neurofilament 
expression and neurite outgrowth 
Type I cells 











































 As observed from the table 1: 1) cAMP is potentially involved, but it is not 
essential in the transduction mechanism to acute hypoxia (Wang et al., 1991, Perez-
Garcia et al., 1991); 2) cAMP is involved in long-term adaptative changes to chronic 
hypoxia (Jackson and Nurse, 1995, Abudara and Eyzaguirre, 1998); 3) the role of cAMP in 
the transduction mechanism may be different between the rat and rabbit CB: in rabbit, the 
administration of agents that increase cAMP levels potentiated or mimicked the effects 
mediated by acute hypoxia, as an example, inihibition of  K+ channels (Lopez-Lopez et al., 
1993) while in rat, cAMP levels did not inhibit K+ currents (Hatton and Peers, 1996). 
 The role of cAMP in the homeostasis/basal activity of the CB may be involved in 
the mantainance of a basal activity of the CB (translated in basal release of 
neurotransmitters or basal CSN electrival activity), which is important to mantain resting 
ventilation since CB resection or CSN denervation affects leading to hypoventilation  
(Bisgard et al. 1976, Bisgard and Vogel 1871, Eugenin et al. 1989).  
  
 In conclusion, our work is the first to characterize: 1) the expression and function 
of sAC in the CB and central chemoreceptors; 2) 9 tmAC isoforms in the CB, and 3) PDE4 
in the CB. Thus, our work provides new insights concerning the role of cAMP signaling 
pathway in the CB, how adenylyl cyclases and phosphodiesterases are regulated by 
O2/CO2.  Current therapeutics are known to modify cAMP levels via modification of these 
two enzyme systems; our novel findings provides a better understanding of how these 
agents could potentially change carotid body function depending on the level of  
PaO2/CO2. Furthermore, new therapeutic agents may be developed targeting ,these 
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Limitations and future experiments 
 
The conclusions of this work are limited by several factors that deserve 
discussion and open up new doors for future research to better understand the 
transduction mechanism of the carotid body.    
 In this work we used pharmacological, molecular biological and physiology tools 
to study the effect of changes in O2/CO2 in the activity of the enzymes involved in the 
cAMP-signaling pathway: the adenylyl cyclases and phosphodiesterases. The 
characterization of these enzymes was performed through gene expression and the 
pharmacological effect of specific inhibitors and activators of these enzymes on cAMP 
accumulation. One of the limitations of this work was the lack of a biochemistry approach 
to study whether changes in O2 and CO2 could directly affect the activity and affinity of 
PDE and AC.   
 We characterize for the first time the mRNA expression of the nine tmAC 
isoforms, however we were not able to determine if gene expression correlated with 
protein since we were limited by the lack of specific pharmacological tools for each 
isoform. However, since the CB releases a variety of different neurotransmitters, which 
can bind to pre-synaptic receptors in type I cells, it would be clinically relevant to further 
investigate which AC isoforms are related with the specific metabotropic receptors 
identified in the CB. It has been shown for instance, that in mouse airway smooth muscle 
cells, beta adrenergic receptors couple with AC5/6 in lipid rafts/caveolae, while 
prostanglandine E2 receptors couple with AC2 in non-raft membranes (Bogard et al, 
2012). As far as we are aware of, there is no data in literature that relates GPCR and AC 
couple in the carotid body, but with the development of more specific AC pharmacological 
tools (activators and inhibitors), and use of the available KO for the specific tmAC isoforms 
(for a review  (Pierre et al., 2009)), it will be possible to better manipulate cAMP signaling 
in a clinical perspective. For example, AC5, AC6 and AC9 have been characterized in 
human airway smooth muscle cells and their activation has been proposed as potential 
drug targets for asthma treatment  (Billington et al., 1999).  
In this work, levels of cAMP were quantified in the whole CB through EIA 
assays. These assays require tissue homogenization and the cAMP levels determined 






























between type I cells (the sensor) and other constituintes of the CB. It is known that whithin 
the cell, cAMP levels change in microdomains regulated by specific cAMP-effectors, and 
those changes are not measurable when looked at the intact organ. Assays like EIA are 
static and terminal, limiting the ability to perform time series experiments. Also to detect 
cAMP levels with these assays it is necessary to bring cAMP changes whithin the assay 
detection level, which is done using PDE inhibitors. However, there is a clear dynamic role 
of PDEs controling cAMP levels, and inhibition of these enzymes may provide an 
inaccurate depiction of the in vivo conditions. FRET techniques allow overcoming some of 
these limitations: it studies cellular location and temporal organization of cAMP signaling. 
Since it is possible to add a cellular targeting sequence to the FRET sensor, this technique 
allows studying the signaling pathway in specific compartiments such as nucleus, 
mitocondrias, and reticulo. In this work we used this novel approach to confirm that the 
effect observed by HCO3-/CO2 in whole CB was specific of type I cells, However, this 
technique opens up new doors of research in this organ.   
 In our experiments we considered the activity of PKA in the cAMP-signaling of 
the CB. However, we can not discard the contribution of other effectors for the cAMP-
signaling, such as EPAC. Although a cAMP-EPAC pathway has been more associated 
with the O2 sensing pathway in the CB (Rocher et al, 2009), it would be interesting to 
explore if the transduction of O2 and CO2 are mediated by the same enzymes or if PKA is 
more specific for a CO2 transduction mechanism.  
 Concerning CO2 sensing, it would also be interesting to study the effect of HCO3-
/CO2 in carbonic anhydrases, gap junctions and type II cells (and glial cells). 
Intracellular calcium is a second messenger that highly influences cAMP 
signaling pathway. Evidence shows a role of [Ca2+]i in the chemotransduction of both 
hypoxic and hyperoxic stimuli in type I cells (Biscoe and Duchen, 1990; Rigual et al, 1991). 
It is also known that [Ca2+]I and intracellular pH interact in these cells (Buckler et al, 1991). 
Activation of ionotropic receptors induce a rapid increase of [Ca2+]i. Of particular interest, 
increase of ATP release from the CB induces increases of [Ca2+]i in the PG neurons 
(Nunes et al, 2012), which can induce the activation of NTS neurons.  I hypothesize that 
intracellular calcium could be the second messenger that mediates the O2/CO2 sensing, 
while cAMP would be more relevant as an adaptor for chronic conditions in the CB. Thus, 
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it would be interesting to better investigate the regulation of these two second 
messengers.  
        It is unknown if the different patterns of PDE expression/regulation that were 
observed in the SCG, also occur in the CB. It also remains to be explored if the different 
patterns of PDEs could be responsible for functional synapses between specific 
subpopulations of type I cells of the CB with nTS and petrosal ganglia.  
          Lastely, our results provide new insights to explain the efficacy of PDE inhibitors 
(PDE related drugs) in certain hypoxia related conditions such as pulmonary hypertension 



































































O corpo carotídeo (CB) é um pequeno órgão sensível a variações na 
PaO2, PaCO2 e pH. As células tipo I (células glómicas) do corpo carotídeo, as 
unidades sensoriais deste órgão, libertam neurotransmissores em resposta às 
variações dos gases arteriais. Estes neurotransmissores atuam quer em 
recetores pré-sinápticos, localizados nas células tipo I, quer em recetores pós-
sinápticos, localizados nas terminações do nervo do seio carotídeo, ou em 
ambos. A activação dos recetores pré-sinápticos modula a atividade do corpo 
carotídeo, enquanto que, a activação dos recetores pós-sinápticos, de carater 
excitatório, desencadeia um aumento da frequência de descarga das fibras do 
CSN, com subsequente despolarização dos neurónios do gânglio petroso, e 
posterior despolarização de um grupo específico de neurónios do centro 
respiratório central, desencadeando, como resposta final, hiperventilação. Estes 
recetores pré- e pós-sinápticos podem ser classificados em ionotrópicos ou 
metabotrópicos, estando os últimos acoplados a adenilatos ciclases 
transmembranares (tmAC). O mecanismo exato pelo qual as variações dos gases 
arteriais são detetadas pelo CB não se encontra ainda completamente elucidado, 
mas tem sido sugerido que alterações nos níveis de cAMP estejam associadas 
ao mecanismo de deteção de variações de O2 e CO2. Os níveis de cAMP podem 
ser regulados através da sua via de síntese, mediada por dois tipos de adenilatos 
ciclases: tmAC sensível aos neurotransmissores e adenilato ciclase solúvel (sAC) 
sensível a variações de HCO3/CO2, e pela sua via de degradação mediada por 
fosfodiesterases. A via de degradação do cAMP pode ser manipulada 
farmacologicamente, funcionando enquanto alvo terapêutico para o tratamento de 
patologias do foro respiratório (e.g. asma, hipertensão pulmonar, doença 
pulmonar obstructiva crónica e apneia do sono), que induzem um aumento da 
actividade do CB.  
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 O trabalho descrito nesta dissertação partiu da hipótese de que a 
actividade do CB é manipulada por fármacos, que interferem com a via de 
sinalização do cAMP, tendo sido nosso objectivo geral, investigar o papel do 
cAMP na quimiotransdução do CB de rato, e determinar se a actividade dos 
enzimas responsáveis pela via de sinalização do cAMP é ou não regulada por 
variações de O2/CO2.  Assim, a relevância deste trabalho é a de estudar e 
identificar possíveis alvos moleculares (sAC, isoformas de tmAC e PDE) com 
potencial para serem usados no tratamento de patologias relacionadas com o 
controlo respiratório. 
A primeira parte do presente trabalho, centrou-se na caracterização 
farmacológica da PDE4 no CB e em tecidos não quimiorecetores (e.g. gânglio 
cervical superior e artérias carótidas), e na observação do efeito de hipóxia aguda 
na acumulação dos níveis de cAMP, induzidos pelos inibidores de PDE, nestes 
tecidos. A quantificação de cAMP foi efectuada por técnica imunoenzimática 
(EIA), tendo sido elaboradas curvas de dose-resposta para os efeitos de 
inibidores, não específicos (IBMX) e específicos para a PDE2 e PDE4 (EHNA, 
Rolipram e Ro 20-1724), nos níveis de cAMP acumulados, em situações de 
normóxia (20%O2/5%CO2) e hipóxia (5%O2/5%CO2). A caracterização das PDE 
no gânglio cervical superior foi aprofundada, utilizando-se a técnica de 
transferência de energia de ressonância por fluorescência (FRET) em culturas 
primárias de neurónios, na presença de inibidores não específicos (IBMX) e 
específicos para a PDE3 e PDE4 (milrinone e rolipram, respetivamente). Foram 
igualmente estudadas, através de RT-qPCR, as alterações na expressão de 
PDE3A-B e PDE4A-D, no gânglio cervical superior, em resposta a diferentes 
percentagens de oxigénio.  
Na segunda parte do trabalho investigou-se a via de síntese do cAMP no 
CB em resposta a variações na concentração de HCO3/CO2. Em concreto, o 
protocolo experimental centrou-se na caracterização da sAC, dado que a sua 
actividade é regulada por variações de HCO3/CO2. A caracterização da expressão 

































e em tecidos não quimioreceptores periféricos (e.g. gânglio cervical superior, 
petroso e nodoso) por qRT-PCR. A actividade deste enzima foi caracterizada 
indirectamente através da quantificação dos níveis de cAMP (quantificação por 
EIA), induzidos por diferentes concentrações de HCO3/CO2, na presença de MDL-
12,33-A, um inibidore da tmAC. A expressão das isoformas da tmAC no CB e 
gânglio petroso foi determinada por RT-qPCR. Adicionalmente, estudámos a 
contribuição relativa da tmAC e sAC no mecanismo de sensibilidade ao CO2 no 
CB. Para o efeito foram estudadas as alterações: 1)  nos níveis de cAMP 
(quantificado por EIA) na presença de diferentes concentrações de HCO3/CO2 e 
ao longo do tempo (5-30 min); 2) na ativação da proteína cinase A (PKA, FRET 
baseado em sensores) em células tipo I do CB; e 3) na frequência de descarga 
do CSN (registos) na presença e ausência de ativadores e inibidores da sAC, 
tmAC e PKA.  Por último, foi caracterizada a expressão e actividade da sAC nos 
quimioreceptors centrais (locus ceruleus, rafe e medula ventro-lateral) através de 
técnicas de RT-qPCR e EIA. A expressão das isoformas da tmAC foi aprofundada 
no locus coeruleus através de RT-qPCR. Por fim, comparámos a contribuição da 
tmAC e sAC nos níveis de cAMP no locus coeruleus em condições de 
normocapnia e hipercapnia.  
O nosso trabalho teve os seguintes resultados principais: 1) PDE4 está 
funcional no corpo carotídeo, artérias carótidas e gânglio cervical superior de rato, 
embora a PDE2 só se encontre funcional neste último; 2) Os efeitos dos 
inibidores de PDE nos níveis de acumulação de cAMP foram exacerbados em 
situações de hipóxia aguda no CB e artérias carótidas, mas foram atenuados no 
gânglio cervical superior; 3) No gânglio cervical superior, diferentes tipos de 
células apresentaram uma caracterização específica de PDEs, sugerindo uma 
subpopulação de células neste gânglio com funções fisiológicas distintas; 4) 
Embora todas as isoformas de PDE4 e PDE3 estivessem presentes no gânglio, a 
PDE3a, PDE4b e a PDE4d foram as isoformas mais expressas. Por outro lado, 
incubações de gânglio cervical superior, em diferentes percentagens de oxigénio, 
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não alteraram (não regularam) significativamente a expressão das diferentes 
isoformas de PDE neste órgão; 5)  a sAC encontra-se expressa e funcional no CB 
e nos quimiorecetores centrais estudados (locus coeruleus, rafe e medula 
ventrolateral). A sAC apresenta maior expressão no CB comparativamente aos 
restantes orgãos estudados, exceptuando os testículos, orgão controlo. Variações 
de HCO3/CO2 de 0/0 para 24/5 aumentaram os níveis de cAMP no CB e 
quimiorecetores centrais, tendo sido o aumento mais significativo observado no 
CB.  Concentrações acima dos 24mM HCO3/5%CO2 não induziram alterações 
nos níveis de cAMP, sugerindo que a actividade da sAC se encontra saturada em 
condições fisiológicas (normocapnia) e que este enzima não desempenha 
qualquer papel na deteção de situações de hipercapnia; 6) No CB, a expressão 
das isoformas tmAC1, tmAC4, tmAC6 e tmAC9 é mais elevada 
comparativamente à expressão da sAC; 7) Utilizamos diferentes inibidores da 
tmAC (MDL 12-330A, 500µM, 2’5’-ddADO, 30-300µM, SQ 22536, 200µM) e da 
sAC (KH7, 10-100µM) para estudar a contribuição relativa destes enzimas na 
acumulação do cAMP no CB. Tanto a tmAC como a sAC contribuem para a 
acumulação dos níveis de cAMP em condições de hipercapnia. Contudo, existe 
um maior efeito destes inibidores nas condições de 12 mM HCO3/2.5%CO2 do 
que em condições de normocapnia e hipercapnia, sugerindo um papel relevante 
destes enzimas na atividade do CB em situações de hipocapnia; 8) Não se 
observaram variações nos níveis de cAMP em resposta a diferentes 
concentrações de HCO3/CO2 ao longo do tempo (5-30 min). O efeito inibitório 
induzido por ddADO e KH7 foi sobreponível após 5 ou 30 minutos de incubação 
em todas as concentrações de HCO3/CO2 estudadas;  9) Por último, verificou-se 
um aumento na frequência da descarga do nervo do seio carotídeo entre as 
condições de normocapnia e hipercapnia acídica. Ao contrário do KH7 (10µM), o 
2’5’-ddADO reduziu significativamente a frequência de descarga do nervo, quer 
em condições de normocapnia quer de hipercapnia acídica. Contudo, não se 
verificou aumento na frequência de descarga do nervo entre normocapnia e 

































mediada por variações de pH.  
Em conclusão, os resultados decorrentes deste trabalho permitiram 
demonstrar que, embora os enzimas que medeiam a via de sinalização do cAMP 
possam ser bons alvos terapêuticos em condições particulares,  a sua actividade 
não é específica para o CB. Os resultados sugerem ainda que o cAMP não é um 
mediador específico da transdução à hipercapnia neste orgão. Contudo, os 
nossos resultados demonstraram que os níveis de cAMP são mais elevados em 
condições fisiológicas, o que sugere que o cAMP possa ter uma função 
homeostática neste orgão.  Por último, o presente trabalho demonstrou que os 
aumentos de cAMP descritos por outros em condições de hipercapnia, não são 







































































































































































Brain (hippocampus, dentate 
gyrus, cerebellum, córtex, 
thalamus), retina, adrenal 






















Olfactory neurons, brain, heart, 







Kidney, brain, liver, heart, lung, 
brown tissue,  










Brain (striatum, brainstem, 
prefrontral córtex), heart, spinal 
cord, heart, lung, testes, brown 















Heart, brain,kidney,testis, liver, 
spinal cord, lung, testes, brown 
tissue, muscle, adrenal gland 
+ 
Acute or chronic 








Lung, heart, sleen, kidney, brain, 
testes, liver, muscle,  









hypothalamus), spinal cord, 
heart, lungs,testes, brown 










Scheletal muscle, brain, lung, 
liver, spinal cord,heart, kidney, 
adrenal gland 
+   
sAC Ca2+, HCO3- ___ 
Testis, brain, heart, kidney, 
muscle, liver 
+ Sperm capacitation 
AC, adenylate cyclase; FSK, forskolin; CaM, calmoduline; PKC, protein kinase C; Gsα, ; Giα, Gβγ;  Ca2+, 
calcium ion; HCO3-, bicarbonate ion; KO, knockout 










































or IC50) (uM) 
Substract Regulators Expression  
PDE I 
PDE1A Vinpocetine (14) cGMP> cAMP (+)Ca2+/CaM 
(-) PKA, CamKII 
Thyroid, testis, brain 
PDE1B Zaprinast (6 ) cGMP> cAMP Brain, lymphocytes 

































Ro 20-1724/ 6.5 
cAMP 
(+)PKA, ERK, 
phosphatidic acid Lung, immune cells, 
















































PDE7A BRL50481/ 6.7 
cAMP (+/-) PKA 
Brain, lymphocytes, 








PDE9A Zaprinast (35) cGMP unknown kidney 
PDE 
X 













I-sobutyl-1methylxantine (IBMX) is a non-specific PDE inhibitor,  but it is ineffective for inhibition of PDE8 
and PDE9. (+)- positive regulation, (-) negative regulation. (adapted from Francis et al, 2011, 
and Makhlouf et al, 2006). 
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Name Abbrev. Company Function 
Forskolin FSK 
Sigma 
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